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1.1. The role of iron in biological systems 
Of the more than 100 chemical elements known to scientists today, only a 
relatively small number of these elements are found in the human body. In 
fact, only 24 different elements are thought to be essential for humans. The 
largest elemental components of the body, by mass, are oxygen (65%), 
carbon (18%), hydrogen (10%), and nitrogen (3%).1 The other elements in 
the body, such as calcium, phosphorus, iron, copper, and others, are known 
to physiologists as trace elements. Some of this trace elements, which are 
vital to the body's proper functioning, must be present in the proper amounts, 
and  their cellular concentrations must be continuously controls to prevent 
adverse/toxic reactions.  
Metals are involved in a wide range of biochemical processes in all living 
organisms. They are “key” players in different function like: 
 Structural : Zn  
 Lewis catalysis: Zn, Fe, Ni, Mn 
 Electron transfer: Fe, Cu, Mo  
 Group transfer (like: CH3, O, S): V, Fe, Co, Ni, Cu, Mo, W 
 Redox processes: Fe, Cu, Ni, Co, W, V, Mn 
 The use of metals in living organisms is, indeed, important mainly due to 
their redox properties and to the feasibility of metal ion transfer in different 
locations or compartments of the cell. Metalloprotein is a generic term for 
a protein that contains a metal ion cofactor. Indeed, about one quarter to one 
third of all proteins require metals to carry out their functions.2,3,4 The metal 
ion is usually coordinated by nitrogen, oxygen or sulfur atoms and could by 
directly coordinated to amino acids in the polypeptide chain or are present 
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inside a macrocyclic ligand incorporated into the protein. The presence of the 
metal ion inside a protein molecule, change the chemical proprieties of the 
molecules itself, providing functions that cannot easily be performed by only 
amino acids present in the chain. Metalloproteins can bind one or, if is 
necessary, more metals ion to maintain the function and the structure of the 
protein. Also in the word of DNA maintenance/repairs and RNA 
stabilization, metalloproteins are very important for function and structure of 
the genetic material. 5,6 
One of the most abundant essential trace elements in the human body is iron. 
Healthy adults possess from 4 to 6 g of iron, which approximately comprises 
only 0,008% of the body mass (75 kg).7,8 Nevertheless it is necessary for our 
survival. In the human body, we have a lot of proteins that bind iron in a 
different way and we find these metalloproteins with different function. The 
major class of iron-proteins have an electron transfer function, but we can find 
iron-proteins also in transport, catalytic and DNA interaction/maintenance 
function. The bulk of iron is bound to hemoglobin in the red blood corpuscles, 
which is necessary for oxygen transport in the blood. In humans, the 
hemoglobin molecule is an assembly of four globular protein subunits. Each 
subunit is composed of a protein chain tightly associated with a non-protein 
protoporfiniricIX group. This cofactor contain iron as the central atom of the 
heme group, a metal complex that binds molecular oxygen (O2) in the lungs 
and carries it to all the other cells in the body that need oxygen to perform their 
activities (e.g., muscle cells). In addition to hemoglobin, other important 
proteins in the body that contain heme groups (and therefore contain iron) 
include myoglobin, which takes oxygen from hemoglobin and allows the 
oxygen to diffuse throughout the muscle cells, and the cytochromes, that are 
crucial in the electron transfer reaction.7,9 An important class of electron-
transfer proteins utilizes iron–sulfur clusters (Fe-S) as redox centers  (Fig. 1). 
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These proteins are characterized by the presence of iron-sulfur (Fe-S) clusters 
containing sulfide-linked di-, tri-, and tetra-iron centers in variable oxidation 
states. Fe-S clusters are found in a variety of metalloproteins, such as 
the ferredoxins, as well as NADH dehydrogenase, hydrogenases, Coenzyme 
Q - cytochrome c reductase, Succinate - coenzyme Q reductase and 
nitrogenase. (Fe-S) clusters are best known for their role in the oxidation-
reduction reactions of mitochondrial electron transport. Both Complex I and 
Complex II of oxidative phosphorylation have multiple (Fe-S) clusters. They 
have many other functions including catalysis as illustrated by aconitase, 
generation of radicals as illustrated by SAM-dependent enzymes, and as sulfur 
donors in the biosynthesis of lipoic acid and biotin. Additionally some (Fe-S) 
proteins regulate gene expression.  
 
 
Figure 1. Examples of protein cofactors containing iron. From left to right; 
HEME group, [2Fe2S] cluster, [4Fe4S] cluster 
 
Other proteins, such as those needed for DNA repair or DNA replication and 
cell division, also require on iron. Furthermore, iron is used to help to 
produce the connective tissues in our body, some of the neurotransmitters in 
our brain, and to maintain the immune system. Iron (Z=26) is one of the 
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major element on earth and present two different oxidation state with 
different spectroscopical characteristics: 
 Ferric (Fe3+): d5 with electronic state 6S, electronic configuration t2g3 
eg
2, fundamental state in octhaedrical geometry 6A and is a 
paramagnetic ion  
 Ferrous (Fe2+): d6 with electronic state 5D, electronic configuration 
t2g
4 eg
2, fundamental state in octhaedrical geometry 5Tg and is a 
paramagnetic ion  
Iron have generally a coordination number of 4 with tetrahedric geometry, 5 
(heme group without O2) or 6 with octhaedrical geometry. Iron is an 
essential element for metabolic processes intrinsic to life, and yet the 
properties that make iron a necessity also make it potentially deleterious. The 
biological importance of iron is largely attributable to its chemical properties 
as a transition metal. It readily engages in one-electron oxidation-reduction 
reactions between its ferric (Fe3+) and ferrous (Fe2+) states and have a redox 
potential between -300mV and +700mM. However, the same chemical 
property explains why an excess of “free,” reactive iron is toxic. In the 
cytoplasm, a significant fraction of iron(III) is reduced to iron(II) by a 
molecule of hydrogen peroxide, forming a hydroperoxyl radical and a 
proton. Iron(II) is oxidized by hydrogen peroxide to iron(III), forming a 
hydroxyl radical and a hydroxide ion in the process. The net effect is a 
disproportionation of hydrogen peroxide to create two different oxygen-
radical species, with water as a byproduct. 
Fe2+ + H2O2 → Fe3+ + OH· + OH− 
Fe3+ + H2O2 → Fe2+ + OOH· + H+ 
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The ability to change the oxidation state changing of iron Fe3+ in Fe2+  allows 
the iron to be part of the “Fenton-type” redox chemistry; the highly reactive 
hydroxyl radical (OH•) and the hydroperoxyl radical (OOH·) can damage 
lipid membranes, proteins, and nucleic acids inside the cell. To avoid this 
kind of reaction, iron homeostasis is strictly controlled in all the phase from 
iron transport, to storage and regulatory proteins. That allows the cells to use 
the benefits of iron, but also limits its ability to do harm.10,11 
 
1.2. Iron metabolism and its cellular uptake 
The common oxidation state for the iron is the Fe3+; iron uptake is tightly 
regulated by the human body, which has no pathway of iron excretion. Only 
small amounts of iron are lost daily due to mucosal and skin epithelial cell 
sloughing, desquamation of skin and urinary cells, blood loss, or sweat. To 
compensate this loss only about 1-2 mg of dietary iron per day is absorbed 
by duodenal enterocytes. This amount of iron compared to the amount 
ingested is typically low. The efficiency with which iron is absorbed varies 
largely depending on the source. Generally the best absorbed forms of iron 
come from animal products,8,12 we can also absorbed the vegetable iron but 
in a less amount. Like most mineral nutrients, the majority of the iron 
absorbed from digested food or supplements is absorbed in the duodenum by 
enterocytes of the duodenal lining. These cells have special molecules that 
allow them to move iron into the body. To be absorbed, dietary iron can be 
absorbed as part of a protein such as heme protein or iron must be in its 
ferrous Fe2+ form. Iron absorption from diet is enhanced in the presence of 
vitamin C and diminished by excess calcium, zinc, or manganese. A ferric 
reductase enzyme, reduces ferric Fe3+ to Fe2+. A protein called divalent metal 
transporter 1 (DMT1), which can transport several divalent metals across the 
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plasma membrane, then transports iron across the enterocyte’s cell 
membrane into the cell. Iron is released directly into the blood stream by 
ferroportin which is located at the basolateral membrane of duodenal 
enterocytes. It is oxidized to the Fe3+ form and binds to transferrin (Tf). Tf-
2Fe3+ complexes circulate in the plasma, and deliver iron to all the tissues 
(Fig. 2). Most of the iron is incorporated into hemoglobin, in erythroid 
precursors and mature red blood cells (approx. 1800 mg). Approximately 
400 mg is present in the other tissues (in enzymes and cytochromes) and 
muscle fibers (in myoglobin). Liver (parenchymal cells) and 
reticuloendothelial macrophages are responsible for iron storage (approx. 
1600 mg). The macrophages provide most of the usable iron by degrading 
hemoglobin in aged or damaged erythrocytes and reloading ferric iron into 
transferrin for delivery to cells, because the amount of plasma iron is just 
around 10% (approx. 3mg) of the amount used daily, which means that 
plasma iron is turned over many times each day (Fig. 2). 
 
Figure 2. Circulation of iron in human body. 
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Most cell types take up iron primarily through receptor-mediated endocytosis 
via transferrin receptor 1 (TFR1), transferrin receptor 2 (TFR2). Transferrin-
bound ferric iron is recognized by these transferrin receptors, triggering a 
conformational change that causes endocytosis. A proton pump decreases the 
pH within the endosomes, leading to conformational changes in the 
transferin that result in the release of iron into the cytoplasm from the 
endosome via the divalent metal transporter 1 (DMT1) after being reduced to 
its ferrous state by a STEAP family reductase. In the cytoplasm, ferrous iron 
is found in a soluble, chelatable state which constitutes the labile iron pool 
(~0.001 mM). In this pool, iron is thought to be bound to low-mass 
compounds such as peptides, carboxylates and phosphates, although some 
might be in a free, hydrated form (aqua ions). Alternatively, iron ions might 
be conservated in a non-toxic form the ferritin. Iron from this pool can be 
taken up by mitochondria via mitoferrin to synthesize (Fe-S) clusters and 
heme groups (Fig. 3). Meanwhile, transferrin (Apo-Tf) and transferrin 
receptor are recycled to the cell surface, where each can be used for further 
cycles of iron binding and iron uptake.5,10,13 
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Figure 3. Transferrin bound to two iron atoms (Tf-[Fe(III)2) binds to TfR1 on the 
cell surface where the Tf-[Fe(III)2–TfR1 complex is endocytosed. Acidification of 
the endosome causes the release of Fe(III) from Tf where it is reduced to Fe(II) by 
the STEAP3 oxidoreductase before export by DMT1 (divalent metal transporter 1). 
ApoTf/TfR1 complex is returned to the cell surface where it dissociates and initiates 
another round of iron uptake. 
 
Disruptions in iron homeostasis from both iron deficiency and overload 
account for some of the most common human diseases (e.g. hemoglobin and 
iron deficiency anemia or hemochromatosis). That is why cells developed 
mechanisms for sensing their own need of iron. Iron metabolism is 
maintained by two regulatory systems:  
  the first one functions systemically and relies on the hormone 
hepcidin that directly inhibits ferroportin. By inhibiting ferroportin, 
hepcidin prevents enterocytes of the intestine and macrophages of the 
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reticuloendothelial system from secreting iron into the blood stream, 
thereby functionally reducing the iron level.  
 
  the second one  predominantly controls the cellular iron metabolism 
through iron-regulatory proteins (IRP1 and IRP2). When the iron 
level in the cell is low IRPs bind to iron-responsive elements in 
regulated messenger RNAs of the transferrin receptors and ferritin. 
The binding of IRPs to iron responsive elements (IREs) in the 5’-
untranslated regions (UTRs) of mRNA blocks the translation (e.g. of 
ferritin), while IRP binding to the IRE in the 3’-UTR stabilizes the 
mRNA (e.g. of transferrin receptor). When the iron concentration in 
the cell is high IRP1 binds an [4Fe-4S] cluster (and acts like 
aconitase) and IRP2 degrades with the result that they can no longer 
bind to mRNA. This liberates the IRE in the 5’-untranslated region of 
Ferritin mRNA and directs the cell to produce more storage 
molecules. On the other hand the free IRE at the 3’-UTR of 
transferrin receptors accelerates its mRNA degradation resulting in 
decreased protein expression.14,15  
 
1.3. The role of iron in mitochondrial processes 
Mitochondria are well known for their fundamental role in the cellular 
metabolism. The mitochondrion (Fig. 4) is an eukaryotic cellular organelle 
that contains outer and inner membranes composed of phospholipid bilayers 
and proteins.20,17  
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Because of this double-membraned organization, there are five distinct 
compartments: 
 the outer mitochondrial membrane,  
 the intermembrane space (IMS): space between the outer and inner 
membranes  
 the inner mitochondrial membrane 
 the cristae space (formed by infoldings of the inner membrane),  
 and the matrix (space within the inner membrane). Main place for 
iron utilization.  
 
 
Figure 4. Schematic representation of the mitochondrion structure. 
 
The main function of this organella is synthesis of ATP, the energetic 
molecule of our cells. The overall process of oxidizing glucose to carbon 
dioxide is known as cellular respiration. ATP can be produced via:  
 glycolysis, citric acid cycle (TCA or Krebs cycles) and oxidative 
phosphorylation, both components of cellular respiration. 
 beta-oxidation of fatty acids 
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All this kind of reaction takes place in the mitochondria, in the matrix and on 
the internal membrane. During all the reaction in these pathway, we can have 
the direct formation of ATP or the production of high energetic molecules (in 
a reduced form) that can be uses for the synthesis of ATP after ri-oxidation 
in the respiratory chain. This is the last part of the cellular respiration and is 
formed by a large number of electron transport protein in order to convert the 
electron flow in ATP. Iron is directly involved in the ATP synthesis, because 
several protein present cytochromes or iron sulfur cluster (Fe-S) as cofactor 
to catalyze the electron transport. So the mitochondria require iron and this 
transport inside the mitochondria is a crucial step; once iron is transported 
into the mitochondrion it can then be used for heme synthesis, ISC synthesis, 
or stored in mitochondrial ferritin (Ftmt). It is essential that mitochondrial 
iron is maintained in a safe form to prevent oxidative damage, as 
mitochondria are a major source of cytotoxic ROS. This kind of import 
require iron in a reduced (ferrous) form and a membrane potential. Import is 
facilitated by two mitochondrial transporter proteins Mitoferrin1/2, but 
further iron transporters may be identified. 16,17,18,19,89 
 
1.4. The role and types of (Fe-S) cluster  
(Fe-S) clusters are ubiquitous protein cofactors highly conserved from 
bacteria to human. Practically, they play a crucial and essential role in every 
living cell. Initially, the biophysical properties of (Fe-S) cluster proteins 
were used by the earliest forms of life to perform fundamental metabolic 
processes (amino acid metabolism), when the earth’s atmosphere was a 
reducing and anaerobic environment (billion years ago). 
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Reducing environment: 
 Kps(Fe(OH)2) = 4.9 x 10-17    [Fe(II)] = 5.0 x 10-3 
 
 To maintain these cofactors after transformation of the atmosphere into an 
oxidative and aerobic one (which does not support the formation, neither the 
stability of (Fe-S) the organism evolved a whole set of proteins to coordinate 
and solubilize the Fe(III) in a safe, efficient and specific biogenesis system 
for these fundamental cofactors. 
 
 Oxidative environment:  Fe(II)                      Fe(III) 
 Kps(Fe(OH)3) = 2.6 x 10-39 [Fe(III)] = 2.6 x 10-18 
 
Another reason why biosynthesis of ISCs has to be strictly controlled is their 
potential toxicity. Improper biogenesis and maintaining of the iron and the 
clusters may fuel the Fenton chemistry, which produces highly toxic reactive 
oxygen species (ROS).19,21,22  The (Fe-S) clusters contain iron in oxidation 
state Fe2+ or Fe3+ and sulfide ion S2-, and the most common (Fe-S) cluster 
types are2:  
1.  [(RS)42Fe-2S]2-/3- : is the first and simple cluster, it’s call also diamond 
(Fig. 5 A). This cluster has a potential of E°’= -150/-450mV with a 
coordinative motif like Cys-X-X-Cys-Xn-Cys-X-Cys. We can also find one 
or two histidine substituting one or two cys ligands [(Cys)2(His)22Fe-2S]0/-, 
and with this change of ligand we have a more positive potential of E°’= -
100/400mV (Fig. 5 B). 
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2. [(RS)44Fe-4S]-/2-//2-/3-: cluster with the four irons linked with four sulfide 
ions (Fig.5 B). The common name of this cluster is cubane and present a 
potential of E°’= 100/400mV. A different form of this cluster is the 
[(RS)33Fe-4S]2-/3- in this modification  an iron atom is lost from the cubane 
(Fig. 5 C).  
 
 
Figure 5. type of iron sulfur clusters  
 
Fe-S are indispensable for life because of the ability of the iron to accept or 
donate electrons, formally altering between the ferrous (Fe2+) and ferric 
(Fe3+) oxidation states. The ability of the iron to change the oxidation state, 
plus the present of the sulfide ions and the effect of the external ligands, has 
allowed to expand the range of reduction potentials  (–700 mV to 400 mV) 
and are among the most important electron carriers in nature.23 Much is 
known about the electronic structure of iron–sulfur clusters in their various 
oxidation states. For example, in [2Fe-2S] systems, addition of one electron 
to the diferric cluster results in the localized reduction of one of the two iron 
ions, the other one remaining ferric. On the other hand, reduction of the all-
ferric [3Fe-4S]+ cluster results in the extra electron being delocalized onto a 
pair of iron ions having a 2.5+oxidation state (the so-called mixed-valence 
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pair), while the third iron ion remains ferric. Similarly, [4Fe-4S]3+ clusters 
consist of a mixed-valence pair and a ferric pair, [4Fe-4S]2+ clusters contain 
all mixed-valence irons, and [4Fe-4S]+ clusters have a mixed valence and a 
ferrous pair. This variation in the distribution of oxidation number is the 
result of specific ferro- and antiferromagnetic coupling between the Fe ions. 
When the Fe ions are all oxidized, only antiferromagnetic coupling occurs. 
By considering a pair of Fe(III) ions, the five unpaired electrons with an  𝑆 =
 5 2⁄  ground state on each ion sense those on the neighbor Fe through the 
sulfur bridges in such a way as to provide a total ground state with S’= 0 
(i.e., with all the electrons paired). In the case of different oxidation states, 
the five electrons of Fe(III) with a total spin 𝑆 =  5 2⁄   and the six electrons 
of Fe(II) with a total spin 𝑆 = 2 provide a total ground state 𝑆′ =  5 2⁄ − 2 =
 1 2⁄  in the case of antiferromagnetic coupling. However, if the Fe(III)–Fe(II) 
pair interacts strongly, the electron can be considered fully delocalized 
between the two metal centers and the oxidation state for each Fe is 2.5+. In 
this case, the ground state has nine unpaired electrons. The result is the same 
as that obtained when there is ferromagnetic coupling and the two S values 
of 5 2⁄  and 2 sum to 𝑆′ =  
9
2⁄   . In this case, we say that a mixed-valence 
pair occurs. In polymetallic systems, a mixed-valence pair with 𝑆 =  9 2⁄   
may couple in an antiferromagnetic fashion with either a single Fe ion or 
another pair of Fe ions1,2,3. In the resulting cluster, the spin takes the smallest 
possible value. The situation for iron–sulfur clusters is summarized in Fig. 6 
and the resulting global and local spin states are summarized in Table 1. 
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Figure 6. Total spin of the cluster and individual redox states of the iron ions in 
various iron–sulfur clusters as a function of the cluster oxidation state. Filled circles 
indicate Fe(III) ions, empty circles Fe(II) ions, and partially filled circles iron ions 
with a 2.5+ oxidation state. 
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Table 1. Spin Distribution within Iron–Sulfur Clusters 
The spectra of iron–sulfur proteins in the visible and near-ultraviolet (UV) 
range show a broad absorption envelope resulting from several overlapping 
absorption bands deriving from transitions with predominant S → Fe(III) 
charge-transfer character, where S can be either the Cys or the inorganic 
sulfur. Circular dichroism (CD) and magnetic circular dichroism (MCD) 
spectra partially resolve this complex envelope thanks to the different 
selection rules and the appearance of both positive and negative bands. (Fe-
S) clusters contain high-spin Fe(III) and Fe(II): while the former has no spin-
allowed d–d transition high-spin Fe(II) has spin-allowed transitions of the 
type dz
2 →dxz and dz2 →dyx (e → t2 in a tetrahedral environment). Bands 
attributable to these d–d transitions have been detected in CD spectra. 
The (Fe-S) clusters proteins play a central role in different processes like: 
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Function  Type of Cluster  Protein  
Electron transfer 
 
  
  [2Fe-2S] Ferredoxins 
  [3Fe-4S]   
  [4Fe-4S] 
High-potential 
iron–sulfur 
      
Catalysis of a nonredox reaction [4Fe-4S] Aconitase 
      
Catalysis of redox reactions [4Fe-4S] Sulfite reductase 
      
Stabilization of protein structure for 
DNA repair [4Fe-4S] 
Endonuclease III, 
MutY 
      
Sensing and regulation:     
(i) Oxygen sensors: loss of [4Fe-4S]   
original cluster and of [4Fe-4S]/[2Fe-2S]   
Activity [4Fe-4S]/[3Fe-3S] Aconitase 
      
(ii) Sensor of O2   and NO:     
redox-regulated control [2Fe-2S] SoxR protein 
of transcription     
      
(iii) Iron sensor: posttranscriptional [4Fe-4S] 
 Iron regulatory 
protein 
regulation   aconitase 
      
Redox-mediated generation [4Fe-4S] Biotin synthase 
of free radicals   
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1.5.  Biogenesis of (Fe-S) clusters 
The biosynthesis of the (Fe-S) clusters has been well studied in the last 
years.27,28,29,90 The most extensive studies were focused on bacteria 
(Escherichia coli and Azetobacter vinelandii ) and yeast Saccharomyces 
cerevisiae. Three different systems were identified for the biogenesis of 
bacterial (Fe-S) proteins: the NIF system, for specific maturation of 
nitrogenase in azototrophic bacteria; the ISC assembly and SUF systems, for 
the generation of housekeeping (Fe-S) proteins under normal and oxidative-
stress conditions, respectively. The yeast S. cerevisiae has served as an 
excellent model organism to establish the first details of the complex 
biosynthesis pathways in eukaryotes. Recent investigations in human cell 
culture and other model systems have demonstrated that the entire process is 
highly conserved from yeast to human. The synthesis of (Fe-S) clusters and 
their insertion into apo proteins requires almost 30 proteins in the 
mitochondria and cytosol of eukaryotic cells. Three distinct protein 
machineries are required in the (non-plant) eukaryotic cells for the 
biogenesis of the (Fe-S) clusters; the ISC assembly machinery in 
mitochondria (inherited from bacteria during evolution), the ISC export 
machinery located in the mitochondrial inter membrane space, and the 
cytosolic ISC assembly machinery (CIA) (Fig. 7). ISC export and CIA 
machineries are specifically involved in the maturation of cytosolic and 
nuclear ISC proteins, whereas the mitochondrial ISC assembly machinery is 
required for the generation of all cellular (Fe-S) proteins.30,31,32,91,92  
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Figure 7. Schematic representation of (Fe-S) cluster assembly in eukaryotic cell 
1.5.1. Mitochondrial (Fe-S) cluster assembly 
machinery 
Mitochondria perform crucial roles in many biochemical processes. They 
generate ATP by oxidative phosphorylation and participate in numerous 
metabolic pathways such as citric acid cycle, fatty acid degradation, urea 
cycle, and the biosynthesis of lipids and amino acids. Moreover, the 
organelles are involved in the bio-synthesis of various protein cofactors such 
as heme, biotin, lipoic acid, and, last but not least, iron–sulfur (Fe-S) 
clusters. The mitochondrial (Fe-S)  cluster (ISC) assembly machinery 
consists of 17 proteins that operate in three major steps of the maturation 
process: 
1. Core ISC assembly: Nfs1–Isd11 as the sulfur donor cooperates with 
ferredoxin–ferredoxin reductase acting as an electron transfer chain, 
and frataxin to synthesize an [2Fe–2S] cluster on the scaffold protein 
Isu1.  
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2. ISC factors involved in cluster transfer: in this part, the cluster is 
released from Isu1 and transferred toward apoproteins with the help 
of a dedicated Hsp70 chaperone system and the glutaredoxin Grx5.  
3. Late actins ISC targeting factor: Various specialized ISC 
components assist in the generation of [4Fe–4S] clusters and cluster 
insertion into specific target apoproteins. 
Each of these steps involves the participation of several proteins and 
cofactors, which execute specific biosynthetic partial reactions.33,90,93 The 
mitochondrial components required for (Fe-S) cluster formation in higher 
organisms are similar to the bacterial ISC proteins and apparently were 
inherited from a prokaryotic progenitor.34  The central component of the 
mitochondrial ISC assembly machinery (ISC core) is the scaffold protein 
Isu1 (human ISCU) on which de novo assembly of a [2Fe-2S] cluster takes 
place. Isu1 is one of the most conserved proteins in evolution and is found in 
many bacteria, and virtually in all eukaryotes. It has three cysteine residues 
which are necessary for the cluster synthesis.35,36,37 To accomplish de novo 
cluster formation, sources of iron and sulfur are necessary. Iron is imported 
from the cytosol into mitochondria through the innermembrane transporters 
Mitoferrin1/2 (Mrfn1/2) in its ferrous (Fe2+) form, and is delivered to the 
scaffold by Frataxin which was shown to interact with Isu1 in vivo and in 
vitro in an iron stimulated fashion.38, 39, 40 The free cysteine is the source of 
the sulfur; which is released and delivered to Isu1 by the complex of cysteine 
desulfurase Nfs-Isd11 (human NFS1 and ISD11). As an intermediate, a 
persulfide is formed on a conserved cysteine residue of the enzyme, and is 
then transferred to the scaffold protein. Although isolated Isu1 has the 
enzymatic activity (as a cysteine desulfurase) in vitro, the Nfs1–Isd11 
complex is the functional entity for sulfur transfer from Nfs1 to Isu1 in 
vivo.41,42, This reaction is aided by direct interaction between Nfs1 and Isu1. 
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Before the assembly reaction on Isu1 is accomplished the sulfur is reduced 
by the electron transfer chain composed of ferredoxin and ferredoxin 
reductase which receives the electron from NADH (Fig. 8). 
 
 
Figure 8.  First step of ISC biosynthesis process in mitochondria - assembly of   
(Fe-S)cluster on Isu1. 
 
The second major step performed by late components of the ISC assembly 
machinery is the release of the (Fe-S) cluster from Isu1 and its transfer and 
incorporation into recipient apo-proteins. The first interaction is between 
Isu1 and Jaq1 (human HSC20) this interaction open the access to Ssq1 
(human GRP75). This protein is able to interact with both pre two previous 
protein and contain a Hsp70 ATPase domain; the hydrolysis of ATP induce a 
conformational change into the complex and reduce the binding strength of 
the cluster on Isu1. ADP is exchanged for ATP by the exchange factor Mge1 
(human GRLP1/2) which triggers a conformational change of the peptide 
binding domain of Ssq1 from the closed to an open state thus leading to 
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disassembly of the Ssq1–Isu1 complex (Fig. 9) and the cluster is transfer to 
glutaredoxin 5 Grx5 (human GRLX5). 
 
Figure 9. Chaperon cycle from Isu1 to Grx5 
 
The monothiol glutaredoxin Grx5 then helps to transfer the (Fe-S) cluster 
toward apo proteins, presumably via transient binding of the (Fe-S) cluster in 
a glutathione-containing complex (GSH). Afterwards the delivery of the 
assembled (Fe-S) on Grx5, several other proteins can receive the cluster, 
combine two [2Fe-2S] clusters to form a [4Fe-4S] cluster and driving the 
cluster to the correct apo target. Isa1/Isa2 (Human ISCA1/293) and IBA5794 
are fundamentals to the assembly of the [4Fe-4S] cluster, Ind1 (Human 
IND1) is necessary for cluster incorporation into respiratory Complex I of 
oxidative phosphorylation in mitochondria, Nfu1 (human NUF1), Aim1 
(Human BolA3) are all proteins that help the targeting of cluster in a apo 
protein like lipoate sinthase (Fig. 10).44,45,46, The biogenesis of cytosolic and 
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nuclear (Fe-S) proteins requires the close cooperation between the 
mitochondrial ISC machineries and the CIA system. The central constituent 
of the mitochondrial ISC export apparatus is the ATP binding cassette 
(ABC) transporter Atm1 (Human ABCB7) located in the mitochondrial inner 
membrane. The mitochondrion produce a sulfur rich still unknown molecule 
(X-S), that can be exported to the cytosol by the transporter.   
 
Figure 10. Mitochondrial ISC assembly machinery components and 
pathway. 
 
1.5.2. Mitochondrial (Fe-S) cluster export 
machinery 
The necessity of mitochondrial ISC assembly for cytosolic (Fe-S) protein 
maturation was previously explained by the export of ready, preassembled 
clusters. This idea was abandoned when the ISC export system was 
discovered. The export machinery consists of three components; the inner 
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mitochondrial membrane ABC transporter - ABCB7, the intermembrane 
space protein - ALR and three peptide glutathione GSH (Fig. 11). 
Downregulation or depletion experiments of latter proteins in yeast and 
human cell lines lead to defective cytosolic and nucleus (Fe-S) proteins due 
to improper maturation and increased iron uptake in the cell and 
mitochondrial iron overload.48,49   It was shown in vitro that ATPase activity 
of the yeast homologue of ABCB7 (the yeast homologue is called Atm1) is 
stimulated by the sulfhydryl groups (e.g. cysteine residues).50    Because the 
ATPase of ABC transporters is usually stimulated by their physiological 
substrates, this may indicate that the substrate X transported from the 
mitochondria contains a sulfhydryl group in a peptidic environment. 
Moreover, the further step of the export process is performed by the ALR, 
which has sulfhydryl oxidase activity and is located in the mitochondrial 
intermembrane space. ALR has also been shown to assist incorporation of 
disulfide bonds by Mia40 into substrate proteins during protein import and 
trapping in the IMS.51,52,53  The last component of the ISC export machinery 
is the glutathione (GSH). This is a reducing agent, existing at a concentration 
of approximately 5mM in animal cells. Glutathione reduces disulfide bonds 
formed within cytoplasmic proteins to cysteines by serving as 
an electron donor. In summary, all known components of the ISC export 
machinery deal with sulfhydryl chemistry, but identification of their specific 
function will depend on the identification of the exported moiety.19,26 
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Figure 11. Mitochondrial ISC export machinery. 
1.5.3. CIA - cytosolic iron-sulfur cluster 
assembly machinery  
The maturation of cytosolic and nucleus (Fe-S) proteins requires not only the 
functionality of the mitochondrial ISC assembly machinery but also a 
dedicated cytoplasmic system (CIA). The overall process can be subdivided 
into two steps96 (Fig.12): 
1. (Fe-S) scaffold system; An initial step of cytosolic (Fe–S) protein 
biogenesis is the assembly and transient binding of a [4Fe–4S] cluster 
on the cytosolic scaffold 
2. CIA targeting complex; The second major step of cytosolic (Fe–S) 
protein biogenesis involves the transfer of the newly assembled and 
transiently bound [4Fe–4S] cluster and its subsequent insertion into 
dedicated apoproteins 
Till now several proteins were identified to play a crucial role in this process;  
 Cfd1 and Nbp35 (Human Nubp2 and Nubp1 respectively) both P-
loop NTPases that form a tetrameric complex where de novo [4Fe-
4S] cluster formation takes place 
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 Nar1 (Human IOP1) is required for [4Fe-4S] cluster transfer to the 
targeting complex system, 
 Cia2B (Human FAM96B or Mip18) and MMS19 compose the 
scaffold for the targeting process to the final apo protein. 
 Cia1 (Human CIAO1) that mediates protein-protein interaction 
between MMS19 and Nar1,  
 Dre2/Tah18 (Human Anamorsin and Ndor1, respectively) that are 
fundamental for the electron transfer process on the tetramer 
 Cia2A (Human Fam96A) necessary for the maturation of IRP1. 
 
Figure 12. Components of cytosolic ISC assembly machinery. 
 
The assembly process can be dissected into two different steps. First, a [4Fe–
4S] clusters  are assembled on the Cfd1–Nbp35 heterotetrameric scaffold 
complex. This reaction requires a sulfur source (X–S) generated by the 
mitochondrial ISC assembly and exported by the ABCB7 transporter. 
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Generation of the functionally essential N-terminal (Fe-S) cluster (N) of 
Nubp1 depends on the flavoprotein Ndor1 and the (Fe-S) protein anamorsin, 
which serve as an NADPH-dependent electron transfer chain. Second, the 
bridging (Fe-S) clusters are released from Cfd1–Nbp35 and transferred to 
apoproteins (Apo), a reaction mediated by the (Fe-S) protein IOP1 and the 
CIA targeting complex Cia1-Cia2B-MMS19. The latter three proteins 
interact in different parts of the scaffold complex with target (apo) proteins, 
and assure specific (Fe-S) cluster insertion. All the components of the CIA 
machinery are defined by having a primary location in the cytoplasm and 
they act just in the cytosolic (not the mitochondrial) (Fe-S) cluster protein 
maturation. This distinguishes CIA proteins from ISC factors that are 
important for both mitochondrial and cytosolic (Fe-S) cluster biogenesis and 
ISC export proteins that are required for cytosolic cluster biogenesis but are 
located only within the mitochondria. The cytosolic (Fe-S) maturation 
machinery is functionally conserved from yeast to humans and is linked with 
the iron regulation via Cia2A protein, that can interact with Nar1 or Cia1 and 
transfer the cluster to IRP1, protein related to the regulation of iron uptake 
(Fig.13).  
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Figure 13. Summary of the CIA machinery 
 
Depletion experiments of single CIA factors in yeast and human cell lines 
lead to a massive reduction in growth rates, malfunction of iron homeostasis 
(impaired maturation of IRP1) and decrease of cytosolic (Fe-S) protein 
activities, with preserved activity of mitochondrial (Fe-S) proteins. This 
suggests that the cytosolic ISC assembly system works downstream of the 
ISC assembly machinery in mitochondria.57,96,58 Identification of factor X, 
necessary for cytosolic cluster formation, produced by the ISC assembly 
machinery and exported by the ISC export machinery will give a new insight 
into the overall cellular maturation process, and will help to fully understand 
the connection between these three distinct machineries.  
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1.6 Biogenesis of (Fe-S) cluster and human 
diseases  
 
Maturation of (Fe-S) clusters strictly depends on the two mitochondrial ISC 
systems and the CIA machinery providing a tight link between mitochondrial 
function and cytosolic protein translation. Most of the ISC and CIA 
components are essential for the viability of the human cells. (Fe-S) clusters 
are essential cofactors of many proteins so the disruption of their 
biosynthesis leads to dysfunction of many fundamental cellular processes95. 
The central importance of (Fe-S)-protein biogenesis in mammal’s is 
impressively documented in numerous diseases associated with defects in 
(Fe-S) protein biogenesis components or Fe-S proteins. Depletion of 
frataxin, the putative iron donor for (Fe-S) cluster formation on Isu1, causes 
the neurodegenerative disease Friedreich’s ataxia (FRDA)59-64, which is 
associated with (Fe-S) protein activity defects and iron accumulation. In 
FRDA, a progressive degeneration manifests in the central and peripheral 
nervous system in addition to hypertrophic cardiomyopathy. Defects in the 
glutaredoxin Grx5, is associated with diseases exhibiting mainly 
haematological phenotypes, like the sideroblastic anaemia. A splicing defect 
in the ISCU gene in humans results in a myopathy with exercise intolerance 
and intracellular iron overload. Mutations in the mitochondrial inner 
membrane ABC transporter ABCB7 result in X-linked sideroblastic 
anemia66,65,91 with cerebellar ataxia. The manifestations of this disorder 
include an early onset, nonprogressive spinocerebellar ataxia with severe, 
selective cerebellar hypoplasia, accompanied by a mild hypochromic, 
microcytic anemi.a Mutations in the genes IBA57, NFU1, and BOLA3 may 
severely impair diverse mitochondrial metabolic pathways and interfere with 
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energy production. Hence, these diseases have been designated as multiple 
mitochondrial dysfunction syndromes (MMDS)91 which may be fatal at 
perinatal stages. Affected individuals present with hypotonia, respiratory 
insufficiency, encephalopathy, brain malformations, and neurological 
regression. At the biochemical level, patients exhibit metabolic acidosis, 
hyperglycinemia, and severely increased concentrations of lactate and 
ketoacids. Also mutation in mitochondrial and cytosolic (Fe-S) final targets 
proteins are related to many disease.  Genetic mutations in LIAS (Lipoyl 
synthase), an enzyme in the matrix of mitochondria that catalyze the 
formation of lipoyl cofactor, have been identified as a cause of glycine 
encephalopathy91,95,98, also known as nonketotic hyperglycemia, a rare 
autosomal recessive disorder of the glycine cleavage system in which 
deficient enzyme activity leads to glycine accumulation in body tissues. 
Symptoms usually present at birth and early infancy and are marked by 
mental retardation and seizures, involuntary muscle movement, coma, and 
death. Mutations in the putative human (Fe-S) proteins XPD and FANCJ 
cause multiple disease phenotypes including xeroderma pigmentosum and 
Fanconi anaemia. In conclusion, understanding both the physiological 
functions of Fe-S proteins and how (Fe-S) clusters are formed will 
undoubtedly enhance our ability to identify and treat known disorders of (Fe-
S) cluster biogenesis and to recognize hitherto undescribed (Fe-S) cluster-
related diseases. 
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2.1. Topics of the research 
During the three years of my PhD course I worked on recombinant protein 
production of human proteins involved in iron-sulfur protein biogenesis, and 
on its biochemical and structural characterization, with the final aim of 
investigating at an atomic level the functional role of these proteins within the 
(Fe-S) protein biogenesis pathways. In my research, I used a multidisciplinary 
approach exploiting several techniques and disciplines ranging from 
bioinformatics, molecular cloning, cell culture, protein purification, NMR, 
EPR, CD, UV-vis spectroscopies, and mass spectrometry. Specific target 
proteins part of the human CIA machinery were selected and recombinantly 
produced in E. coli cells to investigate their molecular interactions with protein 
targets, in such a way to define the cellular pathway of the CIA machinery at 
the molecular level. In the last period of my PhD program, a final target of the 
mitochondrial ISC assembly machinery, i.e. the human lipoyl synthase, was 
recombinantly produced since genetic mutations in this mitochondrial enzyme 
have been identified as a cause of a rare autosomal recessive disorder of the 
glycine cleavage system in which deficient enzyme activity leads to glycine 
accumulation in body tissues. Symptoms of this disease usually present at birth 
and early infancy and are marked by mental retardation and seizures, 
involuntary muscle movement, coma, and death.  
A general overview of the three projects developed during my PhD thesis are 
reported in the following sections. 
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2.2. Glutaredoxin 3 (GRX3 or PICOT) / 
Anamorsin (CIAPIN1) pathway 
In eukaryotes, both cytosolic and mitochondrial monothiol glutaredoxin 
proteins bind [2Fe-2S] clusters in the same way, i.e., via the formation of a 
[2Fe-2S]-bridged homodimer1,2. However, though the molecular function of 
mitochondrial monothiol glutaredoxins in assisting (Fe-S) protein maturation 
by acting as [2Fe-2S] cluster donors toward partner apo proteins has been 
demonstrated in the last few years3–6, the question of whether cytosolic 
monothiol glutaredoxins can perform the same function in the cytosol still 
remains unsolved. In contrast, the [2Fe-2S] cluster–bound form of cytosolic 
monothiol glutaredoxins has been recently proposed to be implicated, 
together with other protein candidates7, in cytosolic iron trafficking, playing 
a crucial part in iron delivery from the cytosolic labile iron pool to virtually 
all iron-binding proteins in the cell8,9. Recently, it has been also shown that, 
in Saccharomyces cerevisiae, the cytosolic monothiol glutaredoxin-3 can 
transfer the cluster to the iron-responsive transcription factor Aft2 in a way 
that deactivates the iron regulon for iron uptake, but cluster transfer occurs 
only when GRX3 is complexed with the BolA-like protein Fra2 (Human 
BOLA2). to form a [2Fe-2S]2+ bridged heterodimer complex10-13.  
The human proteome contains only one monothiol glutaredoxin (Grx) in the 
cytosol, GRX3 (also commonly named GLRX3 and PICOT). GRX3 is a 
protein of 335 amino acids formed by three domains: one N-terminal 
thioredoxin (Trx) domain with no Trx-related enzymatic role8,14 and two Grx 
domains, call GrxA and GrxB, each able to bind a glutathione-coordinated 
[2Fe-2S] cluster via protein dimerization with the cysteine of a conserved 
CGFS motif present in each domain. Recently, multiple high-throughput 
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yeast two-hybrid19 and affinity-capture MS (BioGRID interaction 1077826) 
screens have shown that GRX3 binds anamorsin (also commonly named 
CIAPIN1), a [2Fe-2S] cluster–binding protein involved in the maturation of 
cytosolic Fe-S proteins, in vivo16,17. However, the interaction mode and 
functional role of this interaction have not yet been defined. Anamorsin 
contains two domains: an N-terminal well-folded domain (N domain, 
hereafter) comprising 172 residues and a largely unstructured C-terminal 
domain of 90 residues named cytokine-induced apoptosis inhibitor 1 
(CIAPIN1 domain), which contains two highly conserved cysteine-rich 
motifs able to independently bind a [2Fe-2S] cluster16,17. These two domains 
are connected by a long flexible linker of 50 residues. Anamorsin is an 
appropriate target to investigate a potential functional role of GRX3 in 
transferring [2Fe-2S] clusters as it interacts with GRX3 in vivo. The final 
goal of this research project is to investigate the ability of GRX3 to transfer 
[2Fe-2S] clusters to final target proteins by studying its interaction with 
anamorsin. Through this work, I will be able to define whether GRX3 is an 
active component of the CIA machinery. 
 
2.3. BOLA2 modulation in the Anamorsin 
maturation pathway  
The functional role of eukaryotic monothiol glutaredoxins (Grx) has been 
largely studied in Saccharomyces cerevisiae, which encodes three 
CysGlyPheSer(CGPS)-type monothiol Grx homologues, Grx3/Grx4 and 
Grx5.18-20 Grx5 is a single domain protein, located in the mitochondrial 
matrix,  Grx3 and Grx4 are located in the  cytoplasm, and each consists of a 
N-terminal thioredoxin (Trx)  domain, with no Trx-related activity,21,22 and 
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of a glutaredoxin  domain capable of binding a [2Fe-2S] cluster through 
protein dimerization and glutathione binding,23. Grx3 and Grx4 have been 
linked to iron regulation through their binding to the transcriptional activator 
Aft1/2, which regulates iron uptake in yeast.25-26 Specifically, to perform this 
regulatory function, Grx3 (or Grx4) needs to be complexed with the BolA-
like protein Fra2 (Human BOLA2), forming a [2Fe-2S]-bridged hetero 
complex,23,27 which, can transfer the cluster to the iron-responsive 
transcription factor Aft228. Starting from this information on yeast and from 
the acquired knowledge on the anamorsin maturation pathway investigated 
in the previous project, I overexpressed the human BOLA2,  studied its 
interaction with GRX3, and characterized the GRX3-BOLA2 driven 
maturation pathway of anamorsin at the molecular level.. 
 
2.4. LIAS (lipoyl synthase) 
Lipoyl cofactors are essential for living organisms and are produced by the 
insertion of two sulfur atoms into the relatively unreactive C–H bonds of an 
octanoyl substrate. This reaction requires lipoyl synthase, a member of the 
radical S-adenosylmethionine (SAM) enzyme superfamily. LIAS contains 
two [4Fe–4S] clusters, which are both essential in catalysis29. One cluster is 
bound by cysteines in a canonical Cx3Cx2C RS motif and participates in the 
reductive cleavage of SAM, whereas a second cluster, bound by cysteines in 
an N-terminal Cx4Cx5C motif as well as a serine residue in a conserved C-
terminal RSSY motif29,30, is the source of the inserted sulfur atoms and is 
degraded during turnover31,32. To this date, four mutations in the LIAS gene 
that result in severe disease states have been described in patients33-35. 
Genetic mutations in LIAS have been identified as a cause of glycine 
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encephalopathy, also known as nonketotic hyperglycemia. Due to the critical 
role of LIAS in several diseases, I overexpressed and purified this protein in 
order to solve the structure of this protein and to characterize its 
spectroscopic and structural properties. These information will allow to 
evaluate how pathogenic mutation can affect the enzyme functionality and 
thus thay will provide the structural basis of the disease states related to the 
genetic mutations in the LIAS gene. 
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3.1. Genome browsing  
One of the main challenges facing the molecular biology community today is 
to make sense of the wealth of data that has been produced by the genome 
sequencing projects. In t3.1he past decade, bioinformatics has become an 
integral part of research and development in the biomedical sciences. 
Bioinformatics now has an essential role both in deciphering genomic, 
transcriptomic and proteomic data, generated by high-throughput 
experimental technologies, and in organizing information gathered from 
traditional biology. It is an interdisciplinary research area at the interface 
between the biological and computational science. The ultimate goal of 
bioinformatics is to uncover the biological information hidden in the mass of 
data and obtain a clearer insight into the fundamental biology of organisms.  
Genome browsing is the first and crucial step for the expression and 
characterization of a recombinant protein. In this step, bioinformatics tools 
are necessary to analyse the nucleotide and amino acid sequences and obtain 
information useful for the choice of the protein target. A number of data 
banks are available and provide the scientific community tools for searching 
gene banks, for the analysis of protein sequences, for the prediction of a 
variety of protein properties. Primary databases contain information and 
annotations of DNA and protein sequences, DNA and protein structures and 
protein expression profiles. Some available databases for genome browsing 
are: 
 NCBI (www.ncbi.nlm.nih.gov/Entrez/) - This web site integrates 
information from several databases (Swissprot, EMBL, all geneBank, 
etc...) 
 UniProt  (http://www.uniprot.org/) - A database for all the proteins  
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 PDB (www.rcsb.org/pdb) - A 3-D biological macromolecular structure 
database 
 Pfam (http://pfam.sanger.ac.uk/) - A collection of different protein 
families organized in terms of different domains as obtained from 
multiple alignments.1 
Secondary or derived databases are so called because they contain the results 
of analysis of the primary resource including information on sequence 
patterns or motifs, variants and mutations and evolutionary relationships.  
Once all biological data is stored, the requirement is to provide bioinformatic 
tools for extracting the meaningful information. The most used programs for 
genome browsing are: 
 BLAST (www.ncbi.nlm.nih.gov/BLAST/): Standard BLAST (Basic 
Local Alignment Search Tool) is a set of similarity search programs 
designed to explore all of the available sequence databases regardless 
of whether the query is protein or DNA. PHIBLAST is designed to 
search for proteins that contain a pattern specified by the user, and 
simultaneously are similar to the query sequence. 
 CLUSTALW (www.ebi.ac.uk/clustalw/) is a general purpose 
multiple sequence alignment program for DNA or proteins. It 
produces biologically meaningful multiple sequence alignments of 
divergent sequences. It calculates the best match for the selected 
sequences, and lines them up so that the identities, similarities and 
differences can be seen. Evolutionary relationships can be seen via 
viewing Cladograms or Phylograms 
 PROSITE (www.expasy.org/prosite/) SCANPROSITE allows to 
scan a protein sequence, provided by the user, for the occurrence of 
patterns and profiles stored in the PROSITE database, or to search in 
protein databases all sequences with a user entered pattern. 
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 STRING (http://string.embl.de/) STRING is a database of predicted 
functional associations among genes/proteins. Genes of similar 
function tend to be maintained in close neighbourhood and tend to be 
present or absent together.2 
 
3.2. Construct design 
Once the target protein is chosen, it is subjected to further bioinformatics 
investigations in order to predict important features like stability, solubility, 
hydrophobicity, secondary and tertiary structures. In this crucial step other 
bioinformatic tools can be used. 
 Several tools can be used in order to predict if the target is a fully 
soluble, transmembrane protein, or a protein containing both soluble and 
transmembrane domains;  
http://www.sbc.su.se/~miklos/DAS/, 
http://www.cbs.dtu.dk/services/TMHMM-2.0/, 
http://www.ch.embnet.org/software/TMPRED/form.html; 
 The presence in the sequence of subcellular targeting signals can be 
confirmed by the tools from servers like: SignalP, TargetP and 
PSORT.org;3,4,5 
http://www.cbs.dtu.dk/services/TargetP/, 
http://www.cbs.dtu.dk/services/SignalP/, 
http://www.psort.org/; 
 Topological and structural predictions can help in the identification of 
intrinsically unstructured regions and the prediction of secondary and 
tertiary structures; 6,7,8,9  
http://iupred.enzim.hu/,  
http://bip.weizmann.ac.il/fldbin/findex/, 
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http://www.sbg.bio.ic.ac.uk/~3dpssm/, 
http://pbil.univ-lyon1.fr/; 
 The construct should be designed with respect to the N-end rules;10 
These tools applied for each target protein, domain or construct selected for 
expression, can increase the probability of obtaining a soluble and well-
folded protein. 
 
3.3. Gene cloning  
In order to get high yield of soluble proteins, many factors have to be taken 
in consideration, such as the choice of the vector, of the cloning strategy, and 
of culture conditions. Of course, the knowledge of the protein characteristics 
will help in this choice, thus increasing the chance of success. In the last 
years several eukaryotic expression systems were optimized, such as 
mammalian, yeast and insect cell expression. Cell-free protein synthesis has 
also a great potential, in particular with membrane proteins. 11,12,13 However, 
especially for NMR which requires high yields of labelled 15N,13C and 2H 
samples, the E.coli expression system is nowadays the most widely used. 
That is why many efforts were focused on the optimization of this expression 
system. The gene cloning is the first part of the heterologous protein 
expression and consists into the creation of an expression vector. This vector 
can present different fusion tag to exploit the gene fusion technology. Gene 
fusion technology can facilitate purification, enhance protein expression and 
solubility, chaperone proper folding, reduce protein degradation, and in some 
cases, generate proteins with a native N-terminus. Factors such as reduced 
temperature, changes the E.coli expression strain, use different promoters or 
induction conditions and co-expression of molecular chaperones and folding 
modulators have all been examined and, in some specific cases, they lead to 
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enhancements of soluble protein production. Nevertheless, protein 
expression remains an arduous task that involves a complex decision tree. To 
date, no technology or reagent is a panacea. Thus, establishing tools and 
optimal conditions for each protein remains an empirical exercise.14 The best 
way to maximize the probability of obtaining a soluble and correctly folded 
target protein is to proceed with a parallel cloning and expression of it with a 
high number of fusion partners.  
There are different way to clone a gene into different plasmid with different 
fusion partner: 
 Classical cloning: digestion of gene and plasmid with a restriction 
enzyme and ligase reaction 
 Ligase independent cloning (LIC)  
 Gateway technology® 
Classical cloning, using restriction enzymes, typically can’t be adapted to 
high-throughput approaches, due to the complication of selecting compatible 
and appropriate restriction enzymes for each cloning procedure and to its 
multistep process. Also LIC approach is not used for the cloning screening. 
High-throughput cloning therefore requires procedures which can help to 
screen a broad range of conditions in less time, for these reasons new cloning 
technologies have been developed in recent years. Landy and coworkers 
have described a universal cloning method (Gateway technology®) based on 
the site-specific recombination of bacteriophage lambda, which facilitates 
the integration of lambda into E.coli chromosome and the switch between the 
lytic and lysogenic cycle.15 By this technology (developed by Invitrogen) it 
is possible to clone a target gene into different expression vectors, after the 
creation of the enrty clone, eliminating the time consuming work with 
restriction enzymes and ligase (Fig.14).  
-Chapter 3- Materials and Methods 
60 
 
 
Figure 14. The two reaction of the Gateway: a PCR reaction and the recombination 
in differents expression vectror. 
 
Gateway technology allows one-step cloning in the pENTR vector, and by 
site-specific recombination the target gene can be inserted in different 
expression vectors. The entry vector is obtained via recombination reaction 
of the pENTR/TOPO vector with our gene (PCR fragment); the reaction is 
catalyzed by the Topoisomerase I. After isolation of the entry vector, the 
second step is to generate an expression construct by performing an LR 
recombination reaction between the entry clone and a Gateway destination 
vector of choice. This cloning method is faster due to the higher reaction 
efficiency and to the fact that only sequencing of the entry clone is required, 
and most of all, the destination vector are compatible with one single entry 
clone making the parallel approach easier. Moreover, using different 
destination vectors allows expressing a chosen protein with different fusions 
or tags, which can increase solubility, yield and make the purification of the 
target much easier. However, the main function of an expression vector is to 
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yield the product of a gene (usually the more product the better).  Therefore, 
expression vectors are ordinarily equipped with very strong promoters; the 
rationale is that the more mRNA that is produced, the more protein product 
will be made. The ideal promoter is strong, has a low basal expression level, 
is easy to induce and is independent from the common components of 
culturing media. The most used promoter system for the bacterial expression 
of recombinant proteins is the T7/lac promoter.16 Genes under the control of 
T7/lac promoter can be transcribed by T7 RNA polymerase, in presence of 
lactose. Since E.coli cells do not produce this type of RNA polymerase, in 
order to use this promoter system they have to be genetically modified by 
incorporation of the genes encoding the T7 RNA polymerase, the lac 
promoter and the lac operator into their genome. The repressor is displaced 
from the lac operator when lactose or a similar molecule like Isopropyl β-D-
1-thiogalactopyranoside (IPTG), is added to the culture (Fig.15). IPTG 
activates genes encoding the T7 RNA polymerase and the target protein in 
the plasmid, because lac operators are located upstream in the bacterial 
genome.  
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Figure 15.. Function of the lacI operator; operative way of the repressor and 
conformational modification of the repressor in the present of the inductor. 
 
Because of the high selectivity of the T7 RNA polymerase, almost all of the 
cell’s resources are converted to target gene expression and the amount of 
desired product can reach up to 50% of the total cell protein in few hours 
after induction. In some cases, (e.g. toxic or membrane proteins) the basal 
expression of the recombinant protein has to be reduced. In order to achieve 
this, host strains containing the pLysS or pLysE vectors that express T7 
lysozyme (natural inhibitor of T7 RNA polymerase) should be used. 
 
 
3.4. Protein expression 
After bio-informatic characterization and choice of the cloning strategy 
several conditions for the target protein expression have to be tested in order 
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to obtain a high yield of soluble protein. The variables which affect the 
expression of a recombinant protein are: host strain, growth medium and 
induction parameters (temperature, IPTG concentration and duration of 
induction step). A preliminary expression test is performed in a small-volume 
scale using at least:  
 different E.coli strains (e.g.: Bl21(DE3), Bl21(DE3) Ripl codon+ 
hight expression of tRNA ,Bl21(DE3)pLysS a protease deficient 
strain, Bl21(DE3) Rosetta for rare codons containing genes and 
Origami(DE3) for disulphide containing proteins); 
 different expression vectors (containing different tags and/or fusion 
partners); 
 three expression temperatures (37-25-17°C);  
 different inducer (IPTG) concentrations and different induction times 
(4-6-16h). 
Expression results are checked on SDS polyacrylamide gels (SDS-PAGE). 
This kind of approach allows to explore a large set of expression conditions 
and to evaluate which one gives the best level of expression and yield of 
soluble protein. A second expression test is performed to better refine the 
expression conditions before the scale-up. On the basis of these preliminary 
results, the expression protocol can be optimised and, in case of negative 
results, it is possible to try the expression of mutants, change the cloning 
strategy, the construct or the expression system. With such an approach it is 
possible to find good expression conditions for many proteins. Anyway some 
proteins can be difficult to obtain,   since E.coli is a prokaryote and lacks 
intracellular organelles, such as the endoplasmic reticulum and the Golgi 
apparatus, which are responsible for post-translation modifications of the 
produced proteins. In case of negative results, variables like bacterial strain, 
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induction time, the kind of vectors and expression promoters can be 
modified. If the main fraction of the protein is produced in the insoluble 
fraction, another approach is to try an in vitro refolding screening with 
different additives in order to get a folded and soluble protein. The last 
choices are to redesign the expressed domains or to switch to other 
expression system.17  
In dependence of the spectroscopic technique of choice, protein expression is 
performed in differently composed media. In fact, when large amounts of 
proteins must be isolated for techniques that do not require isotopic labelling, 
the culture is usually performed in a rich media. Rich media contain water 
soluble extracts of plant or animal tissue (e.g., enzymatically digested animal 
proteins such as peptone and tryptone), and for this reason are rich in 
nutrients and minerals, assuring a fast bacterial growth and a high expression 
level. Their exact composition is unknown and this can impair the 
reproducibility of cultures. Chemically defined (or minimal) media are 
composed of pure ingredients in measured concentrations, dissolved in 
milliQ water; in this way the exact chemical composition of the medium is 
known, allowing high reproducibility of protein yields and grade and type of 
interferents. Typically, this class of media is composed of a buffering agent 
to maintain culture pH around physiological values, a carbon and energy 
source like a simple sugar (glucose) or glycerol, an inorganic nitrogen 
source, usually an ammonium inorganic salt and some other components in a 
define concentration such as metals and vitamins. In dependence of the 
bacterial strain and of the expressed proteins various mineral salts can be 
added and, if necessary, growth factors such as purified amino acids, purines 
and pyrimidines. Chemically defined media are easier to isotopically enrich, 
simply using 15N and 13C enriched nitrogen and carbon sources in its 
composition, even if isotopically enriched complex media are also 
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commercially available. 
 
3.5 Protein purification 
Basically, protein purification is a series of processes intended to isolate a 
single type of protein from a complex mixture. Protein purification is vital 
for the characterization of the function, structure and interactions of the 
protein of interest. Separation of one protein from all others is typically the 
most laborious aspect of protein purification. Separation steps exploit 
differences in protein size, physico-chemical properties and binding affinity. 
The location of expressed protein within the host will affect the choice of 
methods for its isolation and purification. Bacterial host may secrete the 
protein into the growth media, transport it to the periplasmic space, express a 
cytosolic protein or store it as insoluble inclusion bodies (IBs) inside the 
cistoplasm. For insoluble proteins, the first purification step is the extraction 
from inclusion bodies. Indeed, most of the bacterial proteins are removed by 
different extraction steps with native buffer conditions, while the 
recombinant protein is extracted from inclusion bodies with a denaturing 
buffer. One of the most popular techniques of purification, which can be 
adopted for denatured and native state proteins, is immobilized metal ion 
affinity chromatography (IMAC). It is based on the specific coordinate 
covalent bond of amino acids, particularly histidine, to metals. This common 
technique involves engineering the sequence in such a way that 6 to 12 
histidines are added to the N- or C-terminus of the protein. The polyhistidine 
binds strongly to divalent metal ions such as nickel. The protein can be 
passed through a column containing immobilized nickel ions, which binds 
the polyhistidine tag. All untagged proteins pass through the column. The 
protein can be eluted with imidazole, which competes with the polyhistidine 
tag for binding to the column, or by a decrease in pH (typically to 4.5), 
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which decreases the affinity of the tag for the resin (Fig.16).  
 
Figure 16. General purification procedure of a typical His-tagged proteins 
 
After the affinity purification, the fusion-tag must be removed from the 
recombinant protein. Indeed many expression vectors are engineered to 
express a protease clevage site between the fusion-tag and the protein. 
Tobacco Etch Virus (TEV), Factor Xa, Thrombin, Prescission Protease, 
recombinant Enterokinase are some examples of proteases that are normally 
used for the cleavage of tags. A second IMAC is generally performed in 
order to separate the fusion from the target native protein. However, if the 
fused protein is expressed in inclusion bodies, it must be refolded before 
performing the tag cleavage to avoid the sfolding of the protease dude to the 
denaturant agent. 
 This is not always possible, since fusion tags may interfere with protein 
refoldind and hide the cleavage site of the protease. Gel filtration (GF) 
chromatography is the most common used purification step if the protein, 
after affinity chromatography, is not pure enough. GF is the simplest and 
mildest of all the chromatographic techniques; the support for gel filtration 
chromatography is composed of beads which contain holes, called "pores," 
of given sizes. Larger molecules, which can't penetrate the pores, move 
around the beads and migrate through the spaces which separate the beads 
faster than the smaller molecules, which may penetrate the pores. Size 
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exclusion can be performed on a “rough” level, separating the components of 
a sample in major groups to remove for example high or low molecular 
weight contaminants or to exchange buffers, while high resolution 
fractionation of bio- molecules allows to isolate one or more components of 
a protein mixture, to separate monomers from aggregates and last but not 
least to determine molecular weights or to perform a molecular weight 
distribution analysis, provided that suitable standards are available.  
 
3.6. Protein characterization 
3.6.1. Metals content determination by ICP 
Inductively Coupled Plasma (ICP) is an analytical technique used for the 
detection of trace metals and allows multi-elemental, simultaneous analysis 
of elements in the periodic table in a mass range of 7 to 250 (from Li to U), 
with excellent sensitivity (one part in 1015, part of quadrillion ppq). The 
analytical principle used is optical emission spectroscopy, triggered by 
plasma ionization. The liquid sample is introduced in the pre-chamber, 
usually by means of a peristaltic pump, then nebulized and entrained in the 
flow of plasma support gas, which is typically Argon (Fig.17). Making the 
plasma from argon, instead of other gases, has several advantages. First, 
argon is abundant (in the atmosphere, as a result of the radioactive decay of 
potassium) and also has a higher first ionization potential than all other 
elements. Because of this high ionization energy, the reaction (Ar+ + e− → 
Ar) is less energetically favorable than the reaction 
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Figure 17. General scheme of an ICP instrument  
 
 The analytes are excited into a state of radiated light emission by the plasma 
vapour and the emitted radiation is converted to an electrical signal that can 
be measured quantitatively by resolving the light into its component 
radiation (almost always by means of a diffraction grating). The light 
intensity is measured, at the specific wavelength for each element line, with a 
CCD (charge coupled device, basically an array of tiny, light-sensitive 
diodes) which converts it to electrical signals. The electron signal intensity is 
then compared to previously measured intensities of standard solutions of the 
target elements, and a concentration is computed. This spectroscopic 
technique is very suitable for the protein’s metal content determination, since 
it requires very small amounts of sample, and is not perturbed by the 
polypeptidic matrix. 
 
3.6.2. Electron Paramagnetic Resonance (EPR) 
Electron paramagnetic resonance (EPR) or Electron spin resonance (ESR) 
spectroscopy is a very powerful and sensitive method for the characterization 
of the electronic structures of materials with unpaired electrons. There is a 
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variety of ESR techniques, each with its own advantages. In continuous 
wave ESR (CW-ESR), the sample is subjected to a continuous beam of 
microwave irradiation of fixed frequency and the magnetic field is swept29. 
Different microwave frequencies may be used and they are denoted as S-
band (3.5 GHz), X-band (9.25 GHz), K-band (20 GHz), Q-band (35 GHz) 
and W-band (95 GHz). EPR is a technique for studying chemical species that 
have one or more unpaired electrons, such as organic and inorganic free 
radicals or inorganic complexes possessing a transition metal ion. Electron 
paramagnetic resonance is a magnetic resonance technique, based on the 
interaction of unpaired electron spins with an external magnetic field. The 
essential aspects of EPR may be illustrated by considering the hypothetical 
case of a single isolated electron. This electron is characterized by the 
quantum number S = 1/2 and possesses a magnetic moment: 
μ⃗ = −ge ∙ βe ∙ S⃗  
with ge=2.0023 is the electron g-factor or Landé-factor, βe=9.42∙10
–24 J.T–1, 
the electronic Bohr magneton and S⃗  the dimensionless electron spin vector. 
In a magnetic field, B0, there are two energy states for this electron, as 
illustrated in Fig.18. This interaction, known as the Zeeman interaction, is 
expressed by the following Hamiltonian: 
HZI̅̅ ̅̅ = −μe ∙  B̅ =  ge ∙ βe ∙ B0 ∙ Sz  
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Figure 18. Splitting of the energy levels of an electron spin subjected to a magnetic 
field.  
 
In ESR spectroscopy, the magnetic component of a microwave energy, which 
is perpendicular to the magnetic field B0, induces microwave energy 
absorption subject to the resonance condition: 
∆E =  h ∙ v = ge ∙ βe ∙ B0 
where ν is the microware frequency. In a typical experiment the sample is 
placed in a resonant cavity which has a high sensitivity at a fixed microwave 
frequency, the magnetic field Bo is varied until resonance occurs at the value 
B given by the equation above29. By observing spectral line width and 
intensity, it is possible to obtain information about the spin environment. 
Electron spin exchange between identical and non-identical molecules, 
chemical exchange between the paramagnetic molecule and its environment, 
and the interaction of nearby molecules having unpaired spins are some 
examples of environmental effects which can influence line width and 
intensity in the EPR spectrum. Moreover, an observed spectrum can split in 
several lines referred to as hyperfine structure, arising from the electrons 
interacting with surrounding nuclear spins. This last property becomes very 
useful when investigating biological molecules that contain transition metal 
ions in their structure, since it can be exploited to characterize their 
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coordination environment in dependence of their intrinsic geometry. 
 
3.6.3. Mass spectrometry 
Mass Spectrometry is a powerful technique for identifying unknowns, 
studying molecular structure and reaction, and probing the fundamental 
principles of chemistry30. For large samples such as biomolecules, molecular 
masses can be measured with an accuracy of 0.01% of the total molecular 
mass of the sample. Mass spectrometry can be used for different types of 
characterization: 
 Accurate molecular weight measurements, to determine the purity of 
a sample, to verify amino acid substitutions, to detect post-
translational modifications, to calculate the number of disulphide 
bridges; 
 Reaction monitoring: monitor enzyme reactions, chemical 
modification, protein digestion; 
 Amino acid sequencing: sequence confirmation, characterisation of 
peptides, identification of proteins by databases from proteolytic 
fragmentation; 
 Protein structure: protein folding monitored by H/D exchange, 
protein-ligand complex formation under physiological conditions, 
macromolecular structure determination. 
Mass spectrometers can be divided into three fundamental parts: the ionization 
source, the analyzer and the detector (Fig.19). 
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Figure 19. schematic reproduction of a mass-spectrometer 
 
Sample molecules are ionized in the ionization source; these ions are extracted 
into the analyzer region of the mass spectrometer where they are separated 
according to their mass (m)-to-charge (z) ratios (m/z). The separated ions are 
detected and this signal sent to a data system where the m/z ratios are stored 
together with their relative abundance for presentation in the format of a m/z 
spectrum. Many ionization methods are available, each with its own 
advantages and disadvantages, and the choice depend on the type of sample 
under investigation and the mass spectrometer available. The ionization 
methods used for the majority of biochemical analyses are: 
 Electrospray Ionization31 (ESI): is produced by applying a strong 
electric field, under atmospheric pressure,to a liquid passing through 
a capillary tube with a weak flux (normally 1–10µlmin−1). The 
electric field is obtained by applying a potential difference of 3–6kV 
between this capillary and the counter-electrode, separated by 0.3–2 
cm, producing electric fields of the order of 106V m−1 (Fig.20). 
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Figure 20. ESI injector  
 
 Matrix Assisted Laser Desorption Ionization31 (MALDI): it’s a 
widespread and powerful source for the production of intact gas-phase 
ions from a broad range of large, non-volatile and thermally labile 
compounds such as proteins, oligonucleotides, synthetic polymers and 
large inorganic compounds. MALDI20 is achieved in two steps. In the 
first step, the compound to be analyzed is dissolved in a solvent called 
the matrix; the second step involves ablation of bulk portions of this 
solid solution by intense laser (Fig.21). 
 
 
Figure 21. MALDI method. 
The main function of the mass analyzer is to separate, or resolve, the ions 
formed in the ionization source of the mass spectrometer according to their 
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mass-to-charge (m/z) ratios. There are a number of mass analyzers currently 
available, including quadrupoles, time-of-flight (TOF)21 analyzers, magnetic 
sectors, both Fourier transform and quadrupole ion traps, and Orbitrap. These 
mass analyzers have different features, including the m/z range that can be 
covered, the mass accuracy, and the achievable resolution. The detector 
monitors the ion current, amplifies it and the signal is then transmitted to the 
data system where it is recorded as mass spectra. The m/z values of the ions 
are plotted against their intensities to show the number of components in the 
sample, the molecular mass of each component, and the relative abundance 
of the various components in the sample. The time-of-flight (TOF) analyzer 
separates ions according to their mass (m)-to-charge (z) (m/z) ratios, by 
measuring the time it takes for ions to travel through a field free region known 
as the flight tube. The heavier ions are slower than the lighter ones. In negative 
ionization mode, the deprotonated molecular ions (M-) are usually the most 
abundant species, accompanied by some salt adducts and possibly traces of 
dimeric or doubly charged materials. Negative ionization can be used for the 
analysis of oligonucleotides and oligosaccharides. In positive ionization 
mode, the protonated molecular ions (M+) are usually the dominant species, 
although they can be accompanied by salt adducts, a trace of the doubly 
charged molecular ion at approximately half the m/z value, and/or a trace of 
a dimeric species at approximately twice the m/z value. Positive ionization is 
used in general for protein and peptide analyses.21 In Orbitrap22 ions 
are electrostatically trapped in an orbit around a central, spindle shaped 
electrode. The electrode confines the ions so that they both orbit around the 
central electrode and oscillate back and forth along the central electrode's long 
axis. This oscillation generates an image current in the detector plates which 
is recorded by the instrument. The frequencies of these image currents depend 
on the mass to charge ratios of the ions. Mass spectra are obtained by Fourier 
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transformation of the recorded image currents. Orbitraps have a high mass 
accuracy, high sensitivity and a good dynamic range.22 
 
3.6.4. Circular dichroism (CD) 
Circular dichroism (CD) spectroscopy is a spectroscopic technique where the 
CD of molecules is measured over a range of wavelengths. CD spectroscopy 
is used extensively to study chiral molecules of all types and sizes, but it is in 
the study of large biological molecules where it finds its most important 
applications. A primary use is in analysing the secondary structure or 
conformation of macromolecules, particularly proteins as secondary structure 
is sensitive to its environment, temperature or pH, circular dichroism can be 
used to observe how secondary structure changes with environmental 
conditions or on interaction with other molecules. Structural, kinetic and 
thermodynamic information about macromolecules can be derived from 
circular. Plane polarised light can be viewed as being made up of 2 circularly 
polarised components of equal magnitude (Fig.22 AI), one rotating counter-
clockwise (left handed, L) and the other clockwise (right handed, R). 
Circular dichroism (CD) refers to the differential absorption of these 2 
components. If, after passage through the sample being examined, the L and 
R components are not absorbed or are absorbed to equal extents, the 
recombination of L and R would regenerate radiation polarised in the 
original plane (Fig.22 AII). However, if L and R are absorbed to different 
extents, the resulting radiation would be said to possess elliptical polarisation 
(Fig. 22 AII). A CD signal will be observed when a chromophore is chiral 
(optically active) for one of the following reasons:  
 it is intrinsically chiral because of its structure,  
 it is covalently linked to a chiral centre in the molecule 
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Figure 22. (AI) the two components of the polarization light L and R; (AII) 
elliptical polarisation generate from different absorption of the two component 
L and R.  
 
We can have two different signals in a CD spectrum (Fig.22 B): positive if 
the L component is absorbed more than the R component or negative if the R 
component is absorbed more than L component32. 
 
Figure 22 B: peak positive in 1 due to a L major absorption, negative peak in 2 
create by a major absorption of R respect to L and a non-chiral molecules in 3 
 
In proteins the major optically active groups are the amide bonds of the 
peptide backbone, typically disposed in highly ordered arrays such as α-
helices, β-pleated sheets or random coli. In proteins, the chromophores of 
-Chapter 3- Materials and Methods 
77 
 
interest include the peptide bond (absorption below 240 nm), aromatic amino 
acid side chains (absorption in the range 260 to 320 nm) and disulphide 
bonds (weak broad absorption bands centred around 260 nm). In addition, 
non-protein cofactors can absorb over a wide spectral range. Absorption in 
the region of 240 nm is due principally to the peptide bond; there is a weak 
but broad n → π∗ transition centred around 220 nm and a more intense   
  π → π∗ transition around 190 nm. Each secondary structure presents a 
characteristic CD spectrum, so the CD spectroscopy in particular good to 
study the protein folding33. The tertiary folding of the polypeptide chain can 
place these side chains in chiral environments, thus giving rise to CD spectra 
which can serve as characteristic fingerprints of the native structure. CD in 
the near UV, visible and near IR can give a great deal of information on the 
environments of cofactors (which play an integral role in the biological 
activity of the protein) or of other non- covalently bound ligands. Typically, 
the free ligand or cofactor has little or no CD signal; the observed CD signals 
in the complex therefore indicate that the binding site of ligand or cofactor 
confers chirality. 
 
Circular dichroism spectroscopy is particularly good to: 
 Determine whether a protein is folded, and if so characterizing its 
secondary structure;  
 Compare the structures of a protein obtained from different sources 
(e.g. species or expression systems) or comparing structures for 
different mutants of the same protein;  
 Study the conformational stability of a protein under stress (thermal 
stability, pH stability, and stability to denaturants) and how this 
stability is altered by buffer composition or addition of stabilizers; 
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 Determine whether protein-protein interactions alter the conformation 
of the protein. 
 
3.6.5. NMR – protein structural 
characterization  
Discovering the tertiary structure of a protein, or the quaternary structure of a 
protein or a  complexes, can provide important clues about how the protein 
performs its function. Nuclear Magnetic Resonance (NMR) is an 
experimental method of structure determination that can produce information 
at atomic resolution23. NMR experiments are able to provide information 
from which a subset of distances between pairs of atoms can be estimated, 
and the final possible conformations for a protein are determined by solving 
a distance geometry problem. Moreover, NMR spectroscopy is unique 
among the methods available for three-dimensional structure determination 
of proteins at atomic resolution, since the NMR data can be recorded in 
solution24,25. Considering that body fluids such as blood, stomach liquid and 
saliva are protein solutions where these molecules perform their 
physiological functions, knowledge of the molecular structures in solution is 
highly relevant. Furthermore, in addition to protein structure determination, 
NMR applications include investigations of dynamic features of the 
molecular structures, as well as studies of structural, thermodynamic and 
kinetic aspects of interactions between proteins and other solution 
components, which may either be other proteins or low molecular weight 
ligands.23,24    The NMR phenomenon is based on the fact that nuclei of 
atoms have magnetic properties that can be utilized to yield chemical 
information. Quantum mechanically subatomic particles (protons, neutrons 
and electrons) have spin. A spinning nucleus acts as a tiny bar magnet 
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oriented along the spin rotation axis (Fig.23).  
 
Figure 23 The charged nucleus (e.g., 1H) rotating with angular frequency ω (ω =
2πν) creates a magnetic field B and is equivalent to a small bar magnet whose axis 
is coincident with the spin rotation axis. 
 
This tiny magnet is often called a nuclear spin. In some atoms (12C, 16O, 32S) 
these spins are paired and cancel each other out so that the nucleus of the 
atom has no overall spin. However, in many atoms (1H,13C, 31P, 15N, 19F etc) 
the nucleus possess an overall spin that is different to zero (I = 1/2 for the 
previous nuclei). When there is no external or applied magnetic field (B0), 
the nuclear spins orient randomly; however, when there is an applied 
magnetic field, the nuclei orient themselves with or against the larger applied 
field. The α-spin state is parallel to the applied force and has lower energy 
than the β-spin state that is antiparallel to the applied force (Fig.24) 
 
 
Figure 24. Proton spin states in a present of a mangnetic field 
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The small nuclear magnet may spontaneously "flip'' from one orientation 
(energy state) to the other as the nucleus sits in the large magnetic field. 
However, if energy equal to the difference in energies (∆E) of the two 
nuclear spin orientations is applied to the nucleus (or more realistically, 
group of nuclei), much more flipping between energy levels is induced. The 
irradiation energy is in the RF range is typically applied as a short 
(milliseconds or microseconds) pulse. The absorption of energy by the 
nuclear spins causes transitions from higher to lower energy as well as from 
lower to higher energy. This two-way flipping is a hallmark of the resonance 
process. The energy required to induce flipping and obtain an NMR signal is 
just the energy difference: 
∆E =  γhB0/2π 
where h is Planck's constant (6.62607004 × 10−34 joule∙second). The Bohr 
condition (∆E = hν) enables the frequency ν0 of the nuclear transition to be 
written as: 
ν0= γB0/2π  
this last eqaution is often referred to as the Larmor equation, and ω0 = 2π ν0 
is the angular Larmor resonance frequency. The gyromagnetic ratio γ is a 
constant for any particular type of nucleus and is directly proportional to the 
strength of the tiny nuclear magnet. So the energy required to induce flipping 
and obtain an NMR signal is just the energy difference between the two 
nuclear orientations and is shown in Fig. ddd, and depend on the strength of 
the magnetic field B0 in which the nucleus is placed. The energy absorbed by 
the nuclear spins induces a voltage that can be detected by a suitably tuned 
coil of wire, amplified, and the signal displayed as a free induction decay 
(FID) in the time domain; Fourier transformation of the FID, convert the 
signal in the frequency domain spectrum. What we obtain is a spectra 
compose by different signal at different frequency, this different are related 
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to the chemical shift effects. Electrons are negatively charged particles that 
surround nuclei within a molecule. We know that moving charged particles 
will generate a magnetic field. So the electrons around nuclei in a molecule 
generate their own magnetic field that run in the opposite direction as the 
lines of force generated by the external magnetic field B0. This electronic 
magnetic field effect will cause protons with different chemical 
environments to yield resonance frequencies perturbed from the frequency 
defined by the applied external field B0. Differences in the electronic 
environments cause the protons to experience slightly different applied 
magnetic fields owing to the shielding/deshielding effect of the induced 
electronic magnetic fields. In a large molecule such as a protein, the large 
number of protons create a lot of signal and linked to the different chemical 
environment, generate at the end a large one dimensional spectra (1H-1D) 
with a extended overlap. For this reason, protein NMR spectra cannot be 
resolved in a conventional one-dimensional spectra (1D) and multi-
dimensional nuclear magnetic resonance spectroscopy is required to correlate 
the frequencies of different nuclei. Multi-dimensional NMR spectra provide 
both, increased resolution and correlations which are easy to analyse.   
The preparation of the protein sample is a crucial step of this process, since a 
highly purified protein sample is required. Inhomogeneous preparation 
and/or aggregation of the protein as well as low molecular weight impurities 
may severely harm the structure determination. Since the NMR technique 
exploits the property that magnetic nuclei, with an uneven spin quantum 
number such as the isotopes 1H, 2H, 13C, 15N, the protein need isotope 
labeling is necessary for NMR analysis because not all atoms are 
magnetically active.  
There are different types of experiments that can detect through-bonds and 
through-space nucleus/nucleus interactions. With unlabeled protein the usual 
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procedure is to record a set of two dimensional homonuclear (1H-1H) NMR 
experiments starting with homonuclear thought bond (J-coupling) correlation 
method like: 
 Correlation spectroscopy (COSY): used to identify spins which are 
coupled to each other, we obtain cross peak for each pair of coupling 
nuclei. 
 Total correlation spectroscopy (TOCSY): similar to the COSY 
experiment, in that cross peaks of coupled protons are observed. 
However, cross peaks are observed not only for nuclei which are 
directly coupled, but also between nuclei which are connected by a 
chain of couplings. This makes it useful for identifying the larger 
interconnected networks of spin couplings. 
We can also detect the homonuclear correlation thought space with methods 
that establish correlations between nuclei which are physically close to each 
other regardless of whether there is a bond between them. The most use 
experiment is: 
 Nuclear overhauser effect spectroscopy (NOESY): we obtain a 
spectrum similar to COSY, with diagonal peaks and cross peaks, 
however the cross peaks connect resonances from nuclei that are 
close in space.25,26  
Homonuclear NMR is usually restricted to small proteins or peptides 
because of the signal overlap problem in the case of bigger proteins. The 
process of structure determination starts with this experiment, but we must 
know other correlation for solve a structure. For this reason, we need other 
experiment to correlate nitrogen, carbon and hydrogen atoms. For that 
experiment we need an isotope enrich sample (15N,13C and 2H)25,26.    
The 1H-15N HSQC (Heteronuclear Single Quantum Correlation) experiment 
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is probably the first and the most frequently recorded experiment in protein 
NMR. In this experiment we have the correlation between the proton and the 
nitrogen. During the condensation reaction between the amino acids, the 
carboxyl group (-COOH) react with the amino group (-NH2) to form the 
peptide bond (-CO-NH) with the release of a water molecule. 
Each residue of the protein (except proline and the NH2 of the last amino 
acid at the C-terminal) has an amide proton attached to nitrogen in 
the peptide bond, so with the 1H-15N HSQC experiment we can correlate the 
proton with the nitrogen of the amide group. If the protein is folded, the 
peaks are usually well dispersed in the proton/nitrogen dimension, and most 
of the individual peaks can be distinguished. The number of peaks in the 
spectrum should match the number of residues in the protein (though side 
chains with nitrogen-bound protons will add additional peaks). It will 
probably be difficult to solve the structure of the protein if this is not the 
case. The process of structure determination is usually not undertaken until a 
good HSQC spectrum is obtained. In order to analyze the nuclear magnetic 
resonance data, it is important to get a resonance assignment for the protein. 
That is to find out which chemical shift corresponds to which atom. This is 
typically achieved by sequential walking using information derived from 
several different types of NMR experiment. This barrier can be overcome 
with 3D NMR techniques and uniformly 13C and 15N labelled proteins. In the 
case of labelled proteins, it is possible to record an experiment that transfers 
magnetization over the peptide bond, and thus connects different spin 
systems through bonds. The 3D experiments exclusively correlate the 
resonances of the protein backbone, and the experiments used are: HNCA, 
HNCACB, HN(CO)CA, HN(CO)CACB, HNCO and HN(CA)CO.  
In the case of proteins with a molecular weight larger than 30 kDa we have 
to use experiment that help us to reduce the problems created by the larger 
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molecular weight; one of that is the TROSY (Transverse Relaxation 
Optimized Spectroscopy) experiment. The TROSY technique benefits from a 
variety of triple resonance NMR experiments as the 3D HNCA and 
HN(CO)CA.  
After the backbone assign, we can use 3D experiment like H(C)CH-TOCSY 
and (H)CCH-TOCSY to link the side chain spin systems to the backbone 
assignments.27,28 
Another field in the NMR of proteins is the paramagnetic NMR of 
metalloproteins. This kind of experiments are different respect to the 
classical diamagnetic system, in fact the present of a paramagnetic center 
modify the proprieties of the proteins in solution (major line broadening and 
major relaxation). We have now several NMR sequence to obtain the proton 
distance (respect to the paramagnetic center) and dihedral angle.   
Protein NMR techniques are continually being used and developed. 
Improvements in NMR hardware (magnetic field strength, cryoprobes) and 
NMR methodology, combined with the availability of molecular biology and 
biochemical methods for preparation and isotope labeling of recombinant 
proteins, have dramatically increased the use of NMR for the 
characterization of structure and dynamics of biological molecules in 
solution. 
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4.1. Glutaredoxin 3 (Grx3): protein production 
The cDNA coding for human GRX3 (UniProtKB/Swiss-Prot: O76003) was 
acquired from Source BioScience LiefeScience. Four different constructs 
(full-length 1-335 aa, Trx domain 1-119 aa, Trx/Grx 1-236 aa, GrxA 120-
236 aa, GrxA-GrxB 130-335 aa), were amplified by PCR and subsequently 
inserted into the pETG20 A vector modified with Trx-Histag using the 
Gateway technology (Invitrogen). The Cys to Ala substitutions in GRX3 
were obtained using the QuikChange® Site-Directed mutagenesis kit from 
Stratagene (La Jolla, CA). BL21-CodonPlus (DE3)-RIPL Competent E.coli 
Cells (Stratagene, La Jolla, CA) were transformed with the desired 
constructs, and cells were grown in LB or minimal media (with (15NH4)2SO4 
and/or [13C]-glucose) containing 1 mM ampicillin and chloramphenicol at 
37° C under vigorous shaking until the OD at 600 nm reached 0.6. For 
expression of holo GRX3 constructs, cells were grown in the presence of 250 
µM FeCl3. Protein expression was induced by adding 0.5 mM IPTG and 
expression was performed over night at 17°C. Cells were harvested by 
centrifugation at 7500 x g and resuspended in degassed lysis buffer (50 mM 
Tris-HCl pH 8 containing 500 mM NaCl, 5 mM imidazole and 5 mM DTT, 
DNAase 0.01mg/ml, lysozyme 0.01 mg/ml and  MgSO4 1mM. For the 
Trx/Grx, GrxA and full-length constructs, 5 mM GSH was added. Cell 
disruption was performed on ice by sonication alternating 30 seconds of 
sonication and 5 minutes of resting for 10 times. Except for the Trx domain 
construct, the following purification steps were performed under anaerobic 
conditions. The soluble extract, obtained by ultracentrifugation at 40000 x g, 
was loaded on a HiTrap chelating HP column (GE Healthcare) and the 
recombinant proteins were eluted with 50 mM Tris-HCl pH 8, 500 mM NaCl 
and 500  mM imidazole. 5 mM DTT and 5 mM GSH were added to the 
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protein-containing fractions (except for the Trx domain construct). The 
proteins were then concentrated with an Amicon Ultra-15 Centrifugal Filter 
Units with a MWCO of 10 kDa (Millipore). Cleavage of the tags was 
performed by TEV protease in 50 mM Tris-HCl pH 8, 500 mM NaCl, 5 mM 
imidazole, 0.3 mM EDTA, 5 mM GSH and 2 mM DTT overnight at room 
temperature. Than the protein solution was loaded again on the His Trap 
column to separate the digested proteins from the tags. Size exclusion 
chromatography was performed as the final purification step using a HiLoad 
Superdex75 16/60 column (GE Healthcare) and degassed 50 mM phosphate 
buffer pH 7, 5 mM GSH, 5 mM DTT as running buffer. Apo proteins were 
obtained by treatment of the protein (purified in presence of oxygen and 
without adding GSH or DTT into the buffers) with  100 mM EDTA and 20 
mM K4[Fe(CN)6]. Full-length, Trx/Grx, GrxA and GrxA-GrxB constructs 
were chemically reconstituted by incubating the purified apo proteins in 
degassed 50 mM Tris, 100 mM NaCl, 5 mM DTT, 5 mM GSH at pH 8 with 
1 mM FeCl3 and  1  mM Na2S over night at room temperature. Iron 
concentration was determined by inductively coupled plasma mass 
spectrometry (ICP-MS). To estimate the iron content a standard procedure 
has been followed with few modifications (Zhang, et al., 2008). 350μL of 
each sample dilution were treated with 50μl of 5% SDS for 5 minutes and 
then reduced with 50μl of 10mM sodium dithionite followed by addition of 
50μl of 10mM bathophenanthrolinedisulfonic acid disodium salt (BPS) to 
chelate iron(II). Samples were 
incubated in the dark for 20 minutes, mixed and centrifuged for 5 minutes at 
12000 x g. 
Absorbance at 515nm was measured and the concentration was estimated 
through standard 
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curve analysis using NH4Fe(SO4)2. To estimate the sulfide content, a 
standard procedure has been followed with few modifications (Siegel, 1965). 
Samples (600μl) were treated with 50μl of 6% NaOH and incubated for 5 
minutes. Samples were mixed with 125μl of 0.1% DPD (N,N-dimethyl-
pphenylenediamine dihydrochloride, Sigma-Aldrich) followed by addition of 
50μl of 11.5 mM FeCl3 and incubated for 30 minutes at room temperature. 
Sulfide concentration was estimated at 670nm through standard curve 
analysis using sodium sulfide Na2S. 
 
4.1.1. Analytical gel filtration 
The aggregation state of the apo and holo forms of GRX3 WT plus all the 
contruscts or the mixture of GRX3 and anamorsin was analyzed using 
analytical gel filtration. Purified samples were loaded on a SuperdexTM 75 
HR 10/30 analytical column (Amersham Bioscience) or Superdext 200 
increase 10/300 GL (GE Healthacare). Degassed 50 mM phosphate buffer 
pH 7, 5 mM GSH, 5mM DTT was used as an eluent. 
 
4.1.2. UV/vis and EPR spectroscopy 
UV-visible spectra of holo GRX3, holo GrxA,  holo GrxA-GrxB, holo Trx-
GrxA and holo anamorsin in degassed 50 mM phosphate buffer pH 7, 5 mM 
GSH and 5 mM DTT were performed on a Cary 50 Eclipse 
spectrophotometer. EPR spectra of holo GRX3 full-length plus all the holo 
different constructs and holo anamorsin with the [2Fe-2S] cluster in the 
reduced state were recorded in 50 mM phosphate buffer pH 7, 5mM GSH, 5 
mM DTT and 10% glycerol with a Bruker Elexsys E500 spectrometer 
equipped with a X-band microwave bridge (microwave frequency, 9.45 
GHz) and an ER 4131 VT (unit for temperature control). EPR parameters 
were the following: sample temperature 45 K, microwave frequency 9.45 
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GHz; microwave power 5 mW; modulation frequency 9,387691 GHz; 
modulation amplitude 2500 G, time constant 167 ms. To reduce the cluster, 
sodium dithionite was added, in a 1:1 protein/dithionite ratio, under 
anaerobic conditions and the sample was immediately frozen. 
 
4.1.3. Structural characterization of GRX3 by NMR spectroscopy 
Standard 1H-detected triple-resonance NMR experiments for backbone 
resonance assignment were recorded on 0.5 to 1 mM 13C, 15N-labeled 
samples (apo forms of GRX3 Trx/Grx, Trx and GrxA domain) at 298 K, 
using a Bruker AVANCE 500 MHz (GRX3 Trx/Grx and GrxA domains) or 
700 MHz (Trx domain) spectrometer. To identify backbone amide 
resonances affected by paramagnetic relaxation effects, 1H-15N HSQC, 
edited by a 1H inversion recovery and observed in the antiphase component 
(IR-HSQC-AP), were collected, at 700 MHz and 311 K, using a 512 × 100 
data point matrix, collected over a 25 × 40 ppm spectral region. A total of 
2,048 scans per fid were acquired, using inversion recovery, inept transfer, 
and recycle delays of 50 ms, 0.83 ms, and 55 ms, respectively. All NMR data 
were processed using the Topspin software package and were analyzed with 
the program CARA3,4. Secondary structure analysis has been performed by 
TALOS+1and the webserver PECAN2. 15N longitudinal (R1) and transverse 
(R2) relaxation rates and steady-state heteronuclear NOE measurements were 
performed at 14.1 T (600MHz) using the standard pulse sequences on 15N-
labeled samples. The overall rotational correlation times were estimated from 
the R2/R1 ratio, using the program QUADRATIC_DIFFUSION, excluding 
relaxation data of NHs having an exchange contribution to the R2 value or 
exhibiting large-amplitude internal motions.  
1D 1H paramagnetic NMR spectra of 0.5 mM holo GRX3 (in D2O, 50 mM 
phosphate buffer, pH 7, 5 mM GSH and 5 mM DTT) were recorded at 298 K 
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on a Bruker Avance 600 MHz spectrometer, equipped with a selective 1H 
probe head (SEL 1H 5 mm), to detect Hα and Hβ signals of the iron ligands. 
These spectra were acquired by means of the super-WEFT sequence with a 
recycle time of 50 ms.  
 
4.1.4. Cluster transfer and interaction between GRX3 and anamorsin 
To monitor cluster transfer, holo GRX3 full-length was incubated with the 
His12-tag apo form of anamorsin (protein ratio ~ 1:2) in 50 mM phosphate 
buffer pH 7, 5 mM GSH and 5 mM DTT and, after separating the two 
proteins through affinity chromatography, UV-visible, EPR spectra and 
paramagnetic NMR spectra were recorded as described above. The same 
experiment was performed for holo anamorsin and apo GRX3 full-length. 
Cluster transfer and interaction between GRX3 and anamorsin was followed 
by NMR titrating 15N-labeled holo GRX3 (Trx-domain, Trx/Grx) with 
unlabeld full-length anamorsin in 50 mM phosphate buffer pH 7, 5 mM GSH 
and 5 mM DTT containing 10% (v/v) D2O at 298K and monitoring chemical 
shift changes by 1H-15N HSQC spectra. 
Protein-protein interaction between 15N-labeled apo GRX3 (Trx-domain, 
Trx/Grx, GrxA, GrxA-GrxB, full-length) and unlabeled apo anamorsin (N-
terminal domain, C-terminal domain, full-length) and 15N-labeled apo 
anamorsin (full-length, N-terminal domain) and unlabeled apo GRX3 (Trx- 
domain, Trx/Grx, GrxA, full-length) in 50 mM phosphate buffer pH 7, 5 mM 
GSH and 5 mM DTT containing 10% (v/v) D2O at 298K was investigated by 
NMR monitoring chemical shift changes by 1H-15N HSQC spectra after 
addition of increasing amounts of the unlabeled partner. 
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4.2. Anamorsin: protein production 
The cDNA coding for the human full-length anamorsin (UniProtKB/Swiss-
Prot: Q6FI81, Genbank Accession No. BC024196) was commercially 
acquired from Imagenes (ORF Shuttle Clone IOH4051) and after 
amplification by PCR inserted into the Gateway pEntr-TEV-dTopo vector 
(InvitrogenTM). The N-terminal domain and the C-terminally truncated (1-
270aa) construct were PCR-amplified from the pEntr-TEV-D-Topo vector 
containing full-length anamorsin and then re-inserted into the same vector. 
For recombinant expression, all the three constructs were cloned via the 
Gateway technology (InvitrogenTM) into the expression vector pCold-
DEST 12His-tag. This vector is based on the pColdI (Takara Bio Inc, Japan) 
and has been modified by us to make it suitable for the Gateway system. 
According to the vector construction all proteins are expressed with an N-
terminal His12 tag and, for the release from it, a sequence coding for the 
specific recognition site of the TEV protease was located at the 5' end of the 
codifying sequences. All the recombinant proteins contain four additional 
amino acids, GSFT, at the N-terminus.  BL21-CodonPlus (DE3)-RIPL 
Competent Cells (Stratagene, La Jolla, CA) were transformed with the 
anamorsin/pCOLD-DEST construct for the protein expression. The cultures 
were grown at 37°C under vigorous shaking overnight, diluted 1:100 into LB 
medium or minimal medium containing 100 µg/ml ampicillin and 34 µg/ml 
chloramphenicol and grown further at 37°C until OD at 600 nm reached 0.8-
1. The culture was transferred to 25°C and protein expression was induced 
by addition of IPTG to a final concentration of 0.5 mM and the incubation 
was continued for 3 h (rich media) or 4 h (minimal media). The full-length 
anamorsin and C-terminally truncated construct were expressed in the 
presence of 125 µM FeCl3. Subsequently, the cells were harvested by 
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centrifugation (7500 x g, 15 min, 4°C) and the pellets were stored at -20°C. 
The frozen cell pellets were re-suspended in degassed lysis buffer (Tris-HCl 
50mM, NaCl 500mM, glycerol 5%, imidazole 20mM, pH 8) containing 
lysozyme (0.01mg/ml), DNA-se I (0.01mg/ml) and MgSO4 (1mM). Cells 
were incubated on ice for 30 min with gentle shaking and subsequently, 
disrupted on ice by sonication alternating 30 seconds of sonication and 5 
minutes of resting for 10 times. The resulting cell lysate was centrifuged 
(400000 x g, 40 min, 4°C). All the proteins were purified by immobilized 
metal ion affinity chromatography, under anaerobic conditions in a glove 
box for the full-length protein and the C-terminally truncated construct and 
under aerobic conditions for the N-terminal domain. The supernatant was 
applied to a nickel-charged HiTrap chelating HP column (GE Healthcare) 
and the proteins were eluted with degassed elution buffer (50mM Tris-HCl, 
500mM NaCl, 500 mM imidazole, 5% glycerol, pH 8) and concentrated in 
presence of 3mM DTT with an Amicon Ultra-15 Centrifugal Filter Units 
with a MWC of 10 kDa (Millipore). The His-tag was cleaved from the 
recombinant proteins by incubation overnight with TEV protease (3µl 
TEV/1mg anamorsin) and used for reverse Ni(II) affinity chromatography in 
order to remove the cleaved His-Tag. Size exclusion chromatography was 
performed as the final purification step using a HiLoad 16/60 Superdex 75 
pg column (GE Healthcare) and degassed 50mM Tris-HCl, 500mM NaCl, 
2mM DTT, 5% glycerol, pH 8 as a running buffer. The proteins were used 
directly for analysis or frozen in liquid nitrogen and stored at -80°C. 
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4.3. BOLA2: protein production 
The cDNA coding for human BOLA2 (UniProtKB/Swiss-Prot: Q9H3K6) 
was acquired from Life technologies. BOLA2 gene were amplified by PCR 
and subsequently inserted into the pET21a vector using the restriction 
enzymes NdeI and BanH I. BL21(DE3)gold competent E. coli cells 
(Stratagene, La Jolla, CA) were transformed with the obtained plasmid, and 
cells were grown in LB or minimal media (with (15NH4)2SO4 and/or [
13C]-
glucose) containing 1 mM ampicillin at 37° C under vigorous shaking until 
the OD at 600 nm reached 0.6. Protein expression was induced by adding 0.5 
mM IPTG and cells were grown 4 hours at 25°C. Cells were harvested by 
centrifugation at 7500 x g and resuspended in lysis buffer (25 mM MES pH 
6 containing 0.01 mg/ml DNAase, 0.01 mg/ml lysozyme, 1 mM MgSO4, 0.5 
mM EDTA and 5 mM DTT). Cell disruption was performed on ice by 
sonication and the soluble extract, obtained by ultracentrifugation at 40000 x 
g, was loaded on HiTrap SP FF column (GE Healthcare) and BOLA2 protein 
was eluted with 25 mM MES pH 6, 1 M NaCl and 5 mM DTT. The protein 
was then concentrated with an Amicon Ultra-15 Centrifugal Filter Units with 
a MWCO of 3 kDa (Millipore) and then the buffer was exchanged by PD10 
desalting column in 50 mM phosphate buffer pH 7, 5 mM DTT and 5 mM 
GSH. 
 
4.3.1. Biochemical and UV/vis, CD, EPR spectroscopic methods 
The aggregation state of isolated apo and holo proteins and of protein 
mixtures was analyzed in air using analytical gel filtration (superdext 75 HR 
10/30 and superdext 200 10/300 increase columns (Amersham Bioscience 
and GE Healthcare) calibrated with gel filtration marker calibration kit, 
6500-66000 Da (Sigma Aldrich)). Purified samples were loaded on the 
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column pre-equilibrated with degassed 50 mM phosphate buffer pH 7, 5 mM 
GSH, 5 mM DTT. Elution profiles were recorded at 280 nm with a flow rate 
of 0.5 or 0.75 mL/min. UV/vis and CD spectra were anaerobically acquired 
on a Cary 50 Eclipse spectrophotometer and JASCO J-810 
spectropolarimeter, respectively, in degassed 50 mM phosphate buffer pH 7, 
5 mM GSH and 5 mM DTT. EPR spectrum of the 1:4 [2Fe-2S]2 GRX32 and 
apo BOLA2 was recorded after the stoichiometric addition, inside an 
anaerobic chamber, of a degassed sodium dithionite solution to reduce the 
cluster and the obtained protein solution was immediately frozen. The EPR 
spectrum was acquired in degassed 50 mM phosphate buffer pH 7, 5 mM 
GSH, 5 mM DTT and 10% glycerol at 45 K using a Bruker Elexsys E500 
spectrometer working at a microwave frequency of ca. 9.45 GHz and 
equipped with a SHQ cavity and a continuous flow He cryostat (ESR900, 
Oxford instruments) for temperature control. Acquisition parameters were as 
following: microwave frequency, 9.640928 GHz; microwave power, 5 mW; 
modulation frequency, 100 KHz; modulation amplitude, 2.0 G; acquisition 
time constant, 163.84 ms; number of points 1024; number of scans 8; field 
range 2300-4300 G or 2800-3800 G. 
 
4.3.2. NMR spectroscopy 
Standard 1H-detected triple-resonance NMR experiments for backbone 
resonance assignment were recorded on 1 mM 13C, 15N labeled samples (apo 
forms of GRX3(GrxA/B) and BOLA2) in degassed 50 mM phosphate buffer 
pH 7, 5 mM DTT and 5 mM GSH at 298 K, using Bruker AVANCE 500 
MHz and 700 MHz spectrometers. 15N heteronuclear relaxation experiments 
performed on 15N-labeled apo BOLA2 and on 15N-labeled apo 
GRX3(GrxA/B) in presence and in the absence of two equivalents of 
unlabeled apo BOLA2 were collected to measure 15N backbone longitudinal 
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(R1) and transverse (R2) relaxation rates and heteronuclear 
15N{1H} NOEs. 
All NMR data were processed using the Topspin software package and were 
analysed with the program CARA. 
 
4.3.3. Cluster transfer and protein-protein interaction between GRX3 
and BOLA2 
[2Fe-2S]2-GRX32 was incubated under anaerobic conditions with apo 
BOLA2 at increasing BOLA2 concentrations up to a 1:4 protein ratio in 
degassed 50 mM phosphate buffer pH 7, 5 mM GSH and 5 mM DTT. Then, 
UV/vis and CD spectra were recorded on the final protein mixture as 
described above. Protein-protein interaction between 15N labeled apo or holo 
forms of GRX3 or GRX3(GrxA/B) and unlabeled apo BOLA2, between 15N 
labeled apo BOLA2 and unlabeled apo or holo forms of GRX3 or 
GRX3(GrxA/B) in degassed 50 mM phosphate buffer pH 7, 5 mM GSH and 
5 mM DTT containing 10% (v/v) D2O at 298K was investigated by 
1H-15N 
HSQC NMR spectra monitoring spectral changes after addition of increasing 
amounts of the unlabeled partner. Spectral changes were analysed with 
CARA program and plotted following standard procedures. 
 
4.3.4. Cluster transfer and protein-protein interaction between [2Fe-2S]2 
GRX3-BOLA22 and anamorsin 
The chemically reconstituted [2Fe-2S]2 GRX3-BOLA22 complex was 
titrated under anaerobic conditions with increasing concentrations of apo 
anamorsin up to a 1:1 protein ratio in degassed 50 mM  phosphate buffer pH 
7, 5 mM GSH, and 5 mM DTT. Cluster transfer and the protein−protein 
interaction were followed by UV−vis and CD spectroscopy and analytical 
gel filtration chromatography, respectively. 
-Chapter 4- Experimental Section 
100 
 
 
4.4. LIAS: protein production 
The cDNA coding for human LIAS (UniProtKB/Swiss-Prot: O43766) was 
acquired from Life technologies after optimization in a pENTR-like plasmid 
and insert in a pDEST-His MBP expression vector. BL21(DE3)Rosetta Plyss 
competent E. coli cells (Novagen) were transformed with the obtained 
plasmid, and cells were grown in LB or minimal media (with (15NH4)2SO4 
and/or [13C]-glucose) containing 1 mM ampicillin and 1mM 
chloramphenicol at 37° C under vigorous shaking until the OD at 600 nm 
reached 0.6. Protein expression was induced by adding 0.5 mM IPTG and 
cells were grown over night at 25 °C. Cells were harvested by centrifugation 
at 7500 x g and resuspended in lysis buffer (50 mM Tris-HCl pH 8, 0.5M 
NaCl, 5mM imidazole containing 0.01 mg/ml DNAase, 0.01 mg/ml 
lysozyme, 1 mM MgSO4, 0.5 mM EDTA and 5 mM DTT). Cell disruption 
was performed on ice by sonication and the soluble extract, obtained by 
ultracentrifugation at 40000 x g, was loaded, inside an anaerobic chamber, 
on a HiTrap chelating HP column (GE Healthcare) and the recombinant 
proteins were eluted with 50 mM Tris-HCl pH 8, 500 mM NaCl and 500  
mM imidazole. 5 mM DTT was added to the protein-containing fractions 
The proteins were then concentrated with an Amicon Ultra-15 Centrifugal 
Filter Units with a MWCO of 10 kDa (Millipore). Cleavage of the tags was 
performed by TEV protease in 50 mM Tris-HCl pH 8, 500 mM NaCl, 5 mM 
imidazole, 0.2 mM EDTA and 2 mM DTT overnight at room temperature. 
Than the protein solution was loaded again on the His Trap column to 
separate the digested proteins from the tags. Size exclusion chromatography 
was performed as the final purification step using a HiLoad Superdex75 
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16/60 column (GE Healthcare) and degassed 50 mM phosphate buffer pH 7, 
5 mM DTT as running buffer.  
We performed the mutagenesis reaction on the expression vector using 
the  QuikChange Site-Directed Mutagenesis Kits (Agilent) 
 
4.4.1. Biochemical and UV/vis, CD, EPR spectroscopic methods 
The aggregation state of isolated protein was analysed in air using analytical 
gel filtration (superdext 200 10/300 increase columns (Amersham Bioscience 
and GE Healthcare) calibrated with gel filtration marker calibration kit, 
6500-66000 Da (Sigma Aldrich)). Purified samples were loaded on the 
column pre-equilibrated with degassed 50 mM phosphate buffer pH 7 and 5 
mM DTT. Elution profiles were recorded at 280 nm with a flow rate of 0.75 
mL/min. UV/vis and CD spectra were anaerobically acquired on a Cary 50 
Eclipse spectrophotometer and JASCO J-810 spectropolarimeter, 
respectively, in degassed 50 mM phosphate buffer pH 7 and 5 mM DTT. 
EPR spectrum of the LIAS protein was recorded after the stoichiometric 
addition, inside an anaerobic chamber, of a degassed sodium dithionite 
solution to reduce the cluster and the obtained protein solution was 
immediately frozen. The EPR spectrum was acquired in degassed 50 mM 
phosphate buffer pH 7, 5 mM DTT and 10% glycerol at 45 K  using a Bruker 
Elexsys E500 spectrometer working at a microwave frequency of ca. 9.45 
GHz and equipped with a SHQ cavity and a continuous flow He cryostat 
(ESR900, Oxford instruments) for temperature control. Acquisition 
parameters were as following: microwave frequency, 9.640928 GHz; 
microwave power, 5 mW; modulation frequency, 100 KHz; modulation 
amplitude, 2.0 G; acquisition time constant, 163.84 ms; number of points 
1024; number of scans 8; field range 2300-4300 G or 2800-3800 G. 
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4.4.2 NMR spectroscopy 
Standard 1H-detected and 1H-15N HSQC NMR experiments were recorded 
on 0.7 or 1 mM 15N labeled samples in degassed 50 mM phosphate buffer 
pH 7, 5 mM DTT and at 298 K, using Bruker AVANCE 700 MHz 
spectrometers. 1H monodimensional paramagnetic spectra were acquire 
using Bruker 400M Hz equipped with a selective probe for 1H (Sel 1H 5mm 
probe). 
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5.1. The GRX3-Anamorsin maturation 
pathway18  
To investigate Fe-S cluster transfer from GRX3 to anamorsin, several GRX3 
constructs were prepared: (i) full-length GRX3 (fGRX3), (ii) a construct 
lacking the C-terminal Grx domain (GRX3(Trx-GrxA)), (iii) a construct 
containing only the Trx domain (GRX3(Trx)) and (iv) a two-domain 
construct containing both Grx domains (GRX3(GrxA/B)). All the GRX3 
constructs were monomeric in their apo form, as determined by analytical gel 
filtration and by 15N NMR relaxation data, which provided overall 
reorientational correlation times consistent with monomeric protein states 
(GRX3(Trx-GrxA) 13.6 ± 1.0 ns, GRX3(Trx) 8.7 ± 0.4 ns and 
GRX3(GrxA/B) 12.0 ± 1.2 ns; in which errors represent s.d.). The Trx 
domain did not interact with the Grx domains, as indicated by the complete 
superimposition of the 1H-15N HSQC map of GRX3(Trx) with the signals of 
the Trx domain in the 1H-15N HSQC maps of apo-fGRX3 and apo-
GRX3(Trx-GrxA) (Fig.25).  
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Figure 25. Monitoring the intra- and inter-subunit interactions of the Trx domain of 
f GRX3 with the Trx and Grx domains. (a) Overlay of 1H-15N HSQC spectra of 15N 
labeled GRX3(Trx) (red) and of 15N labeled apo fGRX3 (black) recored at 900MHz. 
(b) Overlay of 1H-15N HSQC spectra of 15N labeled GRX3(Trx) (red) and of 15N 
labeled apo GRX3 (Trx-GrxA) (black) recored at 900MHz. 
 
Once they were chemically reconstituted, fGRX3, GRX3(Trx-GrxA) and 
GRX3(GrxA/B) dimerized through their Grx domains, with each domain 
bridging a [2Fe-2S] cluster in the oxidized state, as assessed by UV-visible 
(UV-vis) and EPR spectroscopy and analytical gel filtration data (Fig.26) and 
by determining the Fe/S/protein ratio.  
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Figure 26. Analytical gel filtration chromatograms of isolated proteins in their apo 
and holo state. Purple line: apo fGRX3; green line: [2Fe-2S]2-fGRX32; dark green 
line: apo GRX3(GrxA/B); orange line: [2Fe-2S]2-GRX3(GrxA/B)2 
 
Specifically, all holo proteins exhibited UV-vis spectra typical of oxidized 
[2Fe-2S]2+ protein-bound clusters (Fig.27 b) and were EPR silent, as 
expected for the presence of a S = 0 ground state of an oxidized [2Fe-2S]2+ 
cluster. Upon chemical reduction with sodium dithionite, EPR signals of 
reduced [2Fe-2S]+ protein-bound clusters were observed (Fig.27 c). 
According to analytical gel filtration data and Fe/S/protein ratio 
quantification performed on the chemically reconstituted samples, the 
species [2Fe-2S]2-fGRX32, [2Fe-2S]-GRX3(Trx-GrxA)2 and [2Fe-2S]2-
GRX3(GrxA/B)2 (Fig.27 a) resulted in the major species present in solution. 
In all of the dimeric holo-GRX3 constructs, the Trx domain did not have 
intra- and intersubunit interactions with the Grx domains or with the Trx 
domain of the other monomer, as demonstrated from the complete 
superimposition of the 1H-15N HSQC map of GRX3(Trx) with the signals of 
the Trx domain in the 1H-15N HSQC maps of [2Fe-2S]2-fGRX32 and      
[2Fe-2S]-GRX3(Trx-GrxA)2. Cluster transfer occurred from either [2Fe-
2S]2-fGRX32 or [2Fe-2S]-GRX3(Trx-GrxA)2 to apo-anamorsin, as observed 
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by UV-vis and EPR spectroscopy. Once the two proteins were mixed, the 
absorbance peaks typical of the oxidized [2Fe-2S]2+ cluster of [2Fe-2S]2-
fGRX32 and [2Fe-2S]-GRX3(Trx-GrxA)2 disappeared, and the absorbance 
peaks typical of the oxidized [2Fe-2S]2+ cluster–bound forms of anamorsin 
([2Fe-2S]-anamorsin) appeared (Fig.27 b /c).  
Figure 27. Schematic representation of GRX3 constructs and anamorsin in their 
[2Fe-2S] cluster–bound forms. (I) and (II) indicate the two cluster-bound species of 
[2Fe-2S]-anamorsin2. Fe and S atoms are represented by red and yellow circles, 
respectively. (b,c) UV-vis (b) and EPR (c) spectra of the isolated proteins and 
protein mixtures of the cluster transfer experiments. Green line, [2Fe-2S]2-fGRX32; 
blue line, [2Fe-2S]-GRX3(Trx-GrxA)2; red line, [2Fe-2S]-anamorsin; black line, 1:1 
mixtures of [2Fe-2S]2-fGRX32 or [2Fe-2S]-GRX3(Trx-GrxA)2 with apo-anamorsin; 
dashed line, UV-vis spectra of mixtures of [2Fe-2S]2-fGRX32 and apo-anamorsin at 
increasing anamorsin concentrations up to a 1:1 protein/protein ratio. The EPR g 
values and UV-vis absorbance maxima typical of the [2Fe-2S] cluster–bound forms 
of anamorsin and GRX3 are reported. 
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Both anamorsin and GRX3 protein mixtures were EPR silent, in agreement 
with the presence of the typical S = 0 ground state of an oxidized [2Fe-2S]2+ 
cluster. Upon chemical reduction with sodium dithionite, only EPR signals 
typical of the reduced [2Fe-2S]+ clusters of [2Fe-2S]-anamorsin were 
observed (Fig.27 c), showing that the clusters were transferred from GRX3 
to anamorsin. Incubation of [2Fe-2S]-anamorsin with apo-GRX3(Trx- 
GrxA), even in excess, did not result in any changes of the UV-vis spectrum, 
indicating that the transfer was unidirectional. Finally, the UV-vis results 
showed no efficient cluster transfer (<10%) when [2Fe-2S]2-
GRX3(GrxA/B)2 was mixed with apo-anamorsin (Fig.27).  
 
Figure 27. Schematic representation of [2Fe-2S]2-GRX3(GrxA/B)2 .UV-vis spectra 
of [2Fe-2S]2-GRX3(GrxA/B)2 (orange) and of His-tagged apo-anamorsin recorded 
before (cyan) and after (black) incubation in a ~1:1 protein-protein ratio with [2Fe-
2S]2-GRX3(GrxA/B)2 and its separation through nickel-affinity chromatography. 
 
Altogether, these data demonstrated that [2Fe-2S]2+ clusters were transferred 
from fGRX3 to anamorsin and that the Trx domain of GRX3 was essential to 
efficiently drive this process. To understand why the Trx domain of GRX3, 
which has no cluster-binding properties, drives the observed cluster transfer 
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process, we studied the interaction between the two partner proteins by 
NMR. In the first step, each 15N-labeled GRX3 construct in its apo form, i.e., 
fGRX3, GRX3(Trx-GrxA), GRX3(Trx) and GRX3(GrxA/B), was titrated 
with unlabeled apo-anamorsin. Although no effects were observed in the 1H-
15N HSQC maps when GRX3(GrxA/B) was mixed with anamorsin, chemical 
shift variations and signal broadening effects were observed in the 1H-15N 
HSQC maps of fGRX3, GRX3(Trx-GrxA) and GRX3(Trx) when increasing 
amounts of anamorsin were added. Chemical shift changes were limited to 
the Trx domain signals only, with similar chemical shifts of the Trx domain 
in the 1H-15N HSQC maps of the three final mixtures (Fig.28) 
 
Figure 28. overlay of 1H-15N HSQC spectra of 15N-labeled apo-GRX3(Trx) before 
(black) and after (red) the addition of 1 eq. of apo-anamorsin. 
 
Therefore, the NMR data indicated that a heterocomplex at a 1:1 ratio 
between the two proteins in all three protein mixtures was formed, that the 
Trx domain was essential for the formation of this heterocomplex and that 
the Grx domains did not interact with anamorsin in the complex. To define 
the interaction site of apo-anamorsin with the Trx domain of apo-GRX3, we 
performed NMR titrations by recording 1H-15N HSQC experiments. In the 
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first titration, 15N-labeled GRX3(Trx) was mixed with the apo-CIAPIN1 
domain, and then unlabeled anamorsin N domain was added. In the second, 
15N-labeled apo-anamorsin was mixed with unlabeled GRX3(Trx) or fGRX3. 
No spectral changes were observed upon the addition of unlabeled apo-
CIAPIN1 domain in the first titration, indicating that the CIAPIN1 domain 
does not interact with the Trx domain of GRX3, whereas spectral changes 
were observed upon addition of the unlabeled N domain of anamorsin to the 
GRX3(Trx)-CIAPIN1 domain mixture. Overall, these data showed that apo-
GRX3 and apo-anamorsin form a 1:1 heterodimeric complex through their 
N-terminal domains and that the CIAPIN1 domain of anamorsin and the Grx 
domains of GRX3 are not involved in any permanent interaction in this 
complex. Molecular recognition between the N-terminal domains was 
therefore the crucial factor in determining complex formation between the 
two proteins. When 15N-labeled GRX3(Trx) was titrated with the unlabeled 
N domain of anamorsin, nine signals broadened beyond detection in the 1H-
15N HSQC spectra, and ten signals experienced a small chemical shift 
variation with sizable signal broadening. When detecting the 15N-labeled N 
domain of anamorsin, 15 NH signals broadened beyond detection in the 1H-
15N HSQC spectra, and 22 NH signals experienced chemical shift variation 
with sizable signal broadening (Fig.29). 
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Figure 29Overlay of 1H-15N HSQC spectra of 15N labeled GRX3(Trx) (black) after 
(red) incubation with 1 eq. of the N-domain of anamorsin 
 
 A structural model of the complex, based on these NMR titration data, was 
calculated with HADDOCK1. Specifically, the ‘active’ residues (defined in 
Online Methods) engaged in the protein-protein interaction were Gln45, 
Ala47, Gln48, Glu51, Val52, Glu55, Glu59, Ala103, His104, Ala105, 
Glu107, Thr109 and Lys110 in GRX3(Trx) and Gln52, Ala54, His55, Glu57, 
Glu78, Arg85, Ser117 and Leu121 in the N domain of anamorsin. The 
statistics of the final docking calculation are reported in Table 2. 
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Table 2 Parameters of the data-driven docking model of the complex between 
GRX3(Trx) and the N-domain of anamorsin. 
 
 The residues involved in the protein-protein interaction were located in α-
helices 2 and 4 of GRX3(Trx) and in α-helices 2, 3 and 4 and the loop 
between helix α2 and strand β3 of the N domain of anamorsin (Fig.30). 
 
Figure 30.Backbone NHs (green spheres) experiencing reliable spectral changes in 
the 1H-15N HSQC spectra upon formation of a 1:1 complex between GRX3(Trx) 
and the N domain of anamorsin or between apo-fGRX3 and apo-anamorsin are 
mapped on the docking model of the GRX3(Trx)–anamorsin N domain complex. 
GRX3(Trx) is shown in magenta, and the anamorsin N domain is in blue 
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As the CIAPIN1 domain of anamorsin did not interact with the Trx domain 
of GRX3, these additional observed shifts were necessarily due to the 
interaction between the unstructured linker region of anamorsin and the Trx 
domain of GRX3. This additional interacting region is fundamental to 
stabilize the complex. The first part of the anamorsin linker is rich in 
positively charged lysines (Lys175, Lys180, Lys181 and Lys187) that could 
electrostatically interact with the glutamic acid–rich region of the Trx 
domain of GRX3 (Fig.31). 
           
Figure 31. docking model of the GRX3(Trx)–anamorsin N domain complex. 
GRX3(Trx) is shown in magenta, and the anamorsin N domain is in blue. Orange 
spheres identify residues influenced by the interaction between full-length proteins 
in addition to those (green spheres) observed in the GRX3(Trx)–N domain complex. 
Side chains of the solvent-exposed glutamic acid residues on helix α3 of 
GRX3(Trx) are shown as red sticks, and the first part of the unstructured linker of 
anamorsin is shown as a dashed blue line with lysine residues marked with blue 
circles 
 
 
 
linker 
3 
C-ter K K K 
K 
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To address whether the GRX3–anamorsin complex was still intact once the 
beafore mentioned cluster transfer had occurred between [2Fe-2S]2-fGRX32 
or [2Fe-2S]-GRX3(Trx-GrxA)2 and apo-anamorsin, we performed 1H-15N 
HSQC NMR spectroscopy and analytical gel filtration on mixtures of  
1. 15N-labeled [2Fe-2S]2-fGRX32 and unlabeled apo-anamorsin  
2. 15N-labeled [2Fe-2S]-GRX3(Trx-GrxA)2 and unlabeled apo-
anamorsin at a 1:1 protein/protein ratio (considering the 
monomeric protein concentration for the holo-GRX3 
constructs).  
It resulted that the 1H-15N HSQC maps of the analyzed constructs of GRX3 
in these mixtures were well superimposable with those of the corresponding 
apo mixtures and that gel filtration chromatography showed the presence of a 
1:1 heterodimeric complex. 
 These data indicated that, in both mixtures, the GRX3 molecule of the 1:1 
heterodimeric complex was in the apo state, being thus the [2Fe-2S] cluster 
(or clusters) bound to the anamorsin in the complex, and that the N-terminal 
domains (Trx of GRX3 and N domain of anamorsin) interacted in the 
complex, whereas the C-terminal cluster-binding domains  
(Grx and  CIAPIN1 domains) were not involved in the protein-protein inter-
action, like what was observed in the apo–apo complexes. Additionally, the 
EPR spectra of the two mixtures (Fig.27 c), acquired upon chemical 
reduction with sodium dithionite, and the paramagnetic IR 15N-HSQC-AP 
NMR spectra3 of the 1:1 mixture of 15N-labeled apo-anamorsin and 
unlabeled [2Fe-2S]- GRX3(Trx-GrxA)2 (Fig.32) showed EPR parameters 
and paramagnetic NMR signals typical of the [2Fe-2S]- anamorsin species 
that binds the clusters through its two-conserved cysteine-rich motifs2. This 
indicated that the [2Fe-2S] cluster transfer occurred from both the GrxA and 
GrxB cluster–loaded domains of fGRX3 or from the GrxA cluster–loaded 
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domain of GRX3(Trx-GrxA) to both cluster-binding sites of the anamorsin 
CIAPIN1 domain.   
 
Figure 32.. Paramagnetic NMR spectra to monitor cluster transfer from [2Fe-2S]-
GRX3(Trx-GrxA)2 to apo anamorsin. Overlay of paramagnetic IR-15N-HSQC-AP 
spectra of a ~1:1 apo anamorsin/[2Fe-2S]- GRX3(Trx-GrxA)2 mixture (black) and 
of [2Fe-2S]- anamorsin (red) recorded at 700MHz and 311K. 
 
We have shown at the molecular level that GRX3 can have a functional role 
in cytosolic [2Fe-2S] cluster trafficking by transferring two [2Fe-2S] clusters 
to its protein partner anamorsin. The transfer mechanism was dependent on 
the formation of a protein-protein complex between the N-terminal domains 
of GRX3 and of anamorsin. Their interaction was indeed the fundamental 
requisite to observe [2Fe-2S] cluster transfer from GRX3 to the CIAPIN1 
domain of anamorsin (Fig.33). We suggest that the protein-protein 
interaction between the N-terminal domains puts the cluster-binding 
domains, i.e., the Grx donors and the CAPIN1 acceptor, in the optimal 
reciprocal orientation for the cluster transfer to occur. 
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Figure 33. Working model for the functional role of cluster transfer from GRX3 to 
anamorsin in iron metabolism.  GRX3 dimerized upon binding two [2Fe-2S] 
clusters through its GrxA and GrxB domains (orange), with each domain containing 
a GSH ligand (red). Specific protein-protein recognition between the N-terminal 
domains of [2Fe-2S]2-fGRX32 and apo-anamorsin (in dark orange and blue, 
respectively) drives the transfer of the two [2Fe-2S] clusters bound to fGRX3 to the 
two cysteine-rich motifs of the CIAPIN1 domain of anamorsin 
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In eukaryotes, both cytosolic and mitochondrial monothiol glu-taredoxin proteins bind [2Fe-2S] clusters in the same way, i.e., via the formation of a [2Fe-2S]-bridged homodimer1,2. However, 
though the molecular function of mitochondrial monothiol glutare-
doxins in assisting Fe-S protein maturation by acting as [2Fe-2S] 
cluster donors toward partner apo proteins has been demonstrated 
in the last few years1,3–6, the question of whether cytosolic mono-
thiol glutaredoxins can perform the same function in the cytosol 
still remains unsolved. In contrast, the [2Fe-2S] cluster–bound form 
of cytosolic monothiol glutaredoxins has been recently proposed 
to be implicated, together with other protein candidates7, in cyto-
solic iron trafficking, playing a crucial part in iron delivery from 
the cytosolic labile iron pool to virtually all iron-binding proteins 
in the cell8,9. Recently, it has been also shown that, in Saccharomyces 
cerevisiae, the cytosolic monothiol glutaredoxin-3 can transfer the 
cluster to the iron-responsive transcription factor Aft2 (ref. 10) in 
a way that deactivates the iron regulon for iron uptake, but cluster 
transfer occurs only when GRX3 is complexed with the BolA-like 
protein Fra2 to form a [2Fe-2S]2+-bridged heterodimer complex11–14. 
Monothiol cytosolic glutaredoxins in cooperation with BolA-like 
proteins therefore have a key role in regulating iron homeostasis in 
S. cerevisiae. However, this function is not conserved in humans as 
cellular iron homeostasis is regulated at the RNA level by the iron 
regulatory proteins 1 and 2 (ref. 15). Yeast glutaredoxin-3 alone also 
can bind a [2Fe-2S]2+ cluster in a homodimeric form, with the cluster 
coordinated by the cysteine residue of the conserved CGFS motif of 
each monomer and by two glutathione (GSH) molecules16. However, 
unlike the heterodimeric species formed between glutaredoxin-3 
and Fra2, the [2Fe-2S]2+ cluster–bound form of yeast glutaredoxin-3 
is unable to transfer the cluster to Aft2 (ref. 10). Thus, despite what 
it has been observed for mitochondrial monothiol glutaredoxins1, 
evidence showing that the homodimeric [2Fe-2S] cluster–bound 
form of cytosolic monothiol glutaredoxins can be involved in Fe-S 
protein maturation via a [2Fe-2S] cluster transfer process from their 
homodimeric holo states to partner apo proteins is still lacking.
The human proteome contains only one monothiol glutaredoxin 
(Grx) in the cytosol, GRX3 (also commonly named GLRX3 and 
PICOT). GRX3 consists of three domains: one N-terminal thiore-
doxin (Trx) domain with no Trx-related enzymatic role8,17 and two 
Grx domains each able to bind a glutathione-coordinated [2Fe-2S] 
cluster via protein dimerization2,18. Although the specific func-
tion of the in vivo indispensable17 Trx domain is still unknown, the 
Grx domains of the yeast homologs of GRX3, i.e., Grx3 and Grx4, 
which can bind one [2Fe-2S] cluster each, are absolutely required 
for the trafficking of iron in the cytosol and for the regulation of 
cellular iron homeostasis8,14,17. Recently, multiple high-throughput 
yeast two-hybrid19 and affinity-capture MS (BioGRID interaction 
1077826) screens have shown that GRX3 binds anamorsin (also 
commonly named CIAPIN1), a [2Fe-2S] cluster–binding protein 
involved in the maturation of cytosolic Fe-S proteins, in vivo20,21. 
A specific yeast two-hybrid assay was also performed to identify 
anamorsin-interacting molecules using mouse anamorsin cDNA as 
bait and a cDNA library produced from mouse testis22. Results from 
that study showed that GRX3 preferentially binds anamorsin in cells. 
Furthermore, either GRX3-deficient (Glrx3−/− or anamorsin- 
deficient (Ciapin1−/−) mice are both embryonic lethal. Deletion of the 
anamorsin gene results in embryonic lethality in late gestation (the 
rate of dead Ciapin1−/− embryos is 18.8% at embryonic day 14.5) 
because of a defect in definitive hematopoiesis in the fetal liver23,24, 
whereas 100% of Glrx3−/− mice are dead at embryonic day 14.5 
(ref. 25), although no defects in fetal hematopoiesis are observed in 
Glrx3−/− embryos. Finally, a high-throughput protein-protein inter-
action screen showed that the yeast homolog of anamorsin, Dre2, is 
found in complexes with Grx3 and Grx4 (ref. 26), and Fe-S cluster 
insertion into Dre2 is decreased three-fold upon Grx4 depletion; 
still, Dre2 levels are comparable to those detected in wild-type cells8. 
Taken together, these data provide in vivo evidence that GRX3 and 
anamorsin are physical and functional protein partners involved in 
the Fe-S cluster assembly process. However, the interaction mode 
and functional role of this interaction have not yet been defined.
Anamorsin contains two domains: an N-terminal well-folded 
domain (N domain, hereafter) comprising 172 residues and a largely 
unstructured C-terminal domain of 90 residues named cytokine-
induced apoptosis inhibitor 1 (CIAPIN1, hereafter), which contains 
two highly conserved cysteine-rich motifs able to independently 
bind a [2Fe-2S] cluster20,27. These two domains are connected by a 
long flexible linker of 50 residues27. Anamorsin is an appropriate 
target to investigate a potential functional role of GRX3 in transfer-
ring [2Fe-2S] clusters as (i) it interacts with GRX3 (ref. 22); (ii) the 
insertion of the Fe-S cluster into the yeast homolog of anamorsin, 
1Magnetic Resonance Center CERM, University of Florence, Florence, Italy. 2Department of Chemistry, University of Florence, Florence, Italy. 
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n-terminal domains mediate [2Fe-2s] cluster 
transfer from glutaredoxin-3 to anamorsin
lucia banci1,2*, simone ciofi-baffoni1,2*, Karolina gajda1, riccardo muzzioli1,2, riccardo peruzzini1 & 
Julia Winkelmann1
In eukaryotes, cytosolic monothiol glutaredoxins are proteins implicated in intracellular iron trafficking and sensing via 
their bound [2Fe-2S] clusters. We define a new role of human cytosolic monothiol glutaredoxin-3 (GRX3) in transferring 
its [2Fe-2S] clusters to human anamorsin, a physical and functional protein partner of GRX3 in the cytosol, whose [2Fe-2S] 
cluster–bound form is involved in the biogenesis of cytosolic and nuclear Fe-S proteins. Specific protein recognition between 
the N-terminal domains of the two proteins is the mandatory requisite to promote the [2Fe-2S] cluster transfer from GRX3 
to anamorsin. 
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Dre2, depends on Grx3 and Grx4, the two cytosolic and function-
ally redundant yeast homologs of GRX3 (refs. 8,14); and (iii) Fe-S 
cluster loading on Dre2 is independent of the cytosolic Fe-S protein 
assembly machinery21.
In this work, we investigated the ability of GRX3 to transfer 
[2Fe-2S] clusters to final target proteins by studying its interac-
tion with anamorsin. Protein-protein interaction and cluster trans-
fer were studied in vitro by a set of spectroscopic techniques. We 
found that GRX3 transfers two [2Fe-2S] clusters to anamorsin and 
that the transfer mechanism was dependent on the formation of a 
specific protein-protein complex between the N-terminal domains 
of GRX3 and of anamorsin. Their interaction was indeed the 
fundamental requisite to observe cluster transfer from Grx domains 
of GRX3 to the CIAPIN1 domain of anamorsin. These findings 
provide an advanced view of the functional role of GRX3 in 
iron metabolism.
ReSultS
GRX3 transfers [2Fe-2S]2+ clusters to anamorsin
To investigate Fe-S cluster transfer from GRX3 to anamorsin, a 
number of GRX3 constructs were prepared: (i) full-length GRX3 
(fGRX3), (ii) a construct lacking the C-terminal Grx domain 
(GRX3(Trx-GrxA)) with a resemblance to the topological organiza-
tion of yeast Grx3 and Grx4, (iii) a construct containing only the Trx 
domain (GRX3(Trx)) and (iv) a two-domain construct containing 
both Grx domains (GRX3(GrxA/B)) (Fig. 1a and Supplementary 
Results, Supplementary Fig. 1). All of the GRX3 constructs were 
monomeric in their apo form, as determined by analytical gel filtra-
tion (Supplementary Fig. 1) and/or by 15N NMR relaxation data, 
which provided overall reorientational correlation times consistent 
with monomeric protein states (GRX3(Trx-GrxA) 13.6 ± 1.0 ns, 
GRX3(Trx) 8.7 ± 0.4 ns and GRX3(GrxA/B) 12.0 ± 1.2 ns; in which 
errors represent s.d.). The Trx domain did not interact with the Grx 
domains, as indicated by the complete superimposition of the 1H-15N 
HSQC map of GRX3(Trx) with the signals of the Trx domain in 
the 1H-15N HSQC maps of apo-fGRX3 and apo-GRX3(Trx-GrxA) 
(Supplementary Fig. 2). Once they were chemically reconstituted, 
fGRX3, GRX3(Trx-GrxA) and GRX3(GrxA/B) dimerized through 
their Grx domains, with each domain bridging a [2Fe-2S] cluster 
in the oxidized state, as assessed by UV-visible (UV-vis) and EPR 
spectroscopy and analytical gel filtration data and by determin-
ing the Fe/S/protein ratio. Specifically, all holo proteins exhibited 
UV-vis spectra typical of oxidized [2Fe-2S]2+ protein-bound clusters 
(Fig. 1b) and were EPR silent, as expected for the presence of a S = 0 
ground state of an oxidized [2Fe-2S]2+ cluster. Upon chemical 
reduction with sodium dithionite, EPR signals of reduced [2Fe-2S]+ 
protein-bound clusters were observed (Fig. 1c). According to gel 
filtration data and Fe/S/protein ratio quantification performed on 
the chemically reconstituted samples (Supplementary Fig. 1 and 
Supplementary Table 1), the species [2Fe-2S]2-fGRX32, [2Fe-2S]- 
GRX3(Trx-GrxA)2 and [2Fe-2S]2-GRX3(GrxA/B)2 (Fig. 1a) resulted 
in the major species present in solution. These data on fGRX3 and 
GRX3(GrxA/B) are in agreement with previously reported studies2,28. 
In all of the dimeric holo-GRX3 constructs, the Trx domain did not 
have intra- and intersubunit interactions with 
the Grx domains or with the Trx domain of 
the other monomer, as demonstrated from the 
complete superimposition of the 1H-15N HSQC 
map of GRX3(Trx) with the signals of the Trx 
domain in the 1H-15N HSQC maps of [2Fe- 
2S]2-fGRX32 and [2Fe-2S]-GRX3(Trx-GrxA)2 
(Supplementary Fig. 2).
Cluster transfer occurred from either 
[2Fe-2S]2-fGRX32 or [2Fe-2S]-GRX3(Trx-GrxA)2 
to apo-anamorsin, as observed by UV-vis and 
EPR spectroscopy. Once the two proteins were 
mixed, the absorbance peaks typical of the oxi-
dized [2Fe-2S]2+ cluster of [2Fe-2S]2-fGRX32 
and [2Fe-2S]-GRX3(Trx-GrxA)2 disappeared, 
and the absorbance peaks typical of the oxi-
dized [2Fe-2S]2+ cluster–bound forms of ana-
morsin ([2Fe-2S]-anamorsin)27,29 appeared 
(Fig. 1b). Both anamorsin and GRX3 protein 
mixtures were EPR silent, in agreement with 
the presence of the typical S = 0 ground state 
of an oxidized [2Fe-2S]2+ cluster. Upon chemi-
cal reduction with sodium dithionite, only 
EPR signals typical of the reduced [2Fe-2S]+ 
clusters of [2Fe-2S]-anamorsin were observed 
(Fig. 1c), showing that the clusters were trans-
ferred from GRX3 to anamorsin. Incubation 
of [2Fe-2S]-anamorsin with apo-GRX3(Trx-
GrxA), even in excess, did not result in any 
changes of the UV-vis spectrum, indicating 
that the transfer was unidirectional. Finally, the 
UV-vis results showed no efficient cluster trans-
fer (<10%) when [2Fe-2S]2-GRX3(GrxA/B)2 
was mixed with apo-anamorsin (Fig. 2a). 
Altogether, these data demonstrated that 
[2Fe-2S]2+ clusters were transferred from 
fGRX3 to anamorsin and that the Trx 
domain of GRX3 was essential to efficiently 
drive this process.
Figure 1 | cluster transfer from GRX3 to anamorsin. (a) Schematic representation of GRX3 
constructs and anamorsin in their [2Fe-2S] cluster–bound forms. (I) and (II) indicate the two 
cluster-bound species of [2Fe-2S]-anamorsin previously described in ref. 29. Fe and S atoms  
are represented by red and yellow circles, respectively. (b,c) Uv-vis (b) and EPR (c) spectra  
of the isolated proteins and protein mixtures of the cluster transfer experiments. Green line,  
[2Fe-2S]2-fGRX32; blue line, [2Fe-2S]-GRX3(Trx-GrxA)2; red line, [2Fe-2S]-anamorsin; black line, 
1:1 mixtures of [2Fe-2S]2-fGRX32 or [2Fe-2S]-GRX3(Trx-GrxA)2 with apo-anamorsin; dashed 
line, Uv-vis spectra of mixtures of [2Fe-2S]2-fGRX32 and apo-anamorsin at increasing anamorsin 
concentrations up to a 1:1 protein/protein ratio. The EPR g values and Uv-vis absorbance maxima 
typical of the [2Fe-2S] cluster–bound forms of anamorsin and GRX3 are reported. In the EPR 
spectrum of [2Fe-2S]-anamorsin, the g values of the two clusters, each bound to one of the  
two cysteine-rich motifs of the anamorsin CIAPIN1 domain, are reported29.
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GRX3-anamorsin interaction promotes cluster transfer
To understand why the Trx domain of GRX3, which has no cluster-
binding properties, drives the observed cluster transfer process, we 
studied the interaction between the two partner proteins by NMR. 
In the first step, each 15N-labeled GRX3 construct in its apo form, 
i.e., fGRX3, GRX3(Trx-GrxA), GRX3(Trx) and GRX3(GrxA/B), 
was titrated with unlabeled apo-anamorsin. Although no effects 
were observed in the 1H-15N HSQC maps when GRX3(GrxA/B) 
was mixed with anamorsin (Fig. 2b), chemical 
shift variations and signal broadening effects 
were observed in the 1H-15N HSQC maps of 
fGRX3, GRX3(Trx-GrxA) and GRX3(Trx) 
when increasing amounts of anamorsin were 
added (Fig. 3a and Supplementary Fig. 3). In 
particular, chemical shift changes were limited 
to the Trx domain signals only, with similar 
chemical shifts of the Trx domain in the 
1H-15N HSQC maps of the three final mixtures 
(Fig. 3b and Supplementary Fig. 4). Two 
nonoverlapping NH cross-peaks (assigned 
to Gln45 and Ala47) in the 1H-15N HSQC 
map of 15N-labeled apo-GRX3(Trx), whose 
chemical shifts were largely affected by the 
protein-protein interaction, were selected to 
estimate the stoichiometry of the binding. 
Specifically, the intensity of these two cross-
peaks decreased upon addition of unlabeled 
apo-anamorsin, and the formation of two new 
cross-peaks assigned to the two correspond-
ing NHs of apo-GRX3(Trx) bound to apo-
anamorsin was observed, with their intensities 
increasing with the addition of unlabeled part-
ner. The two NH resonances of each residue are 
therefore representative of the free and bound 
states of GRX3(Trx), respectively. Using their 
intensity ratios in the 1H-15N HSQC maps 
along the results from titration, the molar 
fraction of the two species was determined 
and plotted against the GRX3(Trx)/anamorsin 
protein concentration ratio (Fig. 3a). From the 
analysis of these NMR titration data, it resulted 
that (i) spectral changes were complete at a 1:1 
protein/protein ratio and that (ii) the NH sig-
nals of the Trx domain were affected, whereas 
those of the Grx domains in fGRX3 and 
GRX3(Trx-GrxA) were not. In the final pro-
tein mixtures, line broadening was observed 
for all backbone NH signals of the 15N-labeled 
protein, even for those with no chemical shift 
variations, indicating a sizable increase in the 
molecular weight of the observed species. 
Therefore, the NMR data indicated that a het-
erocomplex at a 1:1 ratio between the two pro-
teins in all three protein mixtures was formed, 
that the Trx domain was essential for the for-
mation of this heterocomplex and that the Grx 
domains did not interact with anamorsin in the 
complex. Data from gel filtration experiments 
performed on the fGRX3-anamorsin protein 
mixture (Supplementary Fig. 1) showed that 
the heterocomplex is a heterodimer.
To define the interaction site of apo- 
anamorsin with the Trx domain of apo-GRX3, 
we performed NMR titrations by recording 
1H-15N HSQC experiments. In the first titration, 
15N-labeled GRX3(Trx) was mixed with the 
apo-CIAPIN1 domain, and then unlabeled anamorsin N domain 
was added. In the second, 15N-labeled apo-anamorsin was mixed 
with unlabeled GRX3(Trx) or fGRX3. No spectral changes were 
observed upon the addition of unlabeled apo-CIAPIN1 domain 
in the first titration, indicating that the CIAPIN1 domain does not 
interact with the Trx domain of GRX3, whereas spectral changes were 
observed upon addition of the unlabeled N domain of anamorsin to 
the GRX3(Trx)-CIAPIN1 domain mixture (Supplementary Fig. 5). 
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Figure 2 | Impaired cluster transfer and no protein-protein interaction between GRX3(Grxa/b) 
and anamorsin. (a) Schematic representation of [2Fe-2S]2-GRX3(GrxA/B)2. Uv-vis spectra of 
[2Fe-2S]2-GRX3(GrxA/B)2 (orange) and of His-tagged apo-anamorsin recorded before (cyan) 
and after (black) incubation in a ~1:1 protein-protein ratio with [2Fe-2S]2-GRX3(GrxA/B)2 and  
its separation through nickel-affinity chromatography. (b) The overlay of 1H-15N HSQC spectra  
of 15N-labeled apo-GRX3(GrxA/B) before (black) and after (red) the addition of 1 eq.  
apo-anamorsin is shown.
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Figure 3 | apo-GRX3 and apo-anamorsin specifically recognize each other via their N-terminal 
domains. (a) left panel, overlay of 1H-15N HSQC spectra of 15N-labeled apo-GRX3(Trx) before 
(black) and after (red) the addition of 1 eq. of apo-anamorsin. Right panel, stoichiometric 
formation of the GRX3-anamorsin complex at a 1:1 protein ratio, as determined by integrating 
two not-overlapping NH cross-peaks of the free (black) and bound (red) state of apo-GRX3(Trx). 
Gln45 () and Ala47 () are indicated with rectangles in the 1H-15N HSQC spectra. Data 
represent mean values ± s.d. (n ≥ 3). (b) overlay of 1H-15N HSQC spectral regions of 15N-labeled 
apo-GRX3(GrxA) (black) and GRX3(Trx) (red) with 1:1 mixtures between 15N-labeled apo-
GRX3(Trx-GrxA) and unlabeled apo-anamorsin (green) and between 15N-labeled apo-GRX3(Trx) 
and unlabeled apo-anamorsin (cyan). Arrows indicate chemical shift changes of NHs belonging to 
the Trx domain, whereas NHs of GrxA domain remain essentially unperturbed.
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These data showed that anamorsin recognizes the Trx domain of 
GRX3 through its N domain. In agreement with this, in the sec-
ond titration, spectral changes were observed in the 1H-15N HSQC 
spectra of apo-anamorsin for the backbone NHs of the N domain of 
anamorsin (Supplementary Fig. 5).
Overall, these data showed that apo-GRX3 and apo-anamorsin 
form a 1:1 heterodimeric complex through their N-terminal 
domains and that the CIAPIN1 domain of anamorsin and the Grx 
domains of GRX3 are not involved in any permanent interaction 
in this complex. Molecular recognition between the N-terminal 
domains was therefore the crucial factor in determining complex 
formation between the two proteins.
anamorsin linker stabilizes the interaction with GRX3
When 15N-labeled GRX3(Trx) was titrated with the unlabeled 
N domain of anamorsin, nine signals broadened beyond detection in 
the 1H-15N HSQC spectra, and ten signals experienced a small chem-
ical shift variation with sizable signal broadening (Supplementary 
Fig. 6). When detecting the 15N-labeled N domain of anamorsin, 
15 NH signals broadened beyond detection in the 1H-15N HSQC 
spectra, and 22 NH signals experienced chemical shift variation 
with sizable signal broadening (Supplementary Fig. 6). A structural 
model of the complex (Fig. 4a), based on these NMR titration data, 
was calculated with HADDOCK30. Specifically, the ‘active’ residues 
(defined in Online Methods) engaged in the protein-protein interac-
tion were Gln45, Ala47, Gln48, Glu51, Val52, Glu55, Glu59, Ala103, 
His104, Ala105, Glu107, Thr109 and Lys110 in GRX3(Trx) and 
Gln52, Ala54, His55, Glu57, Glu78, Arg85, Ser117 and Leu121 in the 
N domain of anamorsin. The statistics of the final docking calcula-
tion are reported in Supplementary Table 2. The residues involved 
in the protein-protein interaction were located in α-helices 2 and 
4 of GRX3(Trx) and in α-helices 2, 3 and 4 and the loop between 
helix α2 and strand β3 of the N domain of anamorsin (Fig. 4a). 
This recognition mode between the Trx domain of GRX3 and the 
N domain of anamorsin was conserved when the two full-length 
proteins were made to interact, as shown by the fact that the same 
interacting regions, comprising α-helices 2 and 4 of the Trx domain 
of GRX3, were identified when 15N-labeled apo-fGRX3 was titrated 
with unlabeled apo-anamorsin (Fig. 4a). However, additional NH 
signals of the Trx domain of GRX3, located in a negatively charged, 
glutamic acid–rich region (Glu71, Glu75, Glu78 and Glu81) adjacent 
to the interaction surface, experienced chemical shift changes 
(Fig. 4a). As the CIAPIN1 domain of anamorsin did not interact with 
the Trx domain of GRX3 (Supplementary Fig. 5), these additional 
observed shifts were necessarily due to the interaction between the 
unstructured linker region of anamorsin and the Trx domain of 
GRX3. This additional interacting region is fundamental to stabilize 
the complex. Indeed, on the NMR timescale, the exchange between 
the free and the bound proteins switched from fast or intermediate, 
when the N-terminal domains of GRX3(Trx) and of anamorsin 
interacted, to slow, when the N domain of GRX3(Trx) interacted 
with full-length anamorsin (Fig. 4b), suggesting that protein-protein 
affinity is increased when the linker is present31. According to the 
structural model of the complex, the C terminus of the N domain 
of anamorsin (where the linker begins) is located near the interac-
tion region (Fig. 4a). The first part of the anamorsin linker is rich 
in positively charged lysines (Lys175, Lys180, Lys181 and Lys187) 
that could electrostatically interact with the glutamic acid–rich 
region of the Trx domain of GRX3. The presence of this addi-
tional protein-protein interaction region was further supported 
by the disappearance of signals in the unstructured and flexible 
C-terminal tail of the N domain of anamorsin (from Phe166 to 
Arg172) in the 1H-15N HSQC NMR spectrum of anamorsin upon 
complex formation (Fig. 4a). In conclusion, the NMR and biomo-
lecular docking data described here defined how the N domains of 
the two proteins recognize each other and identified a role of the 
linker of anamorsin in stabilizing the protein-protein interaction.
anamorsin–GRX3 complex binds two [2Fe-2S]2+ clusters
To address whether the GRX3–anamorsin complex was still intact 
once the aforementioned cluster transfer had occurred between [2Fe- 
2S]2-fGRX32 or [2Fe-2S]-GRX3(Trx-GrxA)2 and apo-anamorsin, 
we performed 1H-15N HSQC NMR spectroscopy and analytical 
gel filtration on mixtures of (i) 15N-labeled [2Fe-2S]2-fGRX32 and 
unlabeled apo-anamorsin and (ii) 15N-labeled [2Fe-2S]-GRX3(Trx-
GrxA)2 and unlabeled apo-anamorsin at a 1:1 protein/protein 
ratio (considering the monomeric protein concentration for the 
holo-GRX3 constructs). It resulted that the 1H-15N HSQC maps 
of the analyzed constructs of GRX3 in these mixtures were well 
superimposable with those of the corresponding apo mixtures 
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Figure 4 | N domains of apo-GRX3 and of apo-anamorsin form a heterodimer stabilized through the unstructured linker of anamorsin. (a) Backbone 
NHs (green spheres) experiencing reliable spectral changes in the 1H-15N HSQC spectra upon formation of a 1:1 complex between GRX3(Trx) and the  
N domain of anamorsin or between apo-fGRX3 and apo-anamorsin are mapped on the docking model of the GRX3(Trx)–anamorsin N domain complex. 
GRX3(Trx) is shown in magenta, and the anamorsin N domain is in blue. orange spheres identify residues influenced by the interaction between full-length 
proteins in addition to those (green spheres) observed in the GRX3(Trx)–N domain complex. Side chains of the solvent-exposed glutamic acid residues on 
helix α3 of GRX3(Trx) are shown as red sticks, and the first part of the unstructured linker of anamorsin is shown as a dashed blue line with lysine residues 
marked with blue circles. (b) overlay of 1H-15N HSQC spectral regions of the 15N-labeled N domain of anamorsin before (black) and after the addition of 
0.5 eq. (blue) and 1 eq. (red) of GRX3(Trx) (left panel) or of apo-fGRX3 (right panel). In the left panel, arrows illustrate chemical shift deviations of Gly91 
and val125 upon addition of GRX3(Trx), which occur on a fast or intermediate exchange regime on the NMR timescale. In the right panel, NH chemical 
shifts of Gly91 and val125 switch to a slow exchange regime on the NMR timescale upon addition of apo-fGRX3. The NH resonances of Gly91 and val125 
showing the presence of free and fGRX3-bound states of the N domain of anamorsin are shown in black and red, respectively.
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Figure 5 | Working model for the functional role of cluster transfer from GRX3 to anamorsin 
in iron metabolism. (a) GRX3 dimerized upon binding two [2Fe-2S] clusters through its GrxA 
and GrxB domains (coral), with each domain containing a GSH ligand (green)28. Specific protein-
protein recognition between the N-terminal domains of [2Fe-2S]2-fGRX32 and apo-anamorsin 
(in orange and blue, respectively) drives the transfer of the two [2Fe-2S] clusters bound to 
fGRX3 to the two cysteine-rich motifs of the CIAPIN1 domain of anamorsin. on this basis, a 
protein-protein adduct, depicted in square brackets, can be assumed as the low-population 
intermediate required to modulate the cluster transfer process. one molecule of fGRX3 is then 
released from this intermediate, whereas the other remains in a complex with anamorsin through 
the interacting N-terminal domains. The latter complex represents an intermediate product 
in the cellular environment as it is expected to terminate, allowing anamorsin to perform its 
electron transfer function in the CIA machinery. (b) The GRX3-dependent maturation process 
of holo-anamorsin (black box) can affect all of the cellular processes involving cytosolic and 
nuclear [4Fe-4S]-dependent proteins as holo-anamorsin, once complexed with NDoR1, is part 
of a cytosolic electron transfer chain (red arrows) responsible for the maturation of cytosolic or 
nuclear [4Fe-4S] cluster–binding proteins (brown arrows)21,36. In yeast, Dre2 complexed with 
Tah18 functions as a source of reducing equivalent for the assembly of di-iron centers of cytosolic 
enzymes (light gray arrows)34. Thus, deficiency in the GRX3-dependent maturation process of 
anamorsin might affect di-iron cofactor biosynthesis, as observed in yeast8.
(Supplementary Fig. 7) and that gel filtra-
tion chromatography showed the presence of 
a 1:1 heterodimeric complex (Supplementary 
Fig. 1). These data indicated that, in both 
mixtures, the GRX3 molecule of the 1:1 het-
erodimeric complex was in the apo state, being 
thus the [2Fe-2S] cluster (or clusters) bound 
to the anamorsin in the complex, and that 
the N-terminal domains (Trx of GRX3 and 
N domain of anamorsin) interacted in the 
complex, whereas the C-terminal cluster-
binding domains (Grx and CIAPIN1 domains) 
were not involved in the protein-protein inter-
action, similar to what was observed in the 
apo–apo complexes. Additionally, the EPR 
spectra of the two mixtures (Fig. 1c), acquired 
upon chemical reduction with sodium dithi-
onite, and the paramagnetic IR 15N-HSQC-AP 
NMR spectra32 of the 1:1 mixture of 15N- 
labeled apo-anamorsin and unlabeled [2Fe-2S]- 
GRX3(Trx-GrxA)2 (Supplementary Fig. 8) 
showed EPR parameters and paramag-
netic NMR signals typical of the [2Fe-2S]- 
anamorsin species that binds the clusters 
through its two conserved cysteine-rich 
motifs29. This indicated that the [2Fe-2S] 
cluster transfer occurred from both the GrxA 
and GrxB cluster–loaded domains of fGRX3 
or from the GrxA cluster–loaded domain of 
GRX3(Trx-GrxA) to both cluster-binding sites 
of the anamorsin CIAPIN1 domain. Finally, 
to define whether both metal binding sites of 
anamorsin in the complex with fGRX3 were 
fully occupied after the transfer, we quanti-
fied the Fe/S ratio before and after [2Fe-2S]2-
fGRX32 was mixed with apo-anamorsin in a 
1:1 ratio (Online Methods). It resulted that this 
ratio was unaltered (Supplementary Table 1), 
indicating that anamorsin received two 
[2Fe-2S] clusters from [2Fe-2S]2-fGRX32, and 
therefore, two [2Fe-2S] clusters were bound per 
protein molecule of anamorsin (Fig. 5a). As we 
were never able to chemically reconstitute ana-
morsin with both [2Fe-2S] clusters bound at 
stoichiometric levels20,27,29, the specific protein- 
protein interaction between fGRX3 and 
anamorsin was essential to achieve complete 
cluster incorporation into anamorsin.
DIScuSSIoN
We have shown at the molecular level that GRX3 can have a func-
tional role in cytosolic [2Fe-2S] cluster trafficking by transferring 
two [2Fe-2S] clusters to its protein partner anamorsin (Fig. 5a). The 
transfer mechanism was dependent on the formation of a protein-
protein complex between the N-terminal domains of GRX3 and of 
anamorsin. Their interaction was indeed the fundamental requisite 
to observe [2Fe-2S] cluster transfer from GRX3 to the CIAPIN1 
domain of anamorsin (Fig. 5a). We suggest that the protein- 
protein interaction between the N-terminal domains puts the 
cluster-binding domains, i.e., the Grx donors and the CAPIN1 
acceptor, in the optimal reciprocal orientation for the cluster trans-
fer to occur. Therefore, it seems that the transfer process from GRX3 
to anamorsin is a thermodynamically favored process under kinetic 
control. This mechanism also guarantees that two [2Fe-2S] clusters 
are concomitantly transferred in a single molecular event to the 
target protein requiring two [2Fe-2S] clusters.
Once the cluster transfer has occurred, the complex between the 
two proteins (Fig. 5a) then needs to be terminated in the cell so 
that the functional process (or processes) performed by the matured 
form of anamorsin can proceed. It has already been shown that 
holo-anamorsin is essential for cytosolic and nuclear [4Fe-4S] pro-
tein assembly and that it is an early step component of the cytosolic 
Fe-S protein assembly (CIA) machinery. Specifically, the matured 
holo form of anamorsin forms a stable complex with the diflavin 
reductase NDOR1 in the cell20,21. This complex, which receives 
electrons from NADPH, has been proposed to act as a source of 
reducing equivalents for the assembly of target but not scaffold Fe-S 
cytosolic proteins21. It is possible that, once anamorsin has received 
the clusters from GRX3, it favors the interaction with NDOR1, thus 
terminating the interaction with GRX3. Recently, we found that 
the unstructured linker is the only region of anamorsin that tightly 
interacts with NDOR1, inducing the formation of a specific and sta-
ble protein complex20. Indeed, the N-terminal domain of anamorsin 
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was not involved in protein-protein recognition, and the C-terminal 
CIAPIN1 domain of anamorsin, containing the [2Fe-2S] redox 
center, only transiently interacts, through complementary charged 
residues, with the flavin mononucleotide (FMN)-binding domain 
of NDOR1 to perform the electron transfer reaction20. Considering 
these previous observations and the fact that this study showed 
that the anamorsin linker was also involved in the interaction with 
GRX3, we suggest that, upon interaction of the GRX3–anamorsin 
complex with NDOR1, the linker might weaken its interaction with 
GRX3 while favoring the interaction with NDOR1. As the stabi-
lizing effect of the linker on GRX3-anamorsin interaction is then 
weakened, the binding affinity of the N-terminal domain of GRX3 
with that of anamorsin might be decreased, and, as a consequence, 
the complex between GRX3 and anamorsin might switch to the 
complex between anamorsin and NDOR1. The linker interaction 
is therefore responsible for modulating the formation and release of 
the various protein-protein complexes needed to induce the redox-
competent state in anamorsin, rendering it able to receive electrons 
from NDOR1. That this linker has multiple functional interactions 
is consistent with its high flexibility, which enables its interaction 
with multiple partners, as commonly observed for intrinsically dis-
ordered proteins or regions33. This mechanism of action can also 
explain how the interaction between the holo forms of anamorsin 
and GRX3 is avoided in the cell, as the stable interaction between 
holo-anamorsin and NDOR1 will be favored with respect to the 
interaction of holo-anamorsin with holo-GRX3.
Our study contributes to the mechanistic understanding of Fe-S 
protein biogenesis in the cytosol, opening a new molecular view for 
the cellular function of GRX3 in humans. Our finding, showing that 
GRX3 has a key role in maturing anamorsin, indirectly links GRX3 
to all of the anamorsin-dependent cellular processes (Fig. 5b). 
In vivo data showed that silencing of human GRX3 expression in 
HeLa cells decreases the activities of the cytosolic Fe-S proteins 
IRP1 and GPAT9. This behavior can be a consequence of an impair-
ment of the GRX3-dependent anamorsin maturation process, 
which therefore makes the CIA machinery unable to function, i.e., 
to assemble the [4Fe-4S] clusters of IRP1 and GPAT. Similarly, in 
the functionally homologous yeast system8, in vivo data showed a 
decrease of Fe-S cluster insertion into two cytosolic Fe-S protein 
targets, the [4Fe-4S] proteins Rli1 and Nar1, upon Grx4 depletion 
as well as a defect in the di-iron cluster assembly of the cytosolic 
ribonucleotide reductase, which, similarly to the CIA machinery, 
depends on the Dre2-anamorsin electron transfer chain34,35. By 
demonstrating this and showing how GRX3 is able to mature 
anamorsin, our findings suggest a new molecular interpretation 
of the available in vivo data on GRX3 (refs. 8,9,34), thus moving 
forward the existing functional information on GRX3 from a 
limited, intracellular iron trafficking protein toward a new, more 
complex functional role. 
received 10 March 2015; accepted 1 July 2015; 
published online 24 august 2015
methoDS
Methods and any associated references are available in the online 
version of the paper.
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Protein production. The cDNA coding for human GRX3 (UniProtKB/Swiss-
Prot: O76003) was acquired from Source BioScience. Five different constructs 
(fGRX3 residues 1–335, GRX3(Trx) residues 1–117, GRX3(Trx-GrxA) residues 
1–236, GRX3(GrxA/B) residues 130–335, GRX3(GrxA) residues 120–236) 
were amplified by PCR and subsequently inserted into the pETG20A vector 
using the Gateway technology (Invitrogen). BL21-CodonPlus (DE3)-RIPL 
Competent E. coli cells (Stratagene, La Jolla, CA) were transformed with the 
obtained plasmids, and cells were grown in LB or minimal medium (with 
(15NH4)2SO4 and/or [13C]glucose) containing 1 mM ampicillin, 1 mM chloram-
phenicol and 250 μM FeCl3 at 37 °C under vigorous shaking until the OD600 nm  
reached 0.6. Protein expression was induced by adding 0.5 mM IPTG, and 
cells were grown overnight at 17 °C. Cells were harvested by centrifugation 
at 7,500g and resuspended in lysis buffer (50 mM Tris-HCl (pH 8) containing 
500 mM NaCl, 5 mM imidazole, 0.01 mg/ml DNAase, 0.01 mg/ml lysozyme, 
1 mM MgSO4, 5 mM GSH and 5 mM DTT). Cell disruption was performed 
on ice by sonication, and the soluble extract, obtained by ultracentrifugation at 
40,000g, was loaded on a HiTrap chelating HP column (GE Healthcare), and the 
recombinant proteins were eluted with 50 mM Tris-HCl (pH 8) 500 mM NaCl 
and 500 mM imidazole, 5 mM DTT and 5 mM GSH. The proteins were then 
concentrated with an Amicon Ultra-15 Centrifugal Filter Units with a MWCO 
of 10 kDa (Millipore). Cleavage of the tag was performed by TEV protease in 
50 mM Tris-HCl (pH 8) 500 mM NaCl, 5 mM imidazole and 3 mM DTT over-
night at room temperature. The protein solution was then loaded on the His-Trap 
column to separate the digested protein from the tag. Size-exclusion chroma-
tography was performed as final purification step using a HiLoad Superdex75 
16/60 column (GE Healthcare) and degassed 50 mM phosphate buffer (pH 7), 
5 mM GSH and 5 mM DTT as running buffer. Apo proteins were obtained by 
addition of 100 mM EDTA and 20 mM K4[Fe(CN)6], followed by a gel filtration 
desalting column. fGRX3, GRX3(Trx-GrxA) and GRX3(GrxA/B) were chemi-
cally reconstituted inside an anaerobic chamber (O2, <5 p.p.m.) by incubating 
the purified proteins in degassed 50 mM Tris, 100 mM NaCl, 5 mM DTT and 5 
mM GSH at pH 8 with 1 mM FeCl3 and 1 mM Na2S overnight at room tempera-
ture. To prevent the possible interference in the cluster transfer experiments of 
free [2Fe-2S] clusters, formed in solution in the reconstitution process, desalting 
with a gel filtration column was performed. Iron and acid-labile sulfide content 
were determined by colorimetric assays as described in ref. 27.
Human anamorsin (full-length protein and the N domain and CIAPIN1 
domains) in its apo and [2Fe-2S]-bound form was obtained following 
previously reported procedures20,27,29.
The aggregation state of isolated apo and holo proteins and of protein 
mixtures was analyzed in air using analytical gel filtration. Purified samples 
were loaded on a SuperdexTM 75 HR 10/30 analytical column (Amersham 
Bioscience) pre-equilibrated with 50 mM phosphate buffer (pH 7), 5 mM GSH 
and 5 mM DTT and calibrated with the Low Molecular Weight Gel Filtration 
Calibration kit (GE Healthcare). The buffer was bubbled with N2 overnight to 
minimize dissolved O2 levels. Elution profiles were recorded at 280 nm with 
a flow rate of 0.5 mL/min.
Protein concentration was determined using a Bradford assay37 with BSA as 
the calibration standard and by UV-vis absorbance using extinction coefficient 
predicted by amino acid protein sequence for the apo protein. The results from 
each determination were in good agreement.
UV-vis and EPR spectroscopy. UV-vis spectra were anaerobically acquired 
on a Cary 50 Eclipse spectrophotometer in degassed 50 mM phosphate buffer 
(pH 7), 5 mM GSH and 5 mM DTT. EPR spectra of [2Fe-2S]2-fGRX32, [2Fe-
2S]-GRX3(Trx-GrxA)2 and [2Fe-2S]-anamorsin and of the protein mixtures 
between [2Fe-2S]2-fGRX32 or [2Fe-2S]-GRX3(Trx-GrxA)2 and apo-anamorsin 
were recorded after the addition of a degassed sodium dithionite solution inside 
an anaerobic chamber to reduce the cluster, and the obtained protein solutions 
were immediately frozen. The EPR spectra were acquired in degassed 50 mM 
phosphate buffer (pH 7), 5 mM GSH, 5 mM DTT and 10% glycerol at 45 K 
using a Bruker Elexsys E500 spectrometer working at a microwave frequency 
of ~9.45 GHz and equipped with a SHQ cavity and a continuous flow He 
cryostat (ESR900, Oxford Instruments) for temperature control. Acquisition 
parameters were as following: microwave frequency, 9.640928 GHz; micro-
wave power, 5 mW; modulation frequency, 100 KHz; modulation amplitude, 
2.0 G; acquisition time constant, 163.84 ms; number of points, 1,024; number 
of scans, 8; field range 2,300–4,300 G or 2,800–3,800 G.
NMR spectroscopy. Standard 1H-detected triple-resonance NMR experiments 
for backbone resonance assignment were recorded on 0.5–1 mM 13C,15N– 
labeled samples (apo forms of GRX3(Trx-GrxA), GRX3(Trx) and GRX3(GrxA)) 
in degassed 50 mM phosphate buffer (pH 7), 5 mM DTT at 298 K, using Bruker 
AVANCE 500-MHz and 700-MHz spectrometers. To identify backbone amide 
resonances affected by paramagnetic relaxation effects, 1H-15N HSQC edited 
by a 1H inversion recovery and observed in the antiphase component (IR-15N-
HSQC-AP) were collected at 700 MHz and 298 K on apo-anamorsin/[2Fe-2S]-
GRX3(Trx-GrxA)2 mixture and [2Fe-2S]-anamorsin, prepared in an anaerobic 
chamber with degassed 50 mM phosphate buffer (pH 7), 5 mM GSH, 5 mM 
DTT32. Resonance assignment of apo- and [2Fe-2S]-anamorsin was already 
available20,27. All NMR data were processed using the Topspin software package 
and were analyzed with the program CARA.
Cluster transfer and interaction between GRX3 and anamorsin. To monitor 
cluster transfer, [2Fe-2S]2-fGRX32 and [2Fe-2S]-GRX3(Trx-GrxA)2 were incu-
bated under anaerobic conditions for 30 min with the apo form of anamorsin 
at increasing anamorsin concentrations up to a 1:1 protein/protein ratio (con-
sidering the monomeric protein concentration for the holo-GRX3 constructs) 
in degassed 50 mM phosphate buffer (pH 7), 5 mM GSH and 5 mM DTT. 
Then, UV-vis, EPR and analytical gel filtration were recorded as described 
above. The same experiment was performed under anaerobic conditions 
incubating, at a 1:1 protein ratio, [2Fe-2S]-anamorsin and apo-fGRX3 and 
[2Fe-2S]2-GRX3(GrxA/B)2 and His12-tagged apo-anamorsin.
The protein-protein interaction between 15N-labeled apo forms of fGRX3, 
GRX3(Trx-GrxA), GRX3(GrxA/B) and GRX3(Trx); unlabeled apo-anamorsin 
(full-length, N domain, CIAPIN1 domain); 15N-labeled apo-anamorsin 
(full-length, N domain); and unlabeled apo-GRX3(Trx) and fGRX3 in degassed 
50 mM phosphate buffer (pH 7) and 5 mM DTT containing 10% (v/v) D2O 
at 298K was investigated by 1H-15N HSQC NMR spectrometry monitoring 
spectral changes after addition of increasing amounts of the unlabeled partner. 
To follow both protein-protein interaction and cluster transfer processes in 
the same experiment, 15N-labeled [2Fe-2S]2-fGRX32 or [2Fe-2S]-GRX3(Trx-
GrxA)2 was titrated under anaerobic conditions with unlabeled anamorsin and 
with 15N-labeled apo-anamorsin with unlabeled [2Fe-2S]-GRX3(Trx-GrxA)2 
in degassed 50 mM phosphate buffer (pH 7), 5 mM GSH and 5 mM DTT 
containing 10% (v/v) D2O at 298 K, and the spectral changes were monitored 
by both 1H-15N HSQC and IR-15N-HSQC-AP NMR spectra32.
The structural docking model of the complex between GRX3(Trx) and 
the N domain of anamorsin was obtained using the HADDOCK program 
and protocol38 from the WeNMR portal39. In the HADDOCK calculations, 
the active residues engaged in the protein-protein interaction are those with 
a high solvent accessibility in the free form of the protein (>50% relative 
accessibility as calculated with NACCESS) and (i) experiencing reliable 
backbone NH chemical shift perturbation upon complex formation (the 
threshold to define significant chemical shift perturbations was taken 
for each protein as the average over all the Δδ values plus 1 σ (s.d.))30 or 
(ii) whose NH cross-peaks in 1H-15N HSQC NMR spectra disappeared 
upon complex formation.
Fe-S cluster quantification. The level of cluster transferred from [2Fe-2S]2-
fGRX32 to apo-anamorsin was quantified through the following procedure: 
(i) [2Fe-2S]2-fGRX32 was titrated under anaerobic conditions with apo- 
anamorsin to up to ~1 eq. in degassed 50 mM phosphate buffer (pH 7), 5 mM 
GSH and 5 mM DTT. The complete transfer of the [2Fe-2S] cluster from 
fGRX3 to anamorsin was observed by UV-vis experiments. (ii) On the start-
ing material [2Fe-2S]2-fGRX32 and on the final mixture, the iron and acid-
labile sulfur content and the protein concentration were estimated following 
the chemical assays described above. The analysis of these data is reported in 
Supplementary Table 1.
37. Bradford, M.M. Rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding. 
Anal. Biochem. 72, 248–254 (1976).
38. de Vries, S.J., van Dijk, M. & Bonvin, A.M. The HADDOCK web server  
for data-driven biomolecular docking. Nat. Protoc. 5, 883–897 (2010).
39. Wassenaar, T.A. et al. WeNMR: structural biology on the grid. J. Grid 
Computing 10, 743–767 (2012).
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Supplementary Results 
Supplementary Table 1. Iron, and acid-labile sulfide analyses of fGRX3, GRX3(Trx-GrxA), 
GRX3(GrxA/B), anamorsin and of fGRX3/anamorsin 1:1 hetero-complex. 
Sample? Fea? Sa?
Chemically reconstituted [2Fe-2S] fGRX3 4.2?±?0.1? 4.1?±?0.1?
Chemically reconstituted [2Fe-2S] GRX3(Trx-GrxA) 1.8?±?0.1? 1.9?±?0.1?
Chemically reconstituted [2Fe-2S] GRX3(GrxA/B) 4.0?±?0.1? 4.1?±?0.1?
[2Fe-2S] anamorsin 2.1?±?0.1? 2.0?±?0.1?
[2Fe-2S] fGRX3 - apo anamorsin 1:1 complex 3.9?±?0.1? 4.3?±?0.1?
aFe? and? acid?labile? S?measurements? are? reported? as?mol? Fe? or? S? per?mol? of? complex? (homodimer? or?
heterodimer)?and?of?anamorsin.?Fe?and?S?measurements?are?obtained?from?two?independent?samples.?Data?
represent?mean?values?±?s.d.?
Supplementary Table 2. Parameters of the data-driven docking model of the complex between 
GRX3(Trx) and the N-domain of anamorsin. Data represent mean values ± s.d. obtained from 200 
structures clustered in 1 cluster. 
HADDOCK?score? ?75.1?±?1.5?
Cluster?size? 200?
RMSD?from?the?overall?lowest?energy?structure 0.5?±?0.3?
Van?der?Waals?energy? ?33.5?±?1.7?
Electrostatic?energy? ?430.9?±?39.3?
Desolvation?energy? 39.6?±?6.2?
Restraints?violation?energy? 51.0?±?3.6?
Buried?Surface?Area? 1454.0?±?24.2?
Z?Score? 0.0?
?
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Supplementary Fig. 1. Spectoscopic and aggregation properties of apo/holo forms of GRX3 and anamorsin before and after their interaction. (a) Schematic
representation of fGRX3, GRX3(GrxA/B) and anamorsin in their apo and [2Fe-2S] cluster bound forms with their corresponding theoretical masses reported on the left. Fe and
S atoms are represented by red and yellow circles, respectively. (b) Analytical gel filtration chromatograms of isolated proteins in their apo and holo states and of the protein
mixtures analyzed in this study. Purple line: apo fGRX3; green line: [2Fe-2S]2-fGRX32; dark green line: apo GRX3(GrxA/B); orange line: [2Fe-2S]2-GRX3(GrxA/B)2; red line:
apo or [2Fe-2S]-anamorsin; black line: 1:1 mixture of apo or [2Fe-2S]2-fGRX32 with apo anamorsin. The experimental masses reported at the top of each chromatographic peak
derive from analytical gel filtration analysis.
?
Supplementary Fig. 2. Monitoring by NMR the intra- and inter-subunit interactions of the Trx domain of fGRX3 with the Trx and Grx domains. (a) Overlay of 1H-15N 
HSQC spectra of 15N labeled GRX3(Trx) (red) and of 15N labeled apo fGRX3 (black) recored at 900MHz. (b) Overlay of 1H-15N HSQC spectra of 15N labeled GRX3(Trx) (red) and 
of 15N labeled apo GRX3(Trx-GrxA) (black) recored at 900MHz. (c) Overlay of 1H-15N HSQC spectra of 15N labeled GRX3(Trx) (red) and of 15N labeled [2Fe-2S]2-fGRX32 (black)
recored at 900MHz. (d) Overlay of 1H-15N HSQC spectra of 15N labeled GRX3(Trx) (red) and of 15N labeled [2Fe-2S]-GRX3(Trx-GrxA)2 (black) recored at 900MHz.
?
Supplementary Fig. 3. Monitoring by NMR the interaction between different constructs of GRX3 and full-length 
anamorsin in their apo forms. (a) Overlay of 1H-15N HSQC spectra of 15N labeled apo GRX3(Trx-GrxA) (black) and of a 1:1 
mixture between 15N labeled apo GRX3(Trx-GrxA) and unlabelled apo anamorsin (red). (b) Overlay of 1H-15N HSQC spectra 
of 15N labeled apo fGRX3 (black) and of a 1:1 mixture between 15N labeled apo fGRX3 and unlabelled apo anamorsin (red). 
(c) Overlay of 1H-15N HSQC spectra of the two mixtures, i.e. 1:1 mixture between 15N labeled apo GRX3(Trx-GrxA) and 
unlabelled apo anamorsin (black) and 1:1 mixture between 15N labeled apo fGRX3 and unlabelled apo anamorsin (red).  
?
Supplementary Figure 4: NMR analysis of the interaction between different constructs of GRX3 and full-length anamorsin in their apo forms Overlay of 1H-15N HSQC 
spectral regions of 15N labeled apo GRX3(GrxA/B) (black) and GRX3(TRX) (red) GRX3 with 1:1 mixtures between 15N labeled apo GRX3(Trx-GrxA) and unlabelled apo anamorsin 
(green), and between 15N labeled apo fGRX3 and unlabelled apo anamorsin (cyano). Arrows indicate chemical shift changes of NHs belonging to the Trx domain, while NHs of GrxA 
and GrxB domains remain essentially unperturbed. 
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Supplementary Fig. 5. Monitoring by NMR the interaction site of apo anamorsin with the Trx domain of apo GRX3. (a)
Overlay of 1H-15N HSQC spectra, recorded at 700 MHz and 298 K, of 15N labeled GRX3(Trx) before (black) and after (red)
incubation with 1 eq. of the apo form of the CIAPIN1 domain of anamorsin, and (b) before and after addition of 1 eq. of the N-
domain of anamorsin to this mixture. (c) Overlay of 1H-15N HSQC spectra of 15N labeled apo anamorsin before (black) and after
(red) incubation with 1 eq. of GRX3(Trx) recorded at 800 MHz and 298 K.
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Supplementary Fig. 6. NMR analysis of the protein-protein interaction between the N-terminal domains of GRX3 and anamorsin. Overlay of 1H-15N HSQC spectra
of 15N labeled GRX3(Trx) (a) and of 15N labeled N-domain of anamorsin (b) before (black) and after (red) incubation with 1 eq. of the N-domain of anamorsin and
GRX3(Trx), respectively, recorded at 950MHz and 800MHz, respectively. Backbone weighted average chemical shift differences ?avg(HN) (i.e. ((?H)2 + (?N/5)2)/2)1/2,
where ?H and ?N are chemical shift differences for 1H and 15N, respectively) versus residue numbers, observed upon addition of 1 eq. of the unlabelled N-domain of
anamorsin to 15N-labeled GRX3(Trx) (c), and upon addition of 1 eq. of unlabelled GRX3(Trx) to 15N labeled N-domain of anamorsin (d). Gray bars indicate Pro residues
and the unassigned backbone NH of Ala 40 of GRX3(Trx), cyano bars indicate backbone NHs which broadened beyond detection. Thresholds of 0.018 ppm (mean value of
?avg(HN) plus 1?, black dashed line) were used in both titrations to identify significant chemical shift differences.
a b
c d
?
Supplementary Fig. 7. Monitoring by NMR the interaction between [2Fe-2S] cluster-bound forms of GRX3 and 
apo anamorsin. (a) Overlay of 1H-15N HSQC spectra of a 1:1 mixture of 15N labeled [2Fe-2S]-GRX3(Trx-
GrxA)2/unlabeled apo anamorsin (red) and a 1:1 mixture of 
15N labeled apo GRX3(Trx-GrxA)/unlabeled apo anamorsin
(black). (b) Overlay of 1H-15N HSQC spectra of a 1:1 mixture of 15N labeled [2Fe-2S]2-fGRX32/unlabeled apo anamorsin
(red) and a 1:1 mixture of 15N labeled apo fGRX3/unlabeled apo anamorsin (black). 
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Supplementary Fig. 8. Paramagnetic NMR spectra to monitor cluster
transfer from [2Fe-2S]-GRX3(Trx-GrxA)2 to apo anamorsin. Overlay of
paramagnetic IR-15N-HSQC-AP spectra of a ~1:1 apo anamorsin/[2Fe-2S]-
GRX3(Trx-GrxA)2 mixture (black) and of [2Fe-2S]- anamorsin (red) recorded at
700MHz and 311K.
??
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5.2. A new tool for NMR3 
As mentioned, a crucial factor for the understanding of structure-function 
relationships in metalloproteins is the identification of NMR signals from 
residues surrounding the metal cofactor. When the latter is paramagnetic, the 
NMR information in the proximity of the metal center may be scarce, 
because fast nuclear relaxation quenches signal intensity and coherence 
transfer efficiency. To identify residues at a short distance from a 
paramagnetic center, we developed a modified version of the 15N-HSQC 
experiment where 
 
 is added an inversion recovery filter prior to HSQC,  
 the INEPT period has been optimized according to fast relaxation of 
interested spins,  
 the inverse INEPT has been eliminated and signals acquired as 
antiphase doublets.  
Large contributions to relaxation and small contributions to chemical shift 
represent the most challenging situation for resonance assignment. 
Unfortunately, some of the metal cofactors that play a fundamental role in 
metalloproteins have negligible magnetic susceptibility anisotropy and, 
therefore, belong to this category4,5. In iron-sulfur containing proteins ((Fe-
S) proteins, hereafter), relatively long electron relaxation times and a highly 
symmetric electronic environment around iron ions give rise to efficient 
nuclear relaxation and negligible hyperfine shifts for resonances of nuclei not 
belonging to iron bound residues but in spatial proximity to the cluster. The 
magnetic coupling between iron ions renders (Fe-S) clusters less 
paramagnetic than isolated, tetra coordinated iron ions6; however the extent 
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of magnetic coupling is difficult to predict ‘‘a priori’’ and may vary even for 
structurally homologous proteins7,8. An understanding of the structural 
properties of residues in the proximity of the cluster is crucial for the 
elucidation of (Fe-S) proteins structure-function relationships. NMR 
methodologies need to be developed in order to detect signals that, on one 
hand cannot be identified in 1D NMR experiments because they are 
overwhelmed from the bulk diamagnetic envelope and, on the other hand, 
cannot be observed in conventional double and triple resonance experiments 
because coherence transfer and NOEs are quenched due to fast relaxation. So 
for testing this modified pulse sequence of a 1H-15N HSQC, we selected the 
c-terminal part of anamorsin. Experiments were recorded on a 11.7 T Bruker 
AVANCE 500 MHz equipped with a triple resonance, inverse detection, 
cryoprobe (TXI). All experiments were recorded using the same overall 
experimental time. Standard 15N-HSQC experiments were recorded using 
Watergate and flip-back pulses to suppress solvent signal. 96 scans were 
recorded over 256 increments, with 1.1 s as recycle delay. For IR-15N-
HSQC-AP experiments, 2,048 scans were collected over 100 increments 
(t1max= 24.7 ms), using an INEPT transfer period of 833 us. Acquisition 
time, recycle delay and inversion recovery (IR) delay were 20, 55 and 50 ms, 
respectively. T1 measurements were obtained from a series of ten IR-15N-
HSQC-AP experiments recorded using IR delays of 50, 35, 25, 15, 10, 7, 5, 
3, 2, 1 ms. The pulse sequence of the IR 15N-HSQC, antiphase detected 
experiment (IR-15N-HSQC-AP) is reported in Fig.34.  
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Figure 34. Pulse scheme of IR-15N-HSQC-AP. Narrow and wide symbols stand for 
90° and 180° pulses, respectively. The pulses were applied along the x axis unless 
noted differently. The phase cycling employed is as follows: ϕ1 = (x,-x)  ϕ2 = (x,x,-
x,-x)  ϕ3= (x,x,x,x,-x,-x,-x,-x)  ϕrec = (x,-x,x,-x,-x,x,-x,x). Quadrature in F1 is 
obtained via States-TPPI of /1 
 
At variance with conventional 15N-HSQC experiments, 1H excitation has 
been accomplished via an IR building block. IR discriminates nuclear spin 
magnetizations according to their T1 relaxation times: a suitable choice of the 
interpulse delay s causes a sign discrimination between fast relaxing signals 
and slow relaxing signals9,10. When IR is combined with a short duty cycle, 
the intensity of diamagnetic signals is significantly suppressed, and the 
paramagnetic 1H resonances that are usually overwhelmed by the bulk 
envelope of diamagnetic signals can be observed. In 15N-HSQC experiments, 
the loss of magnetization during coherence transfer steps is, of course, 
another factor that modulates signal intensity. To circumvent the problem, 
the INEPT period can be shortened according to T2 relaxation properties of 
signals of interest20. When the overall INEPT period is shortened down to 
1.5 ms, coherence transfer efficiency of 57, 37 and 17 % are recovered for 
signals characterized by T2 values of 5, 2 and 1 ms, respectively, while the 
efficiency of coherence transfer from nuclei that experience a smaller 
hyperfine interaction is about 75%. The most critical step of a standard 15N-
HSQC experiment is the inverse INEPT block, during which coherences are 
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back converted into observable, in phase Hy. When both forward and 
backward INEPT steps are used, a signal with T2 = 1 ms (Dm ca. 300 Hz) 
will exhibit, under the very best experimental conditions, an overall transfer 
efficiency of 4%. As a consequence, a reduction of the INEPT period without 
any pulse sequence modification allows one only to detect HN connectivities 
involving 1H resonances ≤ 250 Hz linewidth and fails at larger linewidths. To 
overcome the problem, we removed the inverse INEPT refocusing step and 
we acquired the signal as a doublet, antiphase component without 15N 
decoupling during acquisition. The IR-15N-HSQC-AP experiment is not only 
useful to identify previously undetected signals, but also provides metal-to 
proton distances which, in the proximity of the prosthetic group, are the most 
valuable structural constraint11 The CIAPIN1 domain of the human protein 
anamorsin12,13 is a challenging system to test the sequence presented above. 
It is a 108 amino acid domain that binds a [2Fe-2S]2+ cluster per molecule. 
The CIAPIN1 domain is largely unstructured without significant tertiary 
structure organization (Fig.35).  
 
Figure 35 Overlay of a standard 15N-HSQC (red) and IR-15NHSQC- AP (black) 
experiments acquired on 500 MHz at 298 K on the [2Fe-2S]2+-CIAPIN1 domain. 
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[2Fe-2S]2+ clusters are expected to induce minimal hyperfine shift and 
sizable hyperfine. nuclear relaxation on 1H spins that do not belong to metal 
coordinating cysteine residues but are within a, roughly, 10 A° distance from 
each of the two iron ions. Consistent with expectations, the 15N-HSQC 
spectrum of the protein, recorded under standard conditions, shows only 71 
out of 108 residues. Their assignment was performed via conventional 
double and triple resonance experiments12. As shown in Fig. 35 when IR-
15N-HSQC-AP experiment was performed, 10 additional HN signals, 
completely absent in previous experiments, are now observed. Furthermore, 
three HN signals, barely detectable in conventional experiments, 
significantly increased their intensity. The IR-15N-HSQC-AP experiment 
selectively identifies HN groups from the environment of the paramagnetic 
center that experience significant paramagnetic relaxation and almost 
negligible contributions to chemical shift. In particular, we have shown that 
in the case of proteins involved in the iron-sulfur protein biogenesis, the IR-
15N-HSQC-AP experiment substantially contributes to decrease, and 
eventually abolish, the blind sphere around the metal center that typically 
escape routine NMR investigation. 
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Abstract A crucial factor for the understanding of
structure-function relationships in metalloproteins is the
identification of NMR signals from residues surrounding
the metal cofactor. When the latter is paramagnetic, the
NMR information in the proximity of the metal center may
be scarce, because fast nuclear relaxation quenches signal
intensity and coherence transfer efficiency. To identify
residues at a short distance from a paramagnetic center, we
developed a modified version of the 15N-HSQC experiment
where (1) an inversion recovery filter is added prior to
HSQC, (2) the INEPT period has been optimized according
to fast relaxation of interested spins, (3) the inverse INEPT
has been eliminated and signals acquired as antiphase
doublets. The experiment has been successfully tested on a
human [Fe2S2] protein which is involved in the biogenesis
of iron-sulfur proteins. Thirteen HN resonances, unob-
served with conventional HSQC experiments, could be
identified. The structural arrangement of the protein scaf-
fold in the proximity of the Fe/S cluster is fundamental to
comprehend the molecular processes responsible for the
transfer of Fe/S groups in the iron-sulfur protein assembly
machineries.
Keywords Iron-sulfur proteins  Paramagnetic NMR 
15N-HSQC  Pulse sequences  Paramagnetic relaxation 
Anamorsin
Introduction
Solution state and solid state NMR spectroscopy of para-
magnetic molecules (Knight et al. 2013; Otting 2010; Ar-
nesano et al. 2006) play a fundamental role in the
understanding of many biological processes, such as elec-
tron transfer (Ubbink 2012), metal homeostasis (Lutsenko
2010; Banci et al. 2010), metal trafficking (Finney and
O’Halloran 2003; Banci et al. 2006; Boal and Rosenzweig
2009; Leary et al. 2009). Metalloproteins offer many
examples in which structure, function and dynamics have
been found to be redox dependent (Fetrow and Baxter
1999; Bertini et al. 1995; Lyons et al. 1996), or to be driven
by the coordination chemistry of the metal center (Caillet-
Saguy et al. 2012). Paramagnetic probes (Gaponenko et al.
2004; Keizers and Ubbink 2011; Iwahara et al. 2004) have
been used for decades to study structure (Yagi et al. 2013),
dynamics and solvent accessibility (Bertini et al. 1997) of
large biomolecules (Clore and Iwahara 2009), multidomain
proteins (Russo et al. 2013; Bertini et al. 2007) and bio-
molecular complexes (Volkov et al. 2010), in which only
sparse information is available via conventional NMR
approaches (Bertini et al. 2002; Balayssac et al. 2006;
Machonkin et al. 2002).
The wide, and still growing, range of application of
paramagnetic NMR depends on the fact that electronic
correlation times of metal centers range from 10-13 to
10-8 s (Bertini et al. 2001b). As a consequence, nuclear
relaxation properties of the environment of the metal cen-
ters are versatile. The hyperfine interaction affects NMR
shifts and linewidths to different extents and, therefore one
faces different scenarios depending on the metal ion, on the
coordination environment, and on the nucleus investigated.
As summarized in Fig. 1, for a 1H spin at a fixed distance
from the metal center, calculated contributions (Bertini
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et al. 2001b) to nuclear relaxation and chemical shifts range
from null to thousands Hz and hundreds of ppm, depending
on the paramagnetic probe.
Large contributions to relaxation and small contribu-
tions to chemical shift represent the most challenging sit-
uation for resonance assignment. Unfortunately, some of
the metal cofactors that play a fundamental role in metal-
loproteins have negligible magnetic susceptibility anisot-
ropy and, therefore, belong to this category (Bertini et al.
1994b; Abriata et al. 2009). When the magnetic suscepti-
bility tensor of the metal cofactor is not affected by effi-
cient spin-orbit coupling mechanisms, hyperfine shifts only
arise from unpaired electron spin density delocalized onto
the observed nuclear spin, which typically quenches a few
chemical bonds away from the metal center, unless spin
polarization mechanisms due to the presence of aromatic
ligands occurs (Bertini et al. 1994c). However, the electron
spin-nuclear spin dipolar coupling still contributes to
nuclear relaxation; as a consequence, signals that do not
belong to the first coordination sphere but are spatially
close to the metal cofactor, exhibit negligible hyperfine
shifts but efficient paramagnetic relaxation enhancements
(Im et al. 1998; Skjeldal et al. 1991; Mo et al. 1999).
In iron-sulfur containing proteins (Fe/S proteins, here-
after), relatively long electron relaxation times and a highly
symmetric electronic environment around iron ions give
rise to efficient nuclear relaxation and negligible hyperfine
shifts for resonances of nuclei not belonging to iron bound
residues but in spatial proximity to the cluster. The mag-
netic coupling between iron ions renders Fe/S clusters less
paramagnetic than isolated, tetra coordinated iron ions
(Wilkens et al. 1998); however the extent of magnetic
coupling is difficult to predict ‘‘a priori’’ and may vary
even for structurally homologous proteins (Bertini et al.
1992; Banci et al. 1993). An understanding of the structural
properties of residues in the proximity of the cluster is
crucial for the elucidation of Fe/S proteins structure-func-
tion relationships. In the past, this has been successfully
addressed for small electron transfer proteins such as High
Potential Iron-Sulfur Proteins (HiPIP) and Ferredoxins
(Fdx) (Lin et al. 2009; Volkman et al. 1999; Bentrop et al.
1996; Bertini et al. 1994a). Recently, our group faced the
problem to characterize the functional properties of Fe/S
proteins involved into Fe/S cluster biogenesis (Banci et al.
2011, 2013a; b). At variance with HiPIP and Fdx, char-
acterized by rigid structures and high thermodynamic sta-
bility, these proteins show flexible structures and various
conformational states, particularly in the proximity of the
cofactor binding sites, that are driven by the uptake and
release of the Fe/S cluster (Markley et al. 2013; Li et al.
2013). NMR methodologies need to be developed in order
to detect signals that, on one hand cannot be identified in
1D NMR experiments because they are overwhelmed from
the bulk diamagnetic envelope and, on the other hand,
cannot be observed in conventional double and triple res-
onance experiments because coherence transfer and NOEs
are quenched due to fast relaxation. We present here a
modified version of the 15N-HSQC experiment which
enables the identification of residues at a short distance
from the Fe/S cluster and applied it to the largely
unstructured, C-terminal domain of the human [Fe2S2]
protein anamorsin.
Materials and methods
Protein expression and purification
The C-terminal domain of the human protein anamorsin,
residues 205-312, named cytokine-induced apoptosis
inhibitor 1 (CIAPIN1 domain, hereafter), has been cloned
and produced as an independent domain, according to a
previously reported methodology (Banci et al. 2013a). This
domain was found to bind Fe2S2 clusters with two ferric
ions ([Fe2S2]
2?, hereafter) (Banci et al. 2011, 2013b).
NMR spectroscopy
Experiments were recorded on a 11.7 T Bruker AVANCE
500 equipped with a triple resonance, inverse detection,
Fig. 1 Expected hyperfine shifts versus expected paramagnetic line
broadening in 1H resonances for a number of metal centers for
directly metal bound (subscript B) and non bound (subscript NB)
residues. Tetra and exa indicate tetrahedral and octahedral coordina-
tion geometries, respectively. Values are estimated by using reported
values of electronic relaxation times (Bertini et al. 2001b). For signals
from coordinating residues, a 3.5 A˚ distance from the metal and
hyperfine coupling constants ranging 1–4 MHz were considered. For
non bound residues, a metal to proton distance of 6 A˚ was considered.
Simulations were performed assuming B0 = 11.7 T (500 MHz).
Scales in both x- and y-axis are arbitrary
J Biomol NMR
123
cryoprobe (TXI). All experiments were recorded using the
same overall experimental time. Standard 15N-HSQC
experiments were recorded using Watergate and flip-back
pulses to suppress solvent signal. 96 scans were recorded
over 256 increments, with 1.1 s as recycle delay. To collect
a fast repetition 15N-HSQC, the GARP4 decoupling
scheme was replaced with an adiabatic decoupling that
covers 1,500 Hz and uses a 2 ms 180 pulse. 288 scans
were recorded over 256 increments with a recycle delay of
350 ms. For IR-15N-HSQC-AP experiments, 2,048 scans
were collected over 100 increments (t1max= 24.7 ms), using
an INEPT transfer period of 833 us. Acquisition time,
recycle delay and inversion recovery (IR) delay were 20,
55 and 50 ms, respectively. T1 measurements were
obtained from a series of ten IR-15N-HSQC-AP experi-
ments recorded using IR delays of 50, 35, 25, 15, 10, 7, 5,
3, 2, 1 ms. Signals characterized by T1 values longer than
100 ms were measured using a series of experiments using
a recycle delay of 350 ms and IR delays of 250, 150, 100,
60, 40, 25, 15, 8, 4 ms.
Results and discussion
The IR-15N-HSQC-AP experiment
The pulse sequence of the IR 15N-HSQC, antiphase
detected experiment (IR-15N-HSQC-AP) is reported in
Fig. 2. At variance with conventional 15N-HSQC experi-
ments, 1H excitation has been accomplished via an IR
building block. IR discriminates nuclear spin magnetiza-
tions according to their T1 relaxation times: a suitable
choice of the interpulse delay s causes a sign discrimina-
tion between fast relaxing signals and slow relaxing signals
(Gelis et al. 2003; Machonkin et al. 2004). When IR is
combined with a short duty cycle, the intensity of dia-
magnetic signals is significantly suppressed, and the para-
magnetic 1H resonances that are usually overwhelmed by
the bulk envelope of diamagnetic signals can be observed.
In 15N-HSQC experiments, the loss of magnetization dur-
ing coherence transfer steps is, of course, another factor
that modulates signal intensity. Coherence transfer from Hy
to 2HxNz and vice versa competes with relaxation of the
2HxNz antiphase magnetization which, in a paramagnetic
system, is dominated by 1H T2 relaxation. As shown in
Fig. 3, for a 1H signal with T2 values of 5 ms, about 60% of
signal is retained after a standard INEPT transfer step,
while only 7% is retained for T2 values as short as 1 ms. To
circumvent the problem, the INEPT period can be short-
ened according to T2 relaxation properties of signals of
interest (Piccioli and Poggi 2002). When the overall INEPT
period is shortened down to 1.5 ms, coherence transfer
efficiency of 57, 37 and 17 % are recovered for signals
characterized by T2 values of 5, 2 and 1 ms, respectively,
while the efficiency of coherence transfer from nuclei that
experience a smaller hyperfine interaction is about 75%. In
principle, the hyperfine interaction affects also longitudinal
relaxation rates of 15N spins and additional contributions to
the relaxation of antiphase HxNz magnetization should be
considered. However, paramagnetic dipolar relaxation is
dependent on the c2 of the nucleus and therefore the
paramagnetic relaxation experienced by heteronuclear spin
can be safely neglected (Bermel et al. 2006). The INEPT
approach is useless for 1H resonances with T2\0.5 ms (Dm
ca.[ 600 Hz). For the latter case, the coherence transfer
pathway never exceeds 10% efficiency and therefore the
direct excitation of 15N spins is the best approach (Hsueh
et al. 2010).
Fig. 2 Pulse scheme of IR-15N-HSQC-AP. Narrow and wide sym-
bols stand for 90 and 180 pulses, respectively. The pulses were
applied along the x axis unless noted differently. The phase cycling
employed is as follows: /1 = (x,-x) /2 = (x,x,-x,-x) /
3 = (x,x,x,x,-x,-x,-x,-x) / rec = (x,-x,x,-x,-x,x,-x,x). Quad-
rature in F1 is obtained via States-TPPI of /1
Fig. 3 Efficiency of an INEPT transfer function at different 1H T2
values: b 100 ms, c 10 ms, d 5 ms, e 2 ms, f 1 ms, g 0.5 ms.
Relaxation is neglected in a. Letters have been drawn at the
correspondence of the maximum values for each transfer function.
A dashed line is shown at the 2.65 ms of INEPT step (94 Hz for
1H-15N J coupling). A solid line is shown in correspondence of 10%
transfer efficiency
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The most critical step of a standard 15N-HSQC experi-
ment is the inverse INEPT block, during which coherences
are back converted into observable, in phase Hy. When
both forward and backward INEPT steps are used, a signal
with T2 = 1 ms (Dm ca. 300 Hz) will exhibit, under the very
best experimental conditions, an overall transfer efficiency
of 4%. As a consequence, a reduction of the INEPT period
without any pulse sequence modification allows one only
to detect HN connectivities involving
1H resonances
B250 Hz linewidth and fails at larger linewidths. To
overcome the problem, we removed the inverse INEPT
refocusing step and we acquired the signal as a doublet,
antiphase component without 15N decoupling during
acquisition. In this simplified scheme, the critical 1H T2
relaxation is operative only during t2 acquisition that
should be tuned accordingly. The loss in sensitivity arising
from the acquisition of the antiphase component versus an
in-phase singlet is partly recovered when the direct
acquisition dimension is processed with a 90 phase shift.
i.e. the antiphase doublet is processed in dispersion mode.
When signal linewidth is larger than doublet separation, the
components of in phase doublets partly overlap and cancel
signal (Bertini et al. 2005). However, when the doublet is
phased in dispersion mode, it gives rise to a ‘‘pseudosin-
glet’’ originated by the sum of the two dispersive compo-
nents of the doublet. This contributes to the identification
of broad, fast relaxing peaks and also to discriminate sig-
nals more severely affected by paramagnetic relaxation
with respect to the others.
The IR-15N-HSQC-AP experiment is not only useful to
identify previously undetected signals, but also provides
metal-to proton distances which, in the proximity of the
prosthetic group, are the most valuable structural constraint
(Bertini et al. 2001a). Indeed, when a series of IR-15N-
HSQC-AP experiments is performed in which the inter-
pulse delay of the IR building block, s, is arrayed, non
selective T1 values of
1HN amide resonances are obtained
according to a classical IR 1H experiment where the 90
reading pulse is replaced by the 15N-HSQC-AP block.
Assuming that 1H relaxation is dominated by the electron
spin-nuclear spin metal centered dipolar contribution, T1
hyperfine relaxation directly depends on rMH
-6 .
The case of Fe/S proteins
The CIAPIN1 domain of the human protein anamorsin
(Banci et al. 2013b; Banci et al. 2011) is a challenging
system to test the sequence presented above. It is a 108
amino acid domain that binds a [Fe2S2]
2? cluster per
molecule (Banci et al. 2013a, b). The CIAPIN1 domain is
largely unstructured without significant tertiary structure
organization (Fig. 4). [Fe2S2]
2? clusters are expected to
induce minimal hyperfine shift and sizable hyperfine
nuclear relaxation on 1H spins that do not belong to metal
coordinating cysteine residues but are within a, roughly,
10 A˚ distance from each of the two iron ions. Consistent
with expectations, the 15N-HSQC spectrum of the protein,
recorded under standard conditions, shows only 71 out of
108 residues. Their assignment was performed via con-
ventional double and triple resonance experiments (Banci
et al. 2013a). About 30% of the resonances remain unob-
served due to paramagnetic broadening or exchange con-
tributions. As shown in Fig. 4, when IR-15N-HSQC-AP
experiment was performed, 10 additional HN signals,
completely absent in previous experiments, are now
observed. Furthermore three HN signals, barely detectable
in conventional experiments, significantly increased their
intensity. The repetition of the experiment at different IR
delays allowed us, from the analysis of integrated intensity
of the paramagnetic 1H-15N resonances, to measure the T1
values for 12 out of 13 paramagnetic 1H signals, that have
been identified in IR-15N-HSQC-AP from nuclei spatially
close to the [Fe2S2]
2? cluster. Four of them had T1 shorter
than 10 ms, four in 10–20 ms range, one 20–50 ms range,
and three in the 80–150 ms range. An assignment has been
proposed for 10 out of 13 resonances by the analysis of
chemical shift values, relaxation rates, and 13C-detected
experiments tailored to paramagnetic systems (Banci et al.
2013a).
Fig. 4 Overlay of a standard 15N-HSQC (thin lines) and IR-15N-
HSQC-AP (thick lines) experiments acquired on 500 MHz at 298 K
on the [Fe2S2]
2?-CIAPIN1 domain. The experimental time for both
experiments was ca. 7 h. For the IR-15N-HSQC-AP, acquisition times
of 20 and 24 ms were used in t2 and t1 acquisition dimensions,
respectively, and recycle and IR delays were 55 and 50 ms,
respectively. To rule out effects due to short recycle delays, the
reference 15N HSQC has been recorded with a 350 ms overall recycle
delay. Peaks are labeled according to their assignment (Banci et al.
2013a). Unassigned resonances are indicated with X. Signals
attributed to D281, A282 and G292 were observed also in the
reference experiment but at much lower intensity. For 12 out of 13
peaks T1 values could be obtained. Ten of them have been used as
structural constraints
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Conclusions
The collection of an exhaustive series of double and triple
resonance experiments, in which all parameters have been
previously optimized on the basis of reference systems, is
nowadays the approach of every NMR laboratory involved
in structural biology. Paramagnetic centers cannot be trea-
ted with a routine approach and require knowledge of the
electronic properties of the metal cofactor of the molecule.
We have shown here that fundamental pulse sequence
building blocks such as the 15N-HSQC experiment can be
easily modified in order to improve the outcome of standard
experiments. The IR-15N-HSQC-AP experiment selectively
identifies HN groups from the environment of the para-
magnetic center that experience significant paramagnetic
relaxation and almost negligible contributions to chemical
shift. For the identified HN resonances, the experiment
provides also T1 relaxation times, which are dependent on
the rMH
-6 on the basis of the Solomon equation (Arnesano
et al. 2006) and typically constitute the most precious
structural information for metalloprotein structural studies.
This experiment is valuable for those systems in which
no pseudocontact shift occurs, such as Cu2? proteins and
Fe/S proteins. In particular, we have shown that in the case
of proteins involved in the iron-sulfur protein biogenesis,
the IR-15N-HSQC-AP experiment substantially contributes
to decrease, and eventually abolish, the blind sphere around
the metal center that typically escape routine NMR
investigation. The structural arrangement of protein scaf-
fold in the proximity of the Fe/S cluster is a fundamental
factor to be investigated to comprehend at the molecular
level the events responsible of the transfer of Fe/S groups
in the iron-sulfur protein assembly machineries.
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5.3. The role of BOLA2 in the GRX3 dependent 
Anamorsin maturation pathway19 
Interaction of apo GRX3 with apo BOLA2. Full-length BOLA2 protein was 
overexpressed in E. coli cells and purified in its apo form. Analytical gel 
filtration and 15N NMR relaxation data, which provided a molecular 
reorientational correlation time of 6.9 ± 0.23 ns, showed that the purified apo 
protein is monomeric. Purified apo BOLA2 was unable to bind (Fe-S) 
clusters when a chemical reconstitution approach14 was applied. To 
investigate the interaction between the apo forms of GRX3 and BOLA2, 
chemical shift changes of backbone NHs were followed by 1H−15N HSQC 
NMR experiments upon titration of 15N-labeled apo GRX3 with unlabeled 
apo BOLA2, and of 15N-labeled apo BOLA2 with unlabeled apo GRX3, in 
the presence of 5 mM GSH and 5 mM DTT. Chemical shift variations, which 
were in a fast/intermediate exchange regime on the NMR time scale, were 
observed in the 1H−15N HSQC maps of GRX3 for the backbone NHs of both 
Grx domains, when increasing amounts of unlabeled BOLA2 were added up 
to a 1:2 GRX3-BOLA2 molar ratio, while no significant effects were 
observed on the backbone NHs of the Trx domain of GRX3 (Fig.36A).  
-Chapter 5- Results  
148 
 
 
 
 
Figure 36. Apo GRX3 interacts with apo BOLA2. (A) Overlay of 1H−15N HSQC 
spectra of 15N-labeled apo GRX3 (black), of 15Nlabeled Trx domain of GRX3 
(green), and of a 1:2 mixture of 15Nlabeled apo GRX3 and unlabeled apo BOLA2 
(red). (B) Overlay of 1H−15N HSQC spectra of 15N-labeled apo BOLA2 (black) and 
of a 1:2 mixture of unlabeled apo GRX3 and 15N-labeled apo BOLA2 (red). 
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These chemical shift changes occur simultaneously on both Grx domains, 
thus indicating that BOLA2 does not have a preferential interaction toward 
one of the two Grx domains (Fig.36 A). Similarly, chemical shift variations 
in a fast/intermediate exchange regime on the NMR time scale were 
observed in the 1H−15N HSQC maps of BOLA2 when increasing amounts of 
unlabeled GRX3 were added up to a 1:2 GRX3-BOLA2 molar ratio (Fig.36 
B). The interaction between apo BOLA2 and apo GRX3 was also followed 
by analytical gel filtration chromatography, performed on protein mixtures 
with different apo GRX3 and apo BOLA2 ratios (Fig.37). The formation of 
two peaks was observed by adding apo BOLA2 to apo GRX3 up to a 1:2 
GRX3-BOLA2 ratio:  
 
1. a peak with an apparent molecular mass of 70.4 kDa, 
predominant at 1:1 protein ratio;  
2. a peak with an apparent molecular mass of 74.3 kDa, 
predominant at 1:2 protein ratio.  
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Figure 37. Analytical gel filtration (Superdex 200 10/300 increase column) 
chromatograms of BOLA2 and GRX3 proteins in their apo states and of their 
protein mixtures. Black line: apo GRX3; red line: apo BOLA2; green line: 1:0.5 
mixture of apo GRX3 and apo BOLA2; blue line: 1:1 mixture of apo GRX3 and apo 
BOLA2; cyan line: 1:1.5 mixture of apo GRX3 and 
apo BOLA2; magenta line: 1:2 mixture of apo GRX3 and apo BOLA2. 
 
These results indicated that apo GRX3 forms a heterodimeric complex with 
apo BOLA2 at the 1:1 protein ratio (the 70.4 kDa value matches indeed with 
the sum of the apparent molecular masses of apo GRX3 and apo BOLA2), 
which then evolves, upon addition of a further equivalent of apo BOLA2, to 
form a species which has an apparent molecular mass (74.3 kDa) 
intermediate between that of the heterodimeric complex (70.4 kDa) and that 
of an apo heterotrimeric complex formed by two BOLA2molecules and one 
GRX3 molecule (82 kDa, obtained by the sum of the apparent molecular 
masses of apo GRX3 and two molecules of apo BOLA2). The presence of 
this peak with an intermediate apparent molecular mass can be a 
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consequence of the applied gel filtration conditions, which determined, 
indeed, the presence of a fast exchange equilibrium between the 
heterodimeric and heterotrimeric complexes. Therefore, we performed the 
analytical gel filtration chromatography using a different column, i.e., 
Superdex 75 HR 10/30, and it resulted that apo GRX3 protein interacts with 
apo BOLA2 forming a peak with an apparent molecular mass of 78.8 kDa 
predominant at 1:2.5 GRX3-BOLA2 protein ratio. This value essentially 
corresponds to the sum of the apparent molecular masses of apo GRX3 (52.7 
kDa) and two molecules of apo BOLA2 (11.0 kDa) (Fig.38), thus 
definitively indicating the formation of the apo GRX3-BOLA22 
heterotrimeric complex.  
 
Figure 38. Analytical gel filtration (Superdex 75 HR 10/30 column) chromatograms 
of isolated BOLA2, GRX3(GrxA/B) and GRX3 proteins in their apo states and of 
their protein mixtures. Black line: apo BOLA2; red line: apo GRX3; green line: apo 
GRX3(GrxA/B); cyan line: 1:2.5 mixture of apo GRX3(GrxA/B) and apo BOLA2; 
blue: 1:2.5 mixture of apo GRX3 and apo BOLA2. 
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Since the Trx domain is not involved in the interaction between apo BOLA2 
and apo GRX3, we produced a two domains construct containing the GrxA 
and GrxB domains only, (GRX3(GrxA/B)), to map, by solution NMR, the 
residues involved in the formation of the heterotrimeric complex. With this 
shorter construct, the chemical shift data analysis was indeed simplified by 
the reduction of NMR signal overlap and broadening due to the reduced 
protein size The 1H−15N HSQC signals of the final protein mixture, i.e., 1:2 
15N-labeled apo GRX3(GrxA/B)-apo BOLA2, well superimposed with the 
corresponding signals of a 1:2 apo 15N labeled GRX3-apo BOLA2 mixture, 
indicating that the same complex involving the same interacting region was 
present in solution in the two mixtures, and confirming that Trx domain has 
no specific role in the protein−protein recognition between apo GRX3 and 
apo BOLA2. Comparing the 1H−15N HSQC map of the final apo 
GRX3(GrxA/B)-apo 15N-labeled BOLA2 mixture with that of 15N-labeled 
BOLA2 (Fig.39), 15 signals of BOLA2 experienced significant chemical 
shift variations and two NH signals broadened beyond detection.  
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Figure 39. Overlay of 1H−15N HSQC spectra of 15N-labeled apo BOLA2 (black) 
and of a 2:1 mixture of 15N-labeled apo BOLA2 and unlabeled apo GRX3(GrxA/B) 
(red). In the inset, a zoom of 1H−15N HSQC spectra on the Q51 backbone NH signal 
is reported for 15N labeled apo BOLA2 (black) and for the 0.1:1 (blue), 0.15:1 
(green), 0.25:1 (violet), 0.5:1 (dark green), 0.75:1 (gray), 1:1 (brown), and 2:1 (red) 
mixtures of unlabeled apo GRX3(GrxA/B) 
 
In the reverse titration, when detecting 15N-labeled GRX3-(GrxA/B), 15 NH 
signals broadened beyond detection and 21 NH signals experienced chemical 
shift variations in the 1H−15N HSQC spectrum of the final 1:2 
GRX3(GrxA/B)-BOLA2 mixture once compared with that of  15N-labeled 
GRX3(GrxA/B). Once the affected residues are mapped on the structural 
model of apo BOLA2 (calculated with MODELER 9.15 software using the 
solution structure of apo BOLA2 from Mus musculus21 as template with a 
87% sequence identity) and on the crystal structures of the apo form of the 
single GrxA (PDB ID 3ZYW) and GrxB (PDB ID 2YAN) domains of 
GRX3, well-defined interacting regions were identified on both proteins. On 
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BOLA2 side, it comprises helix α3 and the following strand β3, containing 
His 68, a ligand of the [2Fe-2S]2+ cluster15. On each GrxA and GrxB domain, 
the interacting surface involves helices α2 and α3, strand β4, and the 
surrounding loops and comprises the Cys ligand of the [2Fe-2S]2+ bound 
cluster21. The analytical gel filtration data collected with a Superdex 75 HR 
10/30 column, which showed the formation of a peak with an apparent 
molecular mass of 49.9 kDa in the chromatogram of the protein mixture, 
which essentially corresponds to the sum of the apparent molecular masses 
of apo GRX3(GrxA/B) (29.6 kDa) and two molecules of apo BOLA2 (11.1 
kDa). The interaction of apo BOLA2 with the holo-dimeric form of GRX3, 
i.e., [2Fe-2S]2 GRX32, was characterized by UV−vis, CD, EPR, NMR, and 
analytical gel filtration. Upon stepwise additions of apo BOLA2 to [2Fe-2S]2 
GRX32, the absorbance peaks typical of the oxidized [2Fe-2S]2+ clusters 
bound to GRX3 disappeared in the UV−vis and CD spectra and new 
absorbance peaks appeared. The final spectra (Fig.40 A, B) at a 1:4 [2Fe-
2S]2 GRX32-BOLA2 ratio are very similar to that of the holo complex 
obtained by chemically reconstituting apo GRX3-BOLA22 with two [2Fe-
2S]2+ clusters ([2Fe-2S]2 GRX3-BOLA22, hereafter), as assessed by iron and 
acid-labile sulfide chemical analysis (Fe and acid-labile S values, reported as 
mol Fe or S per mol of trimer, are 3.8 ± 0.1 and 3.9 ± 0.1, respectively).  
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Figure 40. Formation of the [2Fe-2S]2 GRX3-BOLA22 complex from the 
interaction between [2Fe-2S]2 GRX3 and apo BOLA2. (A) UV−vis of [2Fe-2S]2 
GRX32 (black line) the 1:4 [2Fe-2S]2 GRX32-apo BOLA2 mixture (blue line), and 
of chemically reconstituted [2Fe- 2S]2 GRX3-BOLA22 (green line). 
 
 
 
Figure 40. Formation of the [2Fe-2S]2 GRX3-BOLA22 complex from the 
interaction between [2Fe-2S]2 GRX32 and apo BOLA2. (B) CD spectra of [2Fe-2S]2 
GRX32 (black line), of the 1:4 [2Fe-2S]2 GRX32-apo BOLA2 mixture (blue line), 
and of chemically reconstituted [2Fe-2S]2 GRX3-BOLA22 (green line). 
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The 1:4 protein−protein ratio is needed to fully saturate the four Grx 
domains present in the dimeric [2Fe-2S]2 GRX32 complex with BOLA2 
molecules. The final mixture containing [2Fe-2S]2 GRX32 and apo BOLA2 
at a 1:4 molar ratio was EPR silent, as expected for the presence of a S = 0 
ground state of oxidized [2Fe-2S]2+ clusters. Upon chemical reduction with 
sodium dithionite, the EPR signal of a reduced [2Fe-2S]+ protein-bound 
cluster is observed with g values of 2.01, 1.91, and ∼1.87 (gav ∼ 1.93), which 
are the same as those observed on the chemically reconstituted heterotrimeric 
[2Fe-2S]2 GRX3-BOLA22 complex upon sodium dithionite reduction. 
Analytical gel filtration chromatography, performed with a Superdex 75 HR 
10/30 column on the same final mixture, showed the presence of a main peak 
with an apparent molecular mass of 73.2 kDa, which is very close to the sum 
of the apparent molecular masses of apo GRX3 (52.7 kDa) and two 
molecules of apo BOLA2(11.1 kDa) (Fig.40 C). These results indicate that 
[2Fe-2S]2 GRX32 interacts with apo BOLA2 to form, in the final protein 
mixture, a GRX3-BOLA22 heterotrimeric complex that binds [2Fe-2S]2+ 
cluster(s). Holo complex formation between [2Fe-2S]2 GRX32 and apo 
BOLA2 was also followed by NMR, performing 1H−15N HSQC spectra on 
15N-labeled [2Fe-2S]2 GRX32 titrated with unlabeled apo BOLA2 up to a 
protein−protein ratio of 1:4 and vice versa on 15N-labeled BOLA2 titrated 
with unlabeled [2Fe-2S]2 GRX32 up to a 4:1 protein−protein ratio.  
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Figure 40. Formation of the [2Fe-2S]2 GRX3-BOLA22 complex from the 
interaction between [2Fe-2S]2 GRX32 and apo BOLA2. (C) Analytical gel filtration 
(Superdex 75 HR 10/30 column) chromatograms of BOLA2 (magenta) and GRX3 
(cyan) proteins in their apo states, of [2Fe-2S]2 GRX32 complex (black), and of a 
1:4 [2Fe-2S]2 GRX32-apo BOLA2 mixture (green). 
 
In the final mixture of the first titration, the NH signals of GRX3 affected by 
BOLA2 additions belong to residues of both Grx domains, while those of the 
Trx domain remain unperturbed. In the 1H−15N HSQC NMR spectra 
acquired throughout the titration steps, a decrease in the intensity of some 
backbone NH signals of [2Fe-2S]2 GRX32 (located more than 10 Å away 
from the paramagnetic [2Fe-2S]2+ cluster and therefore only affected by 
BOLA2−GRX3 interaction) was observed, with the concomitant appearance 
of new backbone NH signals. This indicates the formation of a new species 
in solution in slow exchange, on the NMR time scale, with the [2Fe-2S]2 
GRX32 species. This species has chemical shifts slightly different from those 
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of the heterotrimeric complex formed by two apo BOLA2 molecules and an 
apo GRX3 molecule. In the final mixture, the NH signals of the [2Fe-2S]2 
GRX32 species fully disappeared in favor of the new NH signals, indicating 
the complete consumption of [2Fe-2S]2 GRX32, which therefore completely 
evolves to the new species. In the reverse titration, upon addition of 
unlabeled [2Fe-2S]2 GRX32, some backbone NHs of 15N-labeled BOLA2 
broaden beyond detection, and others display chemical shift changes in a 
slow exchange regime on the NMR time. The residues undergoing such 
spectral changes are essentially the same as those involved in the apo−apo 
interaction, indicating that the interaction region is the same in both apo and 
holo GRX3−BOLA2 interactions. Overall, the spectroscopic and gel 
filtration data indicate:  
 
1. a complete conversion of the homodimeric [2Fe-2S]2 GRX32 into a 
GRX3-BOLA22 heterotrimeric complex that contains [2Fe-2S]
2+ 
cluster(s) 
2. the GrxA and GrxB domains of GRX3 interact with two 
BolA2molecules, while Trx domain is not involved in such 
interaction.  
 
Two possible scenarios can occur at the 1:4 [2Fe-2S]2 GRX32-BOLA2ratio, 
i.e., the formation of a heterotrimeric GRX3-BOLA22 complex containing 
two [2Fe-2S]2+ clusters together with the formation of a heterotrimeric apo 
GRX3-apo BOLA22 complex, or the formation of two heterotrimeric GRX3-
BolA22 complexes each containing only one 
 [2Fe-2S]2+ cluster.  The two scenarios result from two possible occurring 
molecular mechanisms, A and B shown in Scheme 1.  
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Scheme 1 Possible Solution Equilibria upon Reaction of [2Fe-2S]2 GRX32 With 
apo BOLA2 up to a 1:4 Ratio  
 
The key experimental evidence, that would allow us to provide information 
on whether a favorite mechanism between A and B is operative, is the 
detection of the formation of the apo free GRX3 form, which is observed 
indeed in the A mechanism only (Scheme 1). Analytical gel filtration was 
therefore performed on [2Fe-2S]2 GRX32-apo BOLA2 protein mixtures at 
different protein:protein ratios, using a Superdex 75 HR 10/30 column to 
investigate the possible presence of free apo GRX3.  
These gel filtration analysis showed:  
1. the presence of a main peak with an apparent molecular mass 
which increases from 68.0 to 73.2 kDa upon addition of apo 
BOLA2;  
2. the presence, only for [2Fe-2S]2 GRX32-apo BOLA2 ratios >1:4, 
of a peak with the apparent molecular mass similar to that of apo 
BOLA2;  
3. no formation of a peak with the apparent molecular mass of apo 
GRX3 at any investigated protein:protein ratio (Fig.41). 
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Figure 41. Analytical gel filtration chromatograms of BOLA2 (black) and GRX3 
(red) proteins in their apo states, of [2Fe-2S]2 GRX32 (blue) and of a 1:2 (cyan), 1:4 
(magenta), 1:6 (green) [2Fe-2S]2 GRX32-apo BOLA2 mixtures (Superdex 75 HR 
10/30 column). 
 
The analytical gel filtration chromatography was also performed at higher 
resolution with a Superdex 200 10/300 increase column on protein mixtures 
at substoichiometric [2Fe-2S]2 GRX32-apo BOLA2 ratios of 1:0.25, 1:0.5, 
and 1:1 (Fig.42). It was observed the concurrent formation of: 
1. the 1:1 heterodimeric complex, corresponding to the peak with an 
apparent molecular mass of 71.3 kDa, which is indeed very close 
to the sum of the apparent molecular masses of one molecule of 
apo BOLA2 and one molecule of apo GRX3 (i.e.,70.4 kDa), and  
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2. of the heterotrimeric complex, corresponding to the peak with an 
apparent molecular mass of 87.4 kDa, which is indeed close to 
the sum of the apparent molecular masses of two apo 
BOLA2molecules and one molecule of apo GRX3 (i.e., 82.0 
kDa).  
 
 
Figure 42.BOLA2 (black) and GRX3 (red) proteins in their 
apo states, of [2Fe-2S]2 GRX32 (blue) and of a 1:0.25 (orange), 1:0.5 (light gray),  
1:1 (light magenta) [2Fe-2S]2 GRX32-apo BOLA2 mixtures 
(Superdex 200 10/300 increase column). 
 
The peak of apo GRX3, which is always present at a low percentage in the 
chemically reconstituted [2Fe-2S]2 GRX32 sample, does not increase in its 
intensity upon BOLA2 substoichiometric additions (Fig.42), as expected if 
the A mechanism was the favored process. From these gel filtration data, we 
can conclude that the B mechanism is the preferential occurring process.  
Cluster transfer from [2Fe-2S]2 GRX3- BOLA22 to apo anamorsin was 
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followed by UV−vis, CD spectroscopy, and analytical gel filtration. Once the 
chemically reconstituted [2Fe-2S]2 GRX3- BOLA22 heterotrimeric complex 
was titrated with apo anamorsin up to a 1:1 protein- protein ratio, in the 
UV−vis and CD spectra the absorbance peaks typical of [2Fe-2S]2 GRX3- 
BOLA22 disappeared and the absorbance peaks typical of the [2Fe-2S]2+ 
cluster-bound form of anamorsin ([2Fe-2S] anamorsin)16,17 appeared 
(Fig.43). 
 
 
 
 
 
 
 
 
 
 
 
 
 
-Chapter 5- Results  
163 
 
 
 
Figure 43. (up) UV−vis spectra of [2Fe-2S]2 GRX3-BOLA22 (black line) titrated 
with 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8 equiv of apo anamorsin (black dashed lines). 
(down) CD spectra acquired to follow cluster transfer from [2Fe-2S]2 GRX3-
BOLA22 to apo anamorsin. Black line: chemically reconstituted [2Fe-2S]2 GRX3-
BOLA22; green line: [2Fe-2S] anamorsin; red line: 1:1 mixture of [2Fe-2S]2 GRX3-
BOLA22 and apo anamorsin. 
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 The CD spectrum of the final 1:1 mixture essentially corresponds to that of 
[2Fe-2S] anamorsin, being clearly distinguishable from that of [2Fe-2S]2 
GRX3-BOLA22. 
Analytical gel filtration chromatography performed with Superdex 75 HR 
10/30 column on the final 1:1 mixture showed the presence of a main peak 
with an apparent molecular mass of 128.2 kDa, which essentially 
corresponds to the sum of the apparent molecular masses of [2Fe-2S]2 
GRX3-BOLA22(73.2 kDa) and apo anamorsin (52.0 kDa) (Figure).  
 
 
Figure 44. Analytical gel filtration (75 HR 10/30 column) chromatograms of 
BOLA2 (magenta) and anamorsin (blue) proteins in their apo states, of [2Fe-2S]2 
GRX3-BOLA22 (black), and of a 1:1 mixture between [2Fe-2S]2 GRX3- BOLA22 
and apo anamorsin (red). 
 
Overall, the data showed that (i) both [2Fe-2S]2+ cluster are completely 
transferred from [2Fe-2S]2 GRX3-BOLA22 to apo anamorsin and (ii) the 
final product is a complex formed by an apo GRX3 molecule, two apo 
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BolA2molecules and a [2Fe-2S] anamorsin molecule (GRX3-BOLA22-[2Fe-
2S] anamorsin, hereafter). Moreover, by gel filtrating a 1:1 mixture of apo 
GRX3(GrxA/B)-BOLA22and [2Fe-2S] anamorsin, a peak corresponding to a 
ternary complex formed by GRX3(GrxA/B), BolA2, and anamorsin is not 
observed. This demonstrates that, in the final GRX3-BOLA22-[2Fe-2S] 
anamorsin complex, the interaction between apo GRX3−BOLA22and [2Fe-
2S] anamorsin depends on the presence of the Trx domain of GRX3. We had 
previously shown that the Trx domain of GRX3 interacts with the N-terminal 
domain of anamorsin mediating the cluster transfer between the two 
proteins18. Here we show that the Trx domain, in addition of being essential 
for the complex formation between anamorsin and GRX3-BOLA22 in the 
GRX3-BOLA22-[2Fe-2S] anamorsin complex, maintains the same 
conformational freedom as it has in the homodimeric [2Fe-2S]2 GRX32 
complex.  So the cluster transfer mechanism previously reported for [2Fe-
2S]2 GRX3218 is also operative in the [2Fe-2S]2 GRX3−BOLA22-apo 
anamorsin interaction, i.e., the protein recognition, specifically occurring 
between the N-terminal domains of the two proteins, plays a role in the 
cluster transfer process.  
This data showed that apo BOLA2 and the Grx domains of apo GRX3 
significantly and specifically interact forming an apo heterotrimeric complex 
composed by a GRX3 molecule and two BOLA2 molecules. This complex 
can bind two [2Fe-2S]2+ clusters upon chemical reconstitution. The same 
cluster content was achieved in the heterotrimeric complex obtained by co-
expressing in E. coli cells human BOLA2 and a construct of GRX3 
containing only the two Grx domains15.A heterotrimeric GRX3-
BolA22complex was also obtained by mixing in vitro [2Fe-2S]2 GRX32 with 
apo BOLA2. Both complexes, i.e., the homodimeric GRX3 and the 
heterotrimeric GRX3-BOLA22 complexes containing two [2Fe-2S]2+ 
-Chapter 5- Results  
166 
 
clusters, can thus be active players, at the cellular level, for maturing 
anamorsin. The present data also suggest that the mechanism of cluster 
transfer relying on the interaction between the N-terminal domains of 
anamorsin and GRX318 is common to both cluster transfer processes, i.e., 
from [2Fe-2S]2 GRX32 to apo anamorsin and from [2Fe-2S]2 GRX3-
BOLA22 to apo anamorsin. 
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ABSTRACT: In eukaryotes, the interaction between mem-
bers of the monothiol glutaredoxin family and members of the
BolA-like protein family has been involved in iron metabolism.
To investigate the still unknown functional role of the
interaction between human glutaredoxin-3 (GRX3) and its
protein partner BOLA2, we characterized at the atomic level
the interaction of apo BOLA2 with the apo and holo states of
GRX3 and studied the role of BOLA2 in the GRX3-dependent
anamorsin maturation pathway. From these studies, it emerged
that apo GRX3 and apo BOLA2 form a heterotrimeric
complex, composed by two BOLA2 molecules and one GRX3
molecule. This complex is able to bind two [2Fe-2S]2+ clusters,
each being bridged between a BOLA2 molecule and a monothiol glutaredoxin domain of GRX3, and to transfer both [2Fe-2S]2+
clusters to apo anamorsin producing its mature holo state. Collectively, the data suggest that the heterotrimeric complex can
work as a [2Fe-2S]2+ cluster transfer component in cytosolic Fe/S protein maturation pathways.
■ INTRODUCTION
In eukaryotes, the biosynthetic pathways responsible for the
maturation of Fe/S proteins is a complex, multistep process
involving more than 30 different proteins.1 As a result, atomic
level studies are vital to fully unravel the molecular function of
each single player in the Fe/S protein maturation process. In
this work, we characterized at the atomic level the interaction
between human glutaredoxin-3 (GRX3) and its protein partner
BOLA2 and identified a possible role for BOLA2 in the GRX3-
dependent anamorsin maturation pathway.
The functional role of eukaryotic monothiol glutaredoxins
(Grx) has been largely studied in Saccharomyces cerevisiae,
which encodes three CysGlyPheSer(CGFS)-type monothiol
Grx homologues, Grx3, Grx4, and Grx5.2−4 Grx5 is a single
domain protein, located in the mitochondrial matrix, which
binds a [2Fe-2S] cluster ligated by two protein molecules, each
providing a cysteine ligand, and by two glutathione molecules,
each providing a further cysteine ligand.5,6 Grx5 has been
shown to participate in the mitochondrial iron−sulfur (Fe/S)
cluster (ISC) assembly machinery, acting, in its holo-
homodimeric state, as a donator of a [2Fe-2S] cluster to
partner apo-proteins.7,8 Grx3 and Grx4 are located in the
cytoplasm, and each consists of a N-terminal thioredoxin (Trx)
domain, with no Trx-related activity,9,10 and of a glutaredoxin
domain capable of binding a [2Fe-2S] cluster through protein
dimerization and glutathione binding,11 in the same way as
Grx5 does. Grx3 and Grx4 have been linked to iron regulation
through their binding to the transcriptional activator Aft1/2,
which regulates iron uptake in yeast.12−14 Specifically, to
perform this regulatory function, Grx3 (or Grx4) needs to be
complexed with the BolA-like protein Fra2, forming a [2Fe-
2S]-bridged heterodimeric complex,11,15 which, at variance with
the holo-homodimeric species, can transfer the cluster to the
iron-responsive transcription factor Aft2.16 Based on this
information on yeast, holo-heterodimeric Grx/BolA complexes
have been generally linked to iron homeostasis regulation, while
holo-homodimeric Grx complexes have been related to Fe/S
protein biogenesis.17 Recently, it has been also shown that
double depletion of yeast Grx3/4 specifically impaired all iron-
requiring reactions in the cytosol, in mitochondria, and in the
nucleus, including the synthesis of Fe/S clusters, of heme, and
of di-iron centers.9 These data suggest that holo-homodimeric
cytoplasmatic Grxs species can also function in intracellular iron
trafficking.
In humans, two monothiol Grxs are present, GRX3 and
GRX5.2,18 GRX5 is located in mitochondria essentially
performing the same function as the yeast Grx5 homologue,
i.e., it acts as a [2Fe-2S] cluster transfer protein in the ISC
machinery.19,20 GRX3 consists of three domains: one N-
terminal Trx domain and two Grx domains, each able to bind a
glutathione-coordinated [2Fe-2S] cluster via protein dimeriza-
tion.21,22 GRX3 is located in the cytosol, and similarly to what
was found for yeast Grx3/Grx4, the molecular function of its
holo-homodimeric state ([2Fe-2S]2 GRX32) has been
associated with intracellular iron trafficking, being responsible
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for iron redistribution to virtually all iron-binding proteins or
iron-dependent pathways in the cell.23 Recently, we proposed
that human GRX3 is an active component of the cytosolic Fe/S
cluster assembly (CIA) machinery, as its homodimeric [2Fe-
2S]2 GRX32 form is able to mature the cytosolic [2Fe-2S]-
binding protein anamorsin, an essential component of the CIA
machinery.24 The CIA machinery is responsible for the
maturation of cytosolic and nuclear Fe/S proteins performing
key functions in metabolic catalysis, iron regulation, protein
translation, DNA synthesis, and DNA repair.25,26 Therefore, the
cellular function of GRX3 in maturing the CIA component
anamorsin indirectly affects several crucial life processes.
Similarly to yeast, GRX3 can form a holo-hetero complex
with a BolA-like protein, the cytosolic BOLA2.21 However,
while the yeast Grx3/4 forms a [2Fe-2S]-bridged heterodimer
with a Fra2 molecule, the human GRX3 forms a [2Fe-2S]-
bridged heterotrimer with two BOLA2 molecules ([2Fe-2S]2
GRX3-BOLA22). Since there is no human ortholog of the
transcription factor Aft1, being indeed cellular iron homeostasis
in humans regulated at the RNA-level by the Iron Regulatory
Proteins 1 and 2,27 [2Fe-2S]2 GRX3-BOLA22 heterotrimers
cannot be involved in the same [2Fe-2S] cluster transfer
pathway found in yeast to regulate iron homeostasis. Although
other functions of the [2Fe-2S]2 GRX3-BOLA22 heterotrimer
in human cells might be possible, it seems conceivable that this
complex takes a role in iron metabolism given that (i) [2Fe-
2S]-bridged Grx3−BolA2 interaction is conserved from S.
cerevisiae to humans,17 (ii) human GRX3 binds iron in vivo,22
and (iii) human GRX3 partially rescues the growth defects and
iron accumulation in the S. cerevisiae grx3Δgrx4Δ mutant,
suggesting that human GRX3 partially can complement the
functions of yeast Grx3 and Grx4 in iron homeostasis.28
In this work we have characterized in vitro the interaction of
apo BOLA2 with the apo and holo states of GRX3 and
investigated the role of BOLA2 in the GRX3-dependent
anamorsin maturation pathway.
■ EXPERIMENTAL SECTION
Protein Production. The cDNA coding for human BOLA2
(UniProtKB/Swiss-Prot: Q9H3K6) was acquired from Life technol-
ogies. BOLA2 gene was amplified by PCR and subsequently inserted
into the pET21a vector using the restriction enzymes NdeI and
BanHI. BL21(DE3) gold competent Escherichia coli cells (Stratagene,
La Jolla, CA) were transformed with the obtained plasmid, and cells
were grown in LB or minimal media (with (15NH4)2SO4 and/or [
13C]-
glucose) containing 1 mM ampicillin at 37 °C under vigorous shaking
up to a cell OD600 of 0.6. Protein expression was induced by adding 0.5
mM IPTG, and cells were grown for 4 h at 25 °C. Cells were harvested
by centrifugation at 7500g and resuspended in lysis buffer (25 mM
MES pH 6 containing 0.01 mg/mL DNAase, 0.01 mg/mL lysozyme, 1
mM MgSO4, 0.5 mM EDTA, and 5 mM DTT). Cell disruption was
performed on ice by sonication, and the soluble extract, obtained by
ultracentrifugation at 40000g, was loaded on HiTrap SP FF column
(GE Healthcare). BOLA2 protein was eluted with 25 mM MES pH 6,
1 M NaCl and 5 mM DTT, concentrated with Amicon Ultra-15
Centrifugal Filter Units with a MWCO of 3 kDa (Millipore), and the
buffer exchanged by PD10 desalting column in 50 mM phosphate
buffer pH 7, 5 mM DTT and 5 mM GSH.
Various constructs of human GRX3 (full-length protein, Trx, and
GRX3(GrxA/B) constructs in their apo and/or [2Fe-2S]-bound
forms) were obtained following previously reported procedures.24
[2Fe-2S]2 GRX32 was obtained by chemical reconstitution following a
previously reported procedure.24
Biochemical and UV−vis, CD, EPR Spectroscopic Methods.
The aggregation state of isolated apo and holo proteins and of protein
mixtures was analyzed using analytical gel filtration on Superdex 75
HR 10/30 and Superdex 200 10/300 increase columns (Amersham
Bioscience), calibrated with gel filtration marker calibration kit, 6500−
66000 Da (Sigma-Aldrich), to obtain the apparent molecular masses of
the detected species. Purified samples in degassed phosphate buffer 50
mM pH 7, 5 mM DTT, and 5 mM GSH were loaded on the column
pre-equilibrated with degassed 50 mM phosphate buffer pH 7, 5 mM
GSH, and 5 mM DTT. Elution profiles were recorded at 280 nm with
a flow rate of 0.5 mL/min for Superdex 75 HR 10/30 column and 0.75
mL/min for Superdex 200 10/300 increase column.
UV−vis and CD spectra were anaerobically acquired on a Cary 50
Eclipse spectrophotometer and JASCO J-810 spectropolarimeter,
respectively, in degassed 50 mM phosphate buffer pH 7, 5 mM GSH,
and 5 mM DTT.
EPR spectra of the 1:4 [2Fe-2S]2 GRX32-apo BOLA2 mixture and
of the chemically reconstituted [2Fe-2S]2 GRX3-BOLA22 hetero-
trimeric complex were recorded after the anaerobic reduction of the
cluster by stoichiometric addition of sodium dithionite and immediate
freezing of the protein solution in liquid nitrogen. EPR spectra were
acquired in degassed 50 mM phosphate buffer pH 7, 5 mM GSH, 5
mM DTT, and 10% glycerol at 45 K, using a Bruker Elexsys E500
spectrometer working at a microwave frequency of ca. 9.45 GHz,
equipped with a SHQ cavity and a continuous flow He cryostat
(ESR900, Oxford instruments) for temperature control. Acquisition
parameters were as following: microwave frequency, 9.640928 GHz;
microwave power, 5 mW; modulation frequency, 100 kHz; modulation
amplitude, 2.0 G; acquisition time constant, 163.84 ms; number of
points 1024; number of scans 8; field range 500−6000 G or 2300−
4300 G.
The iron and inorganic sulfur content and the protein concentration
were estimated following standard chemical assays as already
reported.29
NMR Spectroscopy. Standard 1H-detected triple-resonance NMR
experiments for backbone resonance assignment were recorded on 1
mM 13C, 15N-labeled samples (apo forms of GRX3(GrxA/B) and
BOLA2) in degassed 50 mM phosphate buffer pH 7, 5 mM DTT, and
5 mM GSH at 298 K, using Bruker AVANCE 500 and 700 MHz
spectrometers. 15N heteronuclear relaxation experiments were
performed on 15N-labeled apo BOLA2 and on 15N-labeled apo
GRX3(GrxA/B) in the presence and in the absence of 2 equiv of
unlabeled apo BOLA2, in degassed 50 mM phosphate buffer pH 7, 5
mM DTT, and 5 mM GSH at 298 K, to measure 15N backbone
longitudinal (R1) and transverse (R2) relaxation rates and hetero-
nuclear 15N{1H} NOEs. All NMR data were processed using the
Topspin software package and were analyzed with the program CARA.
An apparent dissociation constant (Kd) for the interaction between
apo GRX3(GrxA/B) and apo BOLA2 proteins, in degassed 50 mM
phosphate buffer pH 7, 5 mM DTT at 298 K, was obtained by plotting
the average chemical shift differences δav (i.e., (((ΔH)2 + (ΔN/5)2)/
2)1/2, where ΔH and ΔN are chemical shift differences for backbone
amide 1H and 15N nuclei, respectively) of five well-resolved backbone
NH signals of 15N-labeled GRX3(GrxA/B) and of six well resolved
backbone NH signals of 15N-labeled BOLA2, as a function of BOLA2
and GRX3(GrxA/B) concentrations, respectively. These data were
then fitted to a simple two-component model and averaged to obtain
the final Kd value.
30,31
Protein−Protein Interaction and Cluster Transfer. Apo GRX3
(or apo GRX3(GrxA/B))-apo BOLA2 interaction was investigated by
1H−15N HSQC NMR spectra, titrating 15N-labeled apo forms of
GRX3 or GRX3(GrxA/B) with unlabeled apo BOLA2, and 15N-
labeled apo BOLA2 with unlabeled apo forms of GRX3 or
GRX3(GrxA/B), in degassed 50 mM phosphate buffer pH 7, 5 mM
GSH, and 5 mM DTT containing 10% (v/v) D2O at 298 K. Spectral
changes were monitored upon the addition of increasing amounts of
the unlabeled partner. NMR data were analyzed with CARA program
and plotted following standard procedures.
To follow changes in cluster coordination upon interaction between
[2Fe-2S]2 GRX32 and apo BOLA2, [2Fe-2S]2 GRX32 was incubated
under anaerobic conditions with increasing concentrations of apo
BOLA2 up to a 1:4 protein ratio, in degassed 50 mM phosphate buffer
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pH 7, 5 mM GSH, and 5 mM DTT. UV−vis, EPR, and CD spectra
were then recorded as described above and compared with those
collected on a [2Fe-2S]2 GRX3-BOLA22 complex, which was obtained
by chemically reconstituting a 1:2.5 apo GRX3-apo BOLA2 mixture
following a previously reported procedure.24 Protein−protein
interaction between [2Fe-2S]2 GRX32 and apo BOLA2 was
investigated by 1H−15N HSQC NMR spectra performed on 15N-
labeled [2Fe-2S]2 GRX32 titrated with unlabeled apo BOLA2 and on
15N-labeled apo BOLA2 titrated with unlabeled [2Fe-2S]2 GRX32.
Spectral changes were monitored and analyzed upon the addition of
increasing amounts of the unlabeled partner.
The chemically reconstituted [2Fe-2S]2 GRX3-BOLA22 complex
was titrated under anaerobic conditions with increasing concentrations
of apo anamorsin up to a 1:1 protein ratio in degassed 50 mM
phosphate buffer pH 7, 5 mM GSH, and 5 mM DTT. Cluster transfer
and the protein−protein interaction were followed by UV−vis and CD
spectroscopy and analytical gel filtration chromatography, respectively.
■ RESULTS
Interaction of apo GRX3 with apo BOLA2. Full-length
BOLA2 protein was overexpressed in E. coli cells and purified in
its apo form. Analytical gel filtration and 15N NMR relaxation
data (Supporting Information Figure S1), which provided an
molecular reorientational correlation time of 6.9 ± 0.23 ns,
showed that the purified apo protein is monomeric. Purified
apo BOLA2 was unable to bind Fe/S clusters when a chemical
reconstitution approach29 was applied.
To investigate the interaction between the apo forms of
GRX3 and BOLA2, chemical shift changes of backbone NHs
were followed by 1H−15N HSQC NMR experiments upon
titration of 15N-labeled apo GRX3 with unlabeled apo BOLA2,
and of 15N-labeled apo BOLA2 with unlabeled apo GRX3, in
the presence of 5 mM GSH and 5 mM DTT. Chemical shift
variations, which were in a fast/intermediate exchange regime
on the NMR time scale, were observed in the 1H−15N HSQC
maps of GRX3 for the backbone NHs of both Grx domains,
when increasing amounts of unlabeled BOLA2 were added up
to a 1:2 GRX3-BOLA2 molar ratio, while no significant effects
were observed on the backbone NHs of the Trx domain of
GRX3 (Figure 1A). These chemical shift changes occur
simultaneously on both Grx domains, thus indicating that
BOLA2 does not have a preferential interaction toward one of
the two Grx domains (Figure 1A, inset). Similarly, chemical
shift variations in a fast/intermediate exchange regime on the
NMR time scale were observed in the 1H−15N HSQC maps of
BOLA2 when increasing amounts of unlabeled GRX3 were
added up to a 1:2 GRX3-BOLA2 molar ratio (Figure 1B).
The interaction between apo BOLA2 and apo GRX3 was
also followed by analytical gel filtration chromatography,
performed on protein mixtures with different apo GRX3 and
apo BOLA2 ratios (Figure 2A). The formation of two peaks
was observed by adding apo BOLA2 to apo GRX3 up to a 1:2
GRX3-BOLA2 ratio: (i) a peak with an apparent molecular
mass of 70.4 kDa, predominant at 1:1 protein ratio; (ii) a peak
with an apparent molecular mass of 74.3 kDa, predominant at
1:2 protein ratio (Figure 2A). These results indicated that apo
GRX3 forms a heterodimeric complex with apo BOLA2 at the
1:1 protein ratio (the 70.4 kDa value matches indeed with the
sum of the apparent molecular masses of apo GRX3 and apo
BOLA2), which then evolves, upon addition of a further
equivalent of apo BOLA2, to form a species which has an
apparent molecular mass (74.3 kDa) intermediate between that
of the heterodimeric complex (70.4 kDa) and that of an apo
heterotrimeric complex formed by two BOLA2 molecules and
one GRX3 molecule (82 kDa, obtained by the sum of the
apparent molecular masses of apo GRX3 and two molecules of
apo BOLA2). The presence of this peak with an intermediate
apparent molecular mass can be a consequence of the applied
gel filtration conditions, which determined, indeed, the
presence of a fast exchange equilibrium between the
heterodimeric and heterotrimeric complexes. Therefore, we
performed the analytical gel filtration chromatography using a
different column, i.e., Superdex 75 HR 10/30, and it resulted
that apo GRX3 protein interacts with apo BOLA2 forming a
peak with an apparent molecular mass of 76.8 kDa
predominant at 1:2.5 GRX3-BOLA2 protein ratio (Figure
2B). This value essentially corresponds to the sum of the
apparent molecular masses of apo GRX3 (52.7 kDa) and two
molecules of apo BOLA2 (11.1 kDa) (Figure 2B), thus
definitively indicating the formation of the apo GRX3-BOLA22
heterotrimeric complex.
Figure 1. Apo GRX3 interacts with apo BOLA2. (A) Overlay of
1H−15N HSQC spectra of 15N-labeled apo GRX3 (black), of 15N-
labeled Trx domain of GRX3 (green), and of a 1:2 mixture of 15N-
labeled apo GRX3 and unlabeled apo BOLA2 (red). The chemical
shift changes of two backbone NHs belonging to GrxA and GrxB
domains, K192 and D286, respectively, are reported in the inset for
15N-labeled apo GRX3 (black), for 1:1 (blue) and 1:2 (red) mixtures
of 15N-labeled apo GRX3 and unlabeled apo BOLA2. (B) Overlay of
1H−15N HSQC spectra of 15N-labeled apo BOLA2 (black) and of a
1:2 mixture of unlabeled apo GRX3 and 15N-labeled apo BOLA2
(red).
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Since the Trx domain is not involved in the interaction
between apo BOLA2 and apo GRX3, we produced a two-
domain construct containing the GrxA and GrxB domains only,
(GRX3(GrxA/B)), to map, by solution NMR, the residues
involved in the formation of the heterotrimeric complex. With
this shorter construct, the chemical shift data analysis was
indeed simplified by the reduction of NMR signal overlap and
broadening due to the reduced protein size. We titrated 15N-
labeled BOLA2 with unlabeled GRX3(GrxA/B) and 15N-
labeled GRX3(GrxA/B) with unlabeled BOLA2 and followed
the chemical shift changes of backbone NHs via 1H−15N
HSQC experiments. Chemical shift variations are in a fast/
intermediate exchange regime on the NMR time scale in both
titrations, as it occurs for the apo GRX3−apo BOLA2
interaction. By fitting the chemical shifts to a simple two-
component model,30,31 an apparent dissociation constant of 25
± 15 μM was obtained (Figure 3A,B insets).
The 1H−15N HSQC signals of the final protein mixture, i.e.,
1:2 15N-labeled apo GRX3(GrxA/B)-apo BOLA2, well super-
imposed with the corresponding signals of a 1:2 apo 15N-
labeled GRX3-apo BOLA2 mixture, indicating that the same
complex involving the same interacting region was present in
solution in the two mixtures, and confirming that Trx domain
has no specific role in the protein−protein recognition between
apo GRX3 and apo BOLA2 (Supporting Information Figure
S2). Comparing the 1H−15N HSQC map of the final apo
GRX3(GrxA/B)-apo 15N-labeled BOLA2 mixture with that of
15N-labeled BOLA2 (Figure 3B), 15 signals of BOLA2
experienced significant chemical shift variations and two NH
signals broadened beyond detection (Figure 4A).
In the reverse titration, when detecting 15N-labeled GRX3-
(GrxA/B) (Figure 3B), 15 NH signals broadened beyond
detection and 21 NH signals experienced chemical shift
variations in the 1H−15N HSQC spectrum of the final 1:2
GRX3(GrxA/B)-BOLA2 mixture once compared with that of
15N-labeled GRX3(GrxA/B) (Figure 4B).
Once the affected residues are mapped on the structural
model of apo BOLA2 (calculated with MODELER 9.15
software using the solution structure of apo BOLA2 from
Mus musculus32 as template with a 87% sequence identity) and
on the crystal structures of the apo form of the single GrxA
(PDB ID 3ZYW) and GrxB (PDB ID 2YAN) domains of
GRX3, well-defined interacting regions were identified on both
proteins. On BOLA2 side, it comprises helix α3 and the
following strand β3, containing His 68, a ligand of the [2Fe-
2S]2+ cluster21 (Figure 4A). On each GrxA and GrxB domain,
the interacting surface involves helices α2 and α3, strand β4,
and the surrounding loops and comprises the Cys ligand of the
[2Fe-2S]2+ bound cluster21 (Figure 4B).
15N backbone NMR relaxation experiments, performed on
15N-labeled apo GRX3(GrxA/B) in absence or in the presence
of 2 equiv of apo BOLA2, showed an increase in the molecular
reorientational correlation time from 12.0 ± 1.2 ns (consistent
with a monomeric state of GRX3(GrxA/B) in solution) to 27.7
± 4.5 ns. This increase is consistent with the formation of a 1:2
GRX3(GrxA/B)-BOLA2 protein complex, being the molecular
reorientational correlation time of apo BOLA2 6.9 ± 0.23 ns.
This result is in agreement with the analytical gel filtration data
collected with a Superdex 75 HR 10/30 column (Figure 2B),
which showed the formation of a peak with an apparent
molecular mass of 49.9 kDa in the chromatogram of the protein
mixture, which essentially corresponds to the sum of the
apparent molecular masses of apo GRX3(GrxA/B) (29.6 kDa)
and two molecules of apo BOLA2 (11.1 kDa).
Interaction of [2Fe-2S]2 GRX32 with apo BOLA2. The
interaction of apo BOLA2 with the holo-dimeric form of
GRX3, i.e., [2Fe-2S]2 GRX32, was characterized by UV−vis,
CD, EPR, NMR, and analytical gel filtration. Upon stepwise
additions of apo BOLA2 to [2Fe-2S]2 GRX32, the absorbance
peaks typical of the oxidized [2Fe-2S]2+ clusters bound to
GRX3 disappeared in the UV−vis and CD spectra and new
absorbance peaks appeared. The final spectra (Figure 5A,B) at a
Figure 2. Apo GRX3 and apo BOLA2 form a heterotrimeric 1:2 complex. (A) Analytical gel filtration (Superdex 200 10/300 increase column)
chromatograms of BOLA2 and GRX3 proteins in their apo states and of their protein mixtures. Black line: apo GRX3; red line: apo BOLA2; green
line: 1:0.5 mixture of apo GRX3 and apo BOLA2; blue line: 1:1 mixture of apo GRX3 and apo BOLA2; cyan line: 1:1.5 mixture of apo GRX3 and
apo BOLA2; magenta line: 1:2 mixture of apo GRX3 and apo BOLA2. The apparent molecular masses are reported at the top of each
chromatographic peak. (B) Analytical gel filtration (Superdex 75 HR 10/30 column) chromatograms of isolated BOLA2, GRX3(GrxA/B) and
GRX3 proteins in their apo states and of their protein mixtures. Black line: apo BOLA2; red line: apo GRX3; green line: apo GRX3(GrxA/B); cyan
line: 1:2.5 mixture of apo GRX3(GrxA/B) and apo BOLA2; blue: 1:2.5 mixture of apo GRX3 and apo BOLA2. The apparent molecular masses are
reported at the top of each chromatographic peak.
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1:4 [2Fe-2S]2 GRX32-BOLA2 ratio are very similar to that of
the holo complex obtained by chemically reconstituting apo
GRX3-BOLA22 with two [2Fe-2S]
2+ clusters ([2Fe-2S]2
GRX3-BOLA22, hereafter), as assessed by iron and acid-labile
sulfide chemical analysis (Fe and acid-labile S values, reported
as mol Fe or S per mol of trimer, are 3.8 ± 0.1 and 3.9 ± 0.1,
respectively).
The 1:4 protein−protein ratio is needed to fully saturate the
four Grx domains present in the dimeric [2Fe-2S]2 GRX32
complex with BOLA2 molecules. The final mixture containing
[2Fe-2S]2 GRX32 and apo BOLA2 at a 1:4 molar ratio was EPR
silent, as expected for the presence of a S = 0 ground state of
oxidized [2Fe-2S]2+ clusters. Upon chemical reduction with
sodium dithionite, the EPR signal of a reduced [2Fe-2S]+
protein-bound cluster is observed with g values of 2.01, 1.91,
and ∼1.87 (gav ∼ 1.93), which are the same as those observed
on the chemically reconstituted heterotrimeric [2Fe-2S]2
GRX3-BOLA22 complex upon sodium dithionite reduction
(Supporting Information Figure S3). Analytical gel filtration
chromatography, performed with a Superdex 75 HR 10/30
column on the same final mixture, showed the presence of a
main peak with an apparent molecular mass of 73.2 kDa, which
is very close to the sum of the apparent molecular masses of
apo GRX3 (52.7 kDa) and two molecules of apo BOLA2 (11.1
kDa) (Figure 5C). These results indicate that [2Fe-2S]2 GRX32
interacts with apo BOLA2 to form, in the final protein mixture,
a GRX3-BOLA22 heterotrimeric complex that binds [2Fe-2S]
2+
cluster(s). The EPR, UV−vis, CD, and analytical gel filtration
data collected on this final mixture mirror the data previously
obtained on a [2Fe-2S]2 GRX3(GrxA/B)-BOLA22 complex
produced by coexpressing human BOLA2 and GRX3(GrxA/B)
in E. coli cells.21 This indicates that the same type of cluster is
bound to the heterotrimeric complex regardless of following
different holo protein production approaches, i.e., chemical
reconstitution vs in vitro and in cell Fe−S metalation, as well as
different protein constructs, i.e. full-length protein vs a GrxA/
GrxB domain construct.
Holo complex formation between [2Fe-2S]2 GRX32 and apo
BOLA2 was also followed by NMR, performing 1H−15N
HSQC spectra on 15N-labeled [2Fe-2S]2 GRX32 titrated with
unlabeled apo BOLA2 up to a protein−protein ratio of 1:4 and
vice versa on 15N-labeled BOLA2 titrated with unlabeled [2Fe-
2S]2 GRX32 up to a 4:1 protein−protein ratio. In the final
mixture of the first titration, the NH signals of GRX3 affected
by BOLA2 additions belong to residues of both Grx domains,
while those of the Trx domain remain unperturbed. In the
1H−15N HSQC NMR spectra acquired throughout the titration
steps (Figure 5D), a decrease in the intensity of some backbone
NH signals of [2Fe-2S]2 GRX32 (located more than 10 Å away
from the paramagnetic [2Fe-2S]2+ cluster and therefore only
affected by BOLA2−GRX3 interaction) was observed, with the
concomitant appearance of new backbone NH signals. This
indicates the formation of a new species in solution in slow
exchange, on the NMR time scale, with the [2Fe-2S]2 GRX32
species (Figure 5D). This species has chemical shifts slightly
different from those of the heterotrimeric complex formed by
two apo BOLA2 molecules and an apo GRX3 molecule. In the
final mixture, the NH signals of the [2Fe-2S]2 GRX32 species
fully disappeared in favor of the new NH signals, indicating the
complete consumption of [2Fe-2S]2 GRX32, which therefore
completely evolves to the new species (Figure 5D). In the
reverse titration, upon addition of unlabeled [2Fe-2S]2 GRX32,
some backbone NHs of 15N-labeled BOLA2 broaden beyond
detection, and others display chemical shift changes in a slow
exchange regime on the NMR time scale (Figure 5D). The
residues undergoing such spectral changes are essentially the
same as those involved in the apo−apo interaction, indicating
that the interaction region is the same in both apo and holo
Figure 3. GrxA and GrxB domains interact with apo BOLA2. (A)
Overlay of 1H−15N HSQC spectra of 15N-labeled apo GRX3(GrxA/B)
(black) and of a 1:2 mixture of 15N-labeled apo GRX3(GrxA/B) and
unlabeled apo BOLA2 (red). In the inset, a zoom of 1H−15N HSQC
spectra on the K192 and D286 backbone NH signals is reported for
15N-labeled apo GRX3(GrxA/B) (black) and for 1:0.5 (blue), 1:1
(green), 1:1.5 (violet), and 1:2 (red) mixtures of 15N-labeled apo
GRX3(GrxA/B) and unlabeled apo BOLA2. The inset also shows the
δav changes measured for T199 (red circles) and Q202 (blue triangles)
in the GrxA domain of GRX3(GrxA/B) and of K245 (green squares)
and F263 (magenta circles) in the GrxB domain of GRX3(GrxA/B) as
a function of apo BOLA2 concentration. Solid lines show the fitting
curves. (B) Overlay of 1H−15N HSQC spectra of 15N-labeled apo
BOLA2 (black) and of a 2:1 mixture of 15N-labeled apo BOLA2 and
unlabeled apo GRX3(GrxA/B) (red). In the inset, a zoom of 1H−15N
HSQC spectra on the Q51 backbone NH signal is reported for 15N-
labeled apo BOLA2 (black) and for the 0.1:1 (blue), 0.15:1 (green),
0.25:1 (violet), 0.5:1 (dark green), 0.75:1 (gray), 1:1 (brown), and 2:1
(red) mixtures of unlabeled apo GRX3(GrxA/B) and 15N-labeled apo
BOLA2. The inset also shows the δav changes measured for the L50
(black squares), Q51 (red circles), V56 (green up triangles), and N57
(blue down triangles) residues of BOLA2 as a function of apo
GRX3(GrxA/B) concentration. Solid lines show the fitting curves.
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GRX3−BOLA2 interactions. Overall, the spectroscopic and gel
filtration data indicate: (i) a complete conversion of the
homodimeric [2Fe-2S]2 GRX32 into a GRX3-BOLA22
heterotrimeric complex that contains [2Fe-2S]2+ cluster(s);
and (ii) similarly to what we found for the apo/apo
heterotrimeric complex, the GrxA and GrxB domains of
GRX3 interact with two BOLA2 molecules, while Trx domain
is not involved in such interaction.
Two possible scenarios can occur at the 1:4 [2Fe-2S]2
GRX32-BOLA2 ratio, i.e., the formation of a heterotrimeric
GRX3-BOLA22 complex containing two [2Fe-2S]
2+ clusters
together with the formation of a heterotrimeric apo GRX3-apo
BOLA22 complex, or the formation of two heterotrimeric
Figure 4. Mapping the interaction surfaces between BOLA2 and each GrxA and GrxB domain in the apo heterotrimeric complex. The left panels
show backbone weighted average chemical shift differences δav for BOLA2 residues, observed upon addition of unlabeled apo GRX3(GrxA/B) to
15N-labeled apo BOLA2 up to a 2:1 BOLA2-GRX3(GrxA/B) ratio (A) and for GRX3(GrxA/B) residues observed upon addition of 2 equiv of
unlabeled apo BOLA2 to 15N-labeled apo GRX3(GrxA/B) (B). A threshold of 0.15 ppm (mean value of δav plus 1σ, black dashed line) for BOLA2
and of 0.10 ppm for GRX3(GrxA/B) were used to identify significant chemical shift differences. Cyan bars identify residues whose backbone NHs
broaden beyond detection upon complex formation. The δav value for Pro residues was arbitrarily set to zero. The right panels show backbone NHs
experiencing significant chemical shift differences in the 1H−15N HSQC spectra upon the formation of the heterotrimeric apo GRX3(GrxA/B)-
BOLA22 complex mapped as blue and cyan spheres on a structural model of apo BOLA2 (A) and on the crystal structure of GrxA (PDB ID 3ZYW)
and GrxB (PDB ID 2YAN) domains of apo GRX3 (B). Blue spheres identify NHs showing significant chemical shift variations, and cyan spheres
identify backbone NHs broaden beyond detection. Side-chains of His, Cys, and Pro residues are in green, yellow and red, respectively.
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GRX3-BOLA22 complexes each containing only one [2Fe-
2S]2+ cluster. The two scenarios result from two possible
occurring molecular mechanisms, A and B shown in Scheme 1.
The key experimental evidence, that would allow us to
provide information on whether a favorite mechanism between
A and B is operative, is the detection of the formation of the
apo free GRX3 form, which is observed indeed in the A
mechanism only (Scheme 1). Analytical gel filtration was
therefore performed on [2Fe-2S]2 GRX32-apo BOLA2 protein
mixtures at different protein:protein ratios, using a Superdex 75
HR 10/30 column to investigate the possible presence of free
apo GRX3. These gel filtration analysis showed: (i) the
presence of a main peak with an apparent molecular mass
which increases from 68.0 to 73.2 kDa upon addition of apo
BOLA2; (ii) the presence, only for [2Fe-2S]2 GRX32-apo
BOLA2 ratios >1:4, of a peak with the apparent molecular mass
similar to that of apo BOLA2; and (iii) no formation of a peak
with the apparent molecular mass of apo GRX3 at any
investigated protein:protein ratio (Figure 6A).
The analytical gel filtration chromatography was also
performed at higher resolution with a Superdex 200 10/300
increase column on protein mixtures at substoichiometric [2Fe-
2S]2 GRX32-apo BOLA2 ratios of 1:0.25, 1:0.5, and 1:1 (Figure
6B). It was observed the concurrent formation of (i) the 1:1
heterodimeric complex, corresponding to the peak with an
apparent molecular mass of 71.3 kDa, which is indeed very
close to the sum of the apparent molecular masses of one
molecule of apo BOLA2 and one molecule of apo GRX3 (i.e.,
70.4 kDa), and (ii) of the heterotrimeric complex, correspond-
ing to the peak with an apparent molecular mass of 87.4 kDa,
which is indeed close to the sum of the apparent molecular
masses of two apo BOLA2 molecules and one molecule of apo
GRX3 (i.e., 82.0 kDa). The peak of apo GRX3, which is always
present at a low percentage in the chemically reconstituted
[2Fe-2S]2 GRX32 sample, does not increase in its intensity
upon BOLA2 substoichiometric additions (Figure 6B), as
expected if the A mechanism was the favored process. From
these gel filtration data we therefore conclude that the B
mechanism is the preferential occurring process.
[2Fe-2S]2 GRX3-BOLA22 Complex Transfers [2Fe-2S]
2+
Clusters to apo Anamorsin. Cluster transfer from [2Fe-2S]2
GRX3-BOLA22 to apo anamorsin was followed by UV−vis, CD
Figure 5. Formation of the [2Fe-2S] GRX3-BOLA22 complex from the interaction between [2Fe-2S]2 GRX32 and apo BOLA2. (A) UV−vis and
(B) CD spectra of [2Fe-2S]2 GRX32 (black line), of the 1:4 [2Fe-2S]2 GRX32-apo BOLA2 mixture (blue line), and of chemically reconstituted [2Fe-
2S]2 GRX3-BOLA22 (green line). (C) Analytical gel filtration (Superdex 75 HR 10/30 column) chromatograms of BOLA2 (magenta) and GRX3
(cyan) proteins in their apo states, of [2Fe-2S]2 GRX32 complex (black), and of a 1:4 [2Fe-2S]2 GRX32-apo BOLA2 mixture (green). The apparent
molecular masses are reported at the top of each chromatographic peak. (D) In the upper panels, the overlay of 1H−15N HSQC spectral regions of
15N-labeled [2Fe-2S]2 GRX32 (black) and of 1:2 (red) and 1:4 (blue)
15N-labeled [2Fe-2S]2 GRX32/unlabeled apo BOLA2 mixtures. In the lower
panels, the overlay of 1H−15N HSQC spectral regions of 15N-labeled apo BOLA2 (black) and of 2:1 (red) and 4:1 (blue) 15N-labeled apo BOLA2-
unlabeled [2Fe-2S]2 GRX32 mixtures.
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spectroscopy, and analytical gel filtration. Once the chemically
reconstituted [2Fe-2S]2 GRX3-BOLA22 heterotrimeric com-
plex was titrated with apo anamorsin up to a 1:1 protein−
protein ratio, in the UV−vis and CD spectra the absorbance
peaks typical of [2Fe-2S]2 GRX3-BOLA22 disappeared and the
absorbance peaks typical of the [2Fe-2S]2+ cluster-bound form
of anamorsin ([2Fe-2S] anamorsin)29,33 appeared (Figure
7A,B). The CD spectrum of the final 1:1 mixture essentially
corresponds to that of [2Fe-2S] anamorsin, being clearly
distinguishable from that of [2Fe-2S]2 GRX3-BOLA22.
Analytical gel filtration chromatography performed with
Superdex 75 HR 10/30 column on the final 1:1 mixture
showed the presence of a main peak with an apparent
molecular mass of 128.2 kDa, which essentially corresponds
to the sum of the apparent molecular masses of [2Fe-2S]2
GRX3-BOLA22 (73.2 kDa) and apo anamorsin (52.0 kDa)
(Figure 7C). Overall, the data showed that (i) both [2Fe-2S]2+
cluster are completely transferred from [2Fe-2S]2 GRX3-
BOLA22 to apo anamorsin and (ii) the final product is a
complex formed by an apo GRX3 molecule, two apo BOLA2
molecules and a [2Fe-2S] anamorsin molecule (GRX3-
BOLA22-[2Fe-2S] anamorsin, hereafter).
Moreover, by gel filtrating a 1:1 mixture of apo GRX3(GrxA/
B)-BOLA22 and [2Fe-2S] anamorsin, a peak corresponding to
a ternary complex formed by GRX3(GrxA/B), BOLA2, and
anamorsin is not observed (Supporting Information Figure S4),
at variance to what detected in the 1:1 GRX3-BOLA22-[2Fe-
2S] anamorsin mixture, where the corresponding ternary
complex is formed (Figure 7C). This demonstrates that, in
the final GRX3-BOLA22-[2Fe-2S] anamorsin complex, the
interaction between apo GRX3−BOLA22 and [2Fe-2S]
anamorsin depends on the presence of the Trx domain of
GRX3. We had previously shown that the Trx domain of GRX3
interacts with the N-terminal domain of anamorsin mediating
the cluster transfer between the two proteins.24 Here we show
that the Trx domain, in addition of being essential for the
complex formation between anamorsin and GRX3-BOLA22 in
the GRX3-BOLA22-[2Fe-2S] anamorsin complex, maintains
the same conformational freedom as it has in the homodimeric
[2Fe-2S]2 GRX32 complex. Therefore, we propose that the
cluster transfer mechanism previously reported for [2Fe-2S]2
GRX32
24 is also operative in the [2Fe-2S]2 GRX3−BOLA22-
apo anamorsin interaction, i.e., the protein recognition,
specifically occurring between the N-terminal domains of the
two proteins, plays a role in the cluster transfer process.
■ DISCUSSION
BolA-like proteins have recently emerged as novel players in
iron metabolism, being involved, on the basis of genetic and
biochemical studies, in intracellular iron regulation pathways
and in the maturation of Fe/S cluster-containing proteins.3,17,34
Specifically, a role for the cytosolic S. cerevisiae BolA2 (usually
Scheme 1. Possible Solution Equilibria upon Reaction of
[2Fe-2S]2 GRX32 With apo BOLA2 up to a 1:4 Ratio
a
a(A) Two molecules of apo BOLA2 (in blue) interact with a [2Fe-
2S]2 GRX32 molecule (GRX3 molecules are in red) to form a
heterotrimeric GRX3-BOLA22 complex that binds two [2Fe-2S]
2+
clusters and an apo GRX3 molecule. The further addition of 2 equiv of
apo BOLA2 determines the formation of an apo heterotrimeric GRX3-
BOLA22 complex. (B) Two distinct heterodimeric GRX3-BOLA2
complexes, containing one [2Fe-2S]2+ cluster each, are first formed.
Then, the further addition of 2 equiv of apo BOLA2 determines the
formation of two distinct heterotrimeric GRX3-BOLA22 complexes
still containing one [2Fe-2S]2+ cluster each.
Figure 6. The formation of apo GRX3 is not observed upon the interaction of [2Fe-2S]2 GRX32 with apo BOLA2. Analytical gel filtration
chromatograms of (A) BOLA2 (black) and GRX3 (red) proteins in their apo states, of [2Fe-2S]2 GRX32 (blue) and of a 1:2 (cyan), 1:4 (magenta),
1:6 (green) [2Fe-2S]2 GRX32-apo BOLA2 mixtures (Superdex 75 HR 10/30 column), and of (B) BOLA2 (black) and GRX3 (red) proteins in their
apo states, of [2Fe-2S]2 GRX32 (blue) and of a 1:0.25 (orange), 1:0.5 (light gray), 1:1 (light magenta) [2Fe-2S]2 GRX32-apo BOLA2 mixtures
(Superdex 200 10/300 increase column). The apparent molecular masses are reported at the top of each chromatographic peak.
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named Fra2) in iron regulation14,16,35 and for the mitochondrial
human BOLA3 in the production of the lipoate-containing 2-
oxoacid dehydrogenases and in the assembly of the respiratory
chain complexes36 has been established. However, there are no
studies exploring analogous functions for BolA homologues in
S. cerevisiae and humans. In particular, since the Fra2-
dependent, iron signaling pathway described in S. cerevisiae is
not conserved in humans,27 a homologous regulatory function
of BOLA2 in human cells can be excluded.
In this work we have investigated by in vitro studies the role
of the GRX3−BOLA2 interaction in cytoplasmic Fe/S protein
biogenesis, i.e., in the CIA pathway, being inspired (i) by the
general accepted view that BOLA2 protein is involved in
human iron metabolism once interacting with its protein
partner GRX3;17,37 (ii) by knowing that human BOLA2 forms
in vitro a [2Fe-2S]-bridged hetero complex with each
monothiol Grx domain of GRX3;21 and (iii) by our recent
finding that the holo form of GRX3 is capable to mature the
cytosolic Fe/S protein anamorsin, thus proposing GRX3 as a
component of the CIA machinery.24
Our data showed that apo BOLA2 and the Grx domains of
apo GRX3 significantly and specifically interact forming an apo
heterotrimeric complex composed by a GRX3 molecule and
two BOLA2 molecules. This complex is able to bind two [2Fe-
2S]2+ clusters upon chemical reconstitution. The same cluster
content was achieved in the heterotrimeric complex obtained
by co-expressing in E. coli cells human BOLA2 and a construct
of GRX3 containing only the two Grx domains.21 A
heterotrimeric GRX3-BOLA22 complex was also obtained by
mixing in vitro [2Fe-2S]2 GRX32 with apo BOLA2. However, in
this case the formed heterotrimeric GRX3-BOLA22 complex
contains only one [2Fe-2S]2+ cluster per complex. These data
indicate that a heterotrimeric GRX3-BOLA22 complex
containing two [2Fe-2S]2+ clusters can be formed in one-step
process only by inserting two [2Fe-2S]2+ clusters in an apo
heterotrimeric GRX3-BOLA22 complex. Therefore, it is
reasonable to suggest that the apo heterotrimeric GRX3-
BOLA22 complex, similarly to apo GRX3 alone,
24 might be a
physiologically relevant species that receives two [2Fe-2S]2+
clusters in the cytoplasm from a still unknown protein partner.
Figure 7. [2Fe-2S]2 GRX3-BOLA22 transfers its clusters to apo anamorsin upon complex formation. (A) UV−vis spectra of [2Fe-2S]2 GRX3-
BOLA22 (black line) titrated with 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8 equiv of apo anamorsin (black dashed lines). The arrow indicates the direction of the
change in intensity and wavelength of the absorbance peaks with the increase of apo anamorsin concentration. The UV−vis spectra of the final 1:1
protein mixture and of [2Fe-2S] anamorsin are shown as red and green lines, respectively. (B) CD spectra acquired to follow cluster transfer from
[2Fe-2S]2 GRX3-BOLA22 to apo anamorsin. Black line: chemically reconstituted [2Fe-2S]2 GRX3-BOLA22; green line: [2Fe-2S] anamorsin; red
line: 1:1 mixture of [2Fe-2S]2 GRX3-BOLA22 and apo anamorsin. (C) Analytical gel filtration (75 HR 10/30 column) chromatograms of BOLA2
(magenta) and anamorsin (blue) proteins in their apo states, of [2Fe-2S]2 GRX3-BOLA22 (black), and of a 1:1 mixture between [2Fe-2S]2 GRX3-
BOLA22 and apo anamorsin (red). The apparent molecular masses are reported at the top of each chromatographic peak.
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In support of this, our data showed that, similarly to what
observed for the holo homodimeric form of GRX3 containing
two [2Fe-2S]2+ clusters,24 the heterotrimeric complex contain-
ing two [2Fe-2S]2+ clusters matures the CIA machinery
component anamorsin by transferring both clusters to the
CIAPIN1 domain of apo anamorsin to generate [2Fe-2S]
anamorsin. Both complexes, i.e., the homodimeric GRX3 and
the heterotrimeric GRX3-BOLA22 complexes containing two
[2Fe-2S]2+ clusters, can thus be active players, at the cellular
level, for maturing anamorsin. The present data also suggest
that the mechanism of cluster transfer relying on the interaction
between the N-terminal domains of anamorsin and GRX324 is
common to both cluster transfer processes, i.e., from [2Fe-2S]2
GRX32 to apo anamorsin and from [2Fe-2S]2 GRX3-BOLA22
to apo anamorsin.
Now, the arising question is whether and how the cells can
select the homodimeric [2Fe-2S]2 GRX32 vs the heterotrimeric
[2Fe-2S]2 GRX3-BOLA22 complex to mature anamorsin.
Assuming that the interaction between apo BOLA2 and apo
GRX3 is physiologically relevant, the relative cellular levels of
GRX3 and BOLA2, which can be regulated by cellular
conditions (i.e., aerobic vs anaerobic cellular growth, oxidative
stress, etc.), should select which of the two complexes mature
anamorsin. The sensitivity of Fe/S protein biogenesis pathways
toward oxygen and/or oxidative stress has been observed for
members of both bacterial and eukaryotic Fe/S cluster
assembly machineries.38−42 Recently, two new CIA yeast
proteins were found to be specifically involved in the
maturation of the ribosome-associated ABC protein Rli1, and
this function is fundamental under oxidative stress cellular
conditions, as in the absence of oxygen these factors can be
overcome to some extent without losing cell viability.43 It might
be possible therefore that the homodimeric [2Fe-2S]2 GRX32
complex is operative in normal cellular conditions, while the
heterotrimeric [2Fe-2S]2 GRX3-BOLA22 complex works under
oxidative stress. Consistently with this possible model, bacterial
BolA proteins have been observed to be specifically required
under aerobic and oxidative stress conditions. For instance, in
E. coli BolA protein is upregulated under oxidative stress
conditions,44 and in bacterial operons, BolA tends to occur not
only with a monothiol glutaredoxin, but also with proteins
involved in defense against oxidative stress.45 Also in eukaryotic
genomes, the presence of BOLAs strongly correlates with an
aerobic metabolism.46 Last but not least, [2Fe-2S]2 GRX3-
BOLA22 complex is stable in air, while the homodimeric [2Fe-
2S]2 GRX32 is oxidatively labile and is gradually degraded in air
over a period of ∼1 h.21 Thus, BOLA2 binding to GRX3
stabilizes [2Fe-2S]2+ clusters against oxidative degradation,
similarly to what was observed in the yeast [2Fe-2S]2+ Fra2-
Grx3/4 complexes.11
■ CONCLUSION
In conclusion, we propose that the GRX3−BOLA2 interaction
might have a role in the CIA pathway. GRX3 and BOLA2 form
indeed an apo complex composed by two molecules of BOLA2
bound to a molecule of GRX3. This species, upon binding two
[2Fe-2S]2+ clusters, is able to transfer both of them to
anamorsin, thus maturing it in one-step process, similarly to
what we already showed for the holo homodimeric GRX3
form.24 The [2Fe-2S]2+ cluster bound forms of GRX3 and
GRX3-BOLA22 might thus act as [2Fe-2S]
2+ cluster transfer
components in the cytosol, in a similar way as monothiol
glutaredoxins do in mitochondria.7,19,47,48
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Figure S1. 15N backbone amide relaxation parameters of apo BOLA2. 15N R1, R2, and 15N{1H} 
NOE values versus residue number of apo BOLA2 obtained at 600 MHz and 298 K. Missing bars 
indicate Pro residues and the not observable backbone NHs of Met 1, Glu 2, Leu 49. 
S3 
Figure S2. Apo GRX3 interacts with apo BOLA2 as the apo GRX3(GrxA/B) construct does. 
Overlay of 1H‐15N HSQC spectra of a 1:2 mixture between 15N labeled apo GRX3 and unlabelled 
apo BOLA2 (black), of a 1:2 mixture between 15N labeled apo GRX3(GrxA/B) and unlabelled apo 
BOLA2 (red), and of 15N labeled Trx domain of GRX3 (green). 
S4 
Figure S3. EPR spectra monitoring cluster properties upon GRX3 and BOLA2 interaction. 
EPR spectra at 45 K obtained mixing [2Fe-2S]2 GRX32 and apo BOLA2 in a 1:4 ratio (black) and 
chemically reconstituting the heterotrimeric apo GRX3/BOLA22 complex (red), after anaerobic 
reduction with stoichiometric sodium dithionite and rapid freezing in 50 mM phosphate, 5 mM 
GSH, 5 mM DTT buffer at pH 7, 10% glycerol. The g-values are indicated. 
S5 
Figure S4. The Trx domain of GRX3 is essential for complex formation between GRX3-
BOLA22 and anamorsin. Analytical gel filtration (Superdex 200 10/300 increase column) 
chromatograms of apo BOLA2 (red) and [2Fe-2S] anamorsin (green), of apo GRX3(GrxA/B) 
(black) and of a 1:1 mixture between apo GRX3(GrxA/B)-BOLA22 and [2Fe-2S] anamorsin (blue). 
The apparent molecular masses are reported at the top of each chromatographic peak.  
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5.4. Lipoyl Sinthase (LIAS) 
The gene, optimized for the E. coli expression, were inserted in a pENTR 
like vector for the recombination reaction in different expression vectors 
using the gateway® technology. We selected these vectors: 
 pDest His-MBP 
 pDest 14 
 pDest 17 
 pETG 20A 
 pETG 30A 
 pTH34 
 pCold 12-Hit tag. 
After the recombination reaction, different E. coli strains and different 
temperatures were screened for check the expression levels. I performed the 
expression test combining all the plasmid in three E. coli strains (BL21 
(DE3), BL21 (DE3) Rosetta Plyss, BL21 (DE3)RIPL codon+) at three 
temperature after induction; 17°C, 25°C and 37°C (Fig.45). After the 
expression tests, the best condition was selected for the protein purification 
protocol set-up. The protein was purified in anaerobic condition and I obtain 
the protein in the holo form binding two [4Fe-4S] clusters. 
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Figure 45. SDS-PAGE gel of the expression test of the different conditions for 
LIAS 
Before continue with the characterization, we need to know the exact 
molecular weight to confirm the presence of our protein. A MALDI spectrum 
was acquired providing the exact mass of the LIAS (Fig.46)  
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Figure 46. MALDI spectra of the LIAS as purified from cells. 
 
Analytical gel filtration analysis was then performed to evaluate the 
aggregations state of the protein. By performing a calibration curve with 
MW standards ranging from 6000 Da to 66000 Da, LIAS runs (Fig.47) with 
an apparent molecular mass of 41.3 kDa, which nicely matches with the 
theoretical mass of a monomeric protein , i.e. 39 kDa.  
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Figure 47. Analytical gel filtration of LIAS  
 
For the spectroscopic characterization of holo-LIAS, Uv-Vis and CD spectra 
were acquired.  Uv-Vis spectrum showed the presence of a characteristic 
band of a [4Fe-4S] cluster at about 410 nm (Fig.48). 
 
Figure 48. Uv visible spectra of holo LIAS 
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The far-UV (ultraviolet) CD spectrum of holo LIAS showed a characteristic 
peak at 209 nm and 225 nm characteristic of a majority composition of α 
helices as secondary structure elements (Fig.49). 
 
 
Figure 49. CD spectra in the Uv region 
 
We are now working on the characterization of the metal center via 
paramagnetic NMR following the chemical shifts of the Hβ of the cysteine 
ligands. A mono dimensional paramagnetic NMR spectrum with short 
acquisition time for observe these paramagnetic peaks was acquired 
andtemperature temperature dependence of the detected proton signals has 
been performed to understand the magnetic behavior of this system. As we 
can see in Fig.50, we observed chemical shift of the peak at 18.2 ppm (at 298 
K) to 17.5 ppm (at 286K). This high field shift is compatible with an anti-
curie behavior, where the paramagnetism derived from the excited state.  
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This trend is compatible with the presence of an oxidized  [4Fe-4S]2+ cluster 
with 𝑆 = 0. 
 
Figure 50. Chemical shift variation of a para-NMR peak of [4Fe-4S]2+ LIAS 
 
We followed the same peak for monitoring the stability of the [4Fe-4S]2+ 
cluster under thermal denaturation process. We acquire the same set of 
experiments upon increasing the temperature to follow the degradation of the 
coordination sphere of this cluster of LIAS (Fig.51).  
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Figure 51. Intensity and chemical shift variation of LIAS after thermal sfolding. 
 
We can see that the cluster is stable until 317 K (43.85 °C); after this 
temperature, we saw a loss of intensity of the peak. Also, raising the 
temperature, the signal continues to show an anti-curie behavior typical of a 
[4Fe-4S]2+ with 𝑆 = 0. 
Further studies on LIAS and on the two metal binding sites mutants, now 
under investigation, will allow us to obtain more information on the cluster 
binding sites to better understand the relationship between structure and 
function.  
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6.1. Conclusion and future prospective 
 
Iron sulfur cluster cofactors play a central role in a lot of a cellular processes, 
from cellular respiration to DNA maintenance. Because of their importance 
the processes that lead to the biogenesis of these cofactors are conserved in 
all living organisms and strongly regulated to avoid anomalies. The list of 
diseases attributable to defects in (Fe-S) protein biogenesis is growing. 
Mutations or malfunctions in the proteins responsible of the maturation 
processes  of (Fe-S) proteins cause severe disease and mortality in early 
infancy, and there is no evidence of significant tissue specificity.  
During the three years of my PhD program, I focused my attention on the 
expression, purification and characterization of cytosolic human proteins that 
have been implicated in iron metabolism but whose functions, at the 
beginning of my PhD, were still not clearly defined. I characterized these 
proteins at a structural and biochemical level, as well as investigated their 
interactions with protein partners. The results obtained by these studies 
contribute to define the cytosolic Fe-S protein maturation pathways at atomic 
resolution. Specifically, I showed that the cytosolic monothiol glutaredoxin 
in its holo form, i.e. [2Fe-2S]2-GRX32, can interact with the apo form of 
anamorsin forming a stable heterodimeric 1:1 complex via a specific 
recognition occurring between the N-terminal domains of the two proteins. 
Upon protein-protein interaction, the two[2Fe-2S] clusters bound to GRX3 
are transferred from the GRX3 to anamorsin in a specific manner. This study 
allows to propose for the first time that GRX3 is a component of the CIA 
machinery since it is involved in the maturation pathway of anamorsin, 
which, in turn, responsible of the maturation of all cytosolic [4Fe-4S] 
proteins. Following this research line, the interaction between GRX3 and 
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another cytosolic protein, which is a protein partner of GRX3 (human 
BOLA2), but whose function was still undefined, was characterized. The 
protein was recombinantly produced and then its interaction with both apo 
and holo forms of GRX3 investigated. From this studies it emerges that a 
stable heterotrimer is formed between a GRX3 molecule and two BOLA2 
with two [2Fe-2S] clusters shared by each of the two monothiol glutaredoxin 
domains of GRX3 and BOLA2. Since BOLA2 is not interact with the N-
terminal domain of GRX3, this heterotrimer is still able to interact with the 
apo form of anamorsin upon N-terminal domains recognition and transferred 
the two clusters to anamorsin. 
The study of these (Fe-S) proteins give us the possibility also to improve 
paramagnetic NMR-based tools aimed at characterizing (Fe-S) clusters. The 
latter represent the most challenging situation for NMR signal detection and 
resonance assignment of the residues close to the cluster, as a consequence of 
large contributions to relaxation and small contributions to chemical shift of 
this paramagnetic center. Thus, to detect NMR signals of residues in the 
proximity of the metal center, we developed a modified version of the 1H-
¹⁵N-HSQC experiment where (1) an inversion recovery filter is added prior 
to HSQC, (2) the INEPT period has been optimized according to fast 
relaxation of interested spins, (3) the inverse INEPT has been eliminated and 
signals acquired as antiphase doublets. by applying this sequence to 
anamorsin, we were able to recover and assign thirteen HN resonances, 
unobserved with conventional HSQC experiments. This NMR experiment, 
named IR- 15N HSQC-AP, selectively identifies HN groups from the 
environment of the paramagnetic center that experience significant 
paramagnetic relaxation and almost negligible contributions to chemical 
shift, and it is therefore  a valuable tool for those systems in which no 
pseudocontact shift occurs, such as Cu2+ proteins and (Fe-S) proteins. 
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In the last year of the PhD program, I focused my attention to the human 
LIAS protein, a crucial enzyme in the matrix of mitochondria that catalyzes 
the maturation of the lipoyl cofactor. Considering that several mutations of 
the LIAS gene are involved in severe pathologies, we decided to express and 
purify this protein. An optimized expression protocol for the wild-type LIAS 
protein and for two mutants able to “switch off” one or the other of the two 
[4Fe-4S] clusters bound to the wild-type protein are now concluded. We are 
performing crystal screenings for the structural studies, and we characterized 
the metal center by Uv-vis, CD and EPR spectroscopies. On this system we 
are also investigating the metal [4Fe-4S] centers via paramagnetic NMR for 
obtaining structural information provided by the chemical shifts and the 
relaxation times of the paramagnetic signals.  
The (Fe-S) protein biogenesis pathways involve several proteins and 
processes that still need to be characterized. Bioinformatics studies on the 
genomes suggest several new proteins that can be add to the list of all the 
proteins involved in these pathways in both mitochondria and cytosol.     
We need to go ahead with the structural characterization of LIAS to obtain 
more information about the two metal site. Indeed, the structure of this 
protein will be an important goal due its crucial role in humans and its close 
relationship with human diseases. The importance of LIAS also relies on the 
possibility of studying the interaction of LIAS with the mitochondrial protein 
NFU1, a member of the ISC assembly machinery which is already available 
in our lab. This studies will provide information on the maturation process of 
LIAS and on the role of NFU1 in the ISC assembly machinery as this is still 
not clearly defined.  
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Finally, going back to the cytosol, we need to study the tetramer formed by 
Nubp1-Nubp2 to better understand: 
1. The structure of the tetramer, since no data are available. 
2. Whether the holo form of GRX3 can provide its clusters to assemble 
the scaffold [4Fe-4S] cluster on the tetramer 
3.  The role of the electron transfer process driven by anamorsin/Ndor1 
in the formation of the scaffold [4Fe-4S] cluster bound to the 
tetramer. 
 
 
 
